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ABSTRACT 
The main types of hypergolic propellants used at Kennedy Space Center (KSC) are hydrazine 
(HZ) and monomethylhydrazine (MMH). HZ and MMH are classified as hazardous materials 
and they are also known to be potentially carcinogenic to humans; therefore, handling these 
substances and their waste is strictly regulated. The wastes streams from HZ and MMH have 
been estimated to be the main hazardous wastes streams at KSC. Currently at KSC these wastes 
are first neutralized using citric acid and then they are transported on public roads for 
incineration as hazardous materials. A new method using alpha ketoglutaric acid (AKGA) was 
proposed to treat HZ and MMH wastes. From the reaction of AKGA with HZ and MMH two 
stable products are formed, 1,4,5,6-tetrahydro-6-oxo-3-pyridazinecarboxylic acid (PCA) and l-
methyl-1,4,5,6-tetrahydro-6-oxo-3-pyridazinecarboxylic acid (mPCA), respectively. 
The cost of purchasing AKGA is greater than the cost of purchasing citric acid; thus, AKGA can 
only become a cost effective alternative for the treatment of HZ and MMH wastes if the products 
of the reactions (PCA and mPCA) can be safely disposed of into the sewage system without 
affecting the treatment efficiency and effluent quality of the wastewater treatment plant 
(WWTP). In this research mPCA and PCA were analyzed for acute toxicity using fish and 
crustaceans as well as their effect on the wastewater treatment efficiency and viability using AS 
microbes, and their biodegradability by AS organisms. Acute toxicity on fish and crustaceans 
was investigated according to the methods for acute toxicity by USEPA (USEPA Method EPA-
821-R-02-012) using Ceriodaphnia dubia (96 hours) and Pimephales promelas (96 hours) as the 
test organisms. The effect of mPCA and PCA in the treatment efficiency and viability were 
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estimated from respiration inhibition tests (USEPA Method OCSPP 850.3300) and heterotrophic 
plate counts (HPCs). Lastly, the biodegradability of mPCA and PCA was assessed using the 
Closed Bottle Test (USEPA Method OPPTS 835.3110). For mPCA, the 96 hours LC50 for C. 
dubia was estimated at 0.77 ± 0.06 g/L (with a 95% confidence level) and the NOEC was 
estimated at 0.5 g/L. For P. promelas, the LC50 was above 1.5 g/L but it was noticed that mPCA 
had an effect on their behavior. Abnormal behavior observed included loss of equilibrium and 
curved spine. The NOEC on the fish was estimated at 0.75 g/L. PCA did not exhibit a significant 
mortality on fish or crustaceans. The LC50 of PCA in P. promelas and C. dubia was > 1.5 g/L 
and the NOEC was 1.5 g/L for both organisms. An Inhibitory effect on the heterotrophic 
respiration of activated sludge organisms was not observed after exposing them for 180-min to 
PCA and mPCA at concentrations of up to 1.5 g/L compared to the blank controls. Overall the 
impact of PCA and mPCA on total respiration rates was small, and only observed at 1,500 mg/L 
if at all. The difference was apparently caused by inhibition of nitrification rather than 
heterotrophic inhibition. However due to the variability observed in the measurements of the 
replicates, it is not possible to firmly conclude that PCA or mPCA at 1,500 mg/L was inhibitory 
to nitrification. 
 Based on the results from the HPCs, mPCA and PCA did not affect the viability of heterotrophic 
organisms at 750 mg/L. In the BOD-like closed bottle test using a diluted activated sludge mixed 
liquor sample, the AS microorganisms were capable of biodegrading up to 67% of a 2 mg/L 
concentration of PCA (with respect to its theoretical oxygen demand, or ThOD) in 28 days. No 
biodegradation was observed in the samples containing 2 and 5 mg/L of mPCA after 28 days of 
incubation using a diluted activated sludge mixed liquor sample as inoculum. 
iv 
The results of this study show that mPCA is more toxic than PCA to Ceriodaphnia dubia and 
Pimephales promelas.  However neither mPCA nor PCA had an effect on the heterotrophic 
respiration of an AS mixed liquor sample at 1.5 g/L and there was probably no significant 
inhibition of the nitrification respiration. Samples of PCA and mPCA at 2 and 5 mg/L could not 
be completely degraded (with respect to their total theoretical oxygen demand) by dilute AS 
biomass during a 28 day incubation period. mPCA did not show significant degradation in the 
two different biodegradation tests performed. 
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1. INTRODUCTION 
Hypergolic propellants are fuels that ignite when they come in contact with a strong oxidizer 
such as nitrogen tetroxide, hydrogen peroxide, and fluorine. At Kennedy Space Center (KSC) 
hydrazine (HZ) and monomethylhydrazine (MMH) are the two main types of hypergolic fuels 
used and at a smaller scale unsymmetrical di-methylhydrazine (UDMH) is used. Wastes streams 
containing HZ and MMH have been estimated to be the main hazardous wastes streams 
produced at KSC (DeVor, et al., 2010). These wastes are currently neutralized using citric acid. 
Citric acid immobilizes the hydrazine and MMH molecules creating a chemical complex but it 
does not react permanently with these molecules. This complex prevents off-gassing of toxic 
vapors and maintains the fuel molecules in solution. This reaction is reversible and the treated 
solution has to be maintained within a certain pH range. The wastewater is stored on site and 
then it is shipped and transported on public roads for disposal by incineration. Transportation of 
these wastes on public roads poses environmental and public risks due to the possibility of 
accidental spills combined to the toxicity of these hypergolic fuels wastes. HZ and MMH are 
considered probable human carcinogens (USEPA, 1999, HSDB, 1993) and are classified as 
hazardous substances. 
A new approach for hydrazine remediation was patented by New Mexico Highlands University 
(NMHU) (U.S. Patent #7,074,959, 2006). According to the patent, AKGA (alpha ketoglutaric 
acid or 2-ketoglutaric acid) reacts with HZ to form 1,4,5,6-tetrahydro-6-oxo-3-
pyridazinecarboxylic acid (PCA) and from the reaction with MMH it forms 1-methyl-1,4,5,6-
tetrahydro-6-oxo-3-pyridazinecarboxylic acid (mPCA). These two compounds are stable 
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products that are formed almost instantaneously. The possibility of treating hypergolic fuel 
wastes of HZ and MMH with AKGA represents an opportunity to improve safety and reduce the 
risks of the workers who handle the hydrazine wastes. 
The cost of purchasing AKGA is greater than the cost of purchasing citric acid; thus, AKGA can 
only become a cost effective alternative for the treatment of HZ and MMH wastes if the products 
of the reactions (PCA and mPCA) can be safely disposed of into the sewage system without 
affecting the efficiency of the wastewater treatment plant (WWTP). The Cape Canaveral WWTP 
does not presently discharge any effluent to receiving water bodies but, it may be necessary in 
the future so the impact on aquatic organisms also needs to be known. Discharging this waste 
stream into the sewage system for treatment at the local WWTP, would eliminate the costs 
involved in handling the wastes as hazardous substances at KSC. Currently, there is limited 
information on the toxicity and biodegradability of PCA and mPCA. Complete characterization 
of the products of the reactions will be required to determine the environmental and wastewater 
treatment plant impacts related to the discharge of PCA and mPCA into the sewage system. 
Permitting approval will be required for PCA and mPCA disposal by NASA and the Florida 
Department of Environmental Protection (FDEP). 
The main objectives of this study are to identify the toxic concentrations at which mPCA and 
PCA exert a negative effect on the wastewater treatment efficiency and downstream surface 
waters as well as to determine if PCA and mPCA can be biodegraded by a sample of activated 
sludge microorganisms collected from Cape Canaveral Air Force Station Waste Water Treatment 
Plant. The effect of these chemicals on downstream surface water organism was evaluated by 
conducting aquatic toxicity testing using two freshwater species, Fathead minnows (fish), and 
2 
Ceriodaphnia dubia (crustacean). The effect of mPCA and PCA on the wastewater treatment 
efficiency was evaluated by performing respiration inhibition test using activated sludge 
organisms. Using mPCA or PCA as the sole carbon source in a sample of activated sludge 
bacteria, the biodegradation of these compounds was analyzed by a closed bottle test similar to 
the BOD test for both compounds.  
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2. LITERATURE REVIEW 
Overview of Hypergolic Propellants 
Propellants are chemicals used to produce thrust and propel rocket engines. Spontaneously 
ignitable propellants are also named hypergolic propellants. This type of propellants does not 
require an ignition system. In this case the burning is initiated when the oxidizer and the fuel 
come in contact with each other. An advantage of this ignition system is that it has a small 
ignition time delay which reduces the potential explosion hazard during starting. Liquid 
propellants include: oxidizers, fuels, chemical compounds or mixtures of oxidizers and fuel 
ingredients which are capable of self-decomposition. A rocket unit that contains two separated 
liquid propellants, an oxidizer and a fuel, is called bipropellant. Examples of commonly used 
oxidizers include nitrogen tetroxide, fuming nitric acid, hydrogen peroxide, and fluorine and 
hypergolic fuels include hydrazine (HZ) and its derivatives such as monomethylhydrazine 
(MMH), unsymmetrical di-methylhydrazine (UDMH), and Aerozine 50 (A-50), which is a 
mixture of HZ and UDMH. Monopropellants are single substances that contain an oxidizing 
agent and combustible matter. They can be a mixture of different compounds or a homogenous 
material such as hydrogen peroxide or hydrazine (Sutton, et al., 2001). Hydrazine (N2H4) and 
monomethylhydrazine (N2H3(CH3)) have been used extensively as propellants in rockets and 
spacecraft (Nufer, et al., 2009; Oropeza, 2011). They are used in the aerospace industry because 
they are storable and stable, they can withstand the extremes of hot and cold which are present in 
the vacuum of space, and they are relatively lightweight (Nufer, et al., 2009; Oropeza, 2011). 
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Other uses of hydrazine and its derivatives are in the pharmaceutical, fertilizer, and polymer 
industries 
Toxicity of Hydrazine and Monomethylhydrazine 
Hydrazine and monomethylhydrazine are considered to pose a hazard to human health. The 
National Institute of Safety and Health (NIOSH) consider MMH and HZ to be potential 
occupational carcinogens. The Occupational Safety and Health Administration (OSHA) issued 
the 8-hour total weight average (TWA) permissible exposure limit (PEL) as 1 ppm (1.3 mg/m3) 
for HZ and 0.2 ppm (0.35 mg/m3) for MMH. The 8-hour TWA represents the average exposure 
over an 8-hour period, the PEL concentration indicates the concentration of the substance that 
should not be exceeded. This limit represents the highest chemical concentration that an 
employee could be exposed to without incurring the risk of a negative health effect. Some short 
term health effects of getting in contact with MMH and HZ include diarrhea, vomiting, 
respiratory system irritation for MMH; eye, nose, throat irritation, dizziness, nausea, dermatitis, 
skin and eye burns for HZ. 
 Long term effects of HZ and MMH are not available on humans, but in animals the observed 
chronic effects of HZ include effects on the respiratory system, liver, and thyroid; MMH effects 
on animals include impairment of the kidneys and liver function, affect the blood and spleen, and 
convulsions (HSDB, 1993). 
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HZ and MMH Wastes at Kennedy Space Center 
Currently Kennedy Space Center (KSC) produces mainly HZ and MMH and small quantities of 
unsymmetrical dimethylhydrazine (UDMH) waste. The combined volume of waste for these 
hydrazines at KSC is 15,000 gallons per year. KSC presently neutralizes the hydrazine wastes 
using citric acid.  Adding citric acid to the hydrazine wastewater causes an entrapment of the 
hydrazine molecule to prevent off-gassing of toxic hydrazine vapors; the resultant solution is 
treated as a hazardous product and is disposed of by incineration. The reaction with citric acid is 
reversible and depends on the pH of the solution (Oropeza, 2011; Schmidt, 2001). 
A novel method of remediation of hydrazine-contaminated equipment and surfaces was patented 
by researchers at New Mexico Highlands University (NMHU) (Helvenston, 2006). The proposed 
method for HZ and MMH waste treatment consists of using alpha-keto glutaric acid (AKGA) 
which reacts with hydrazine to form the stable pyridazine product 1,4,5,6-tetrahydro-6-oxo-3-
pyridazinecarboxylic acid (PCA) and water. When this AKGA compound reacts with MMH it 
forms another stable pyridazine product 1-methyl-1,4,5,6-tetrahydro-6-oxo-3-
pyridazinecarboxylic acid (mPCA) and water. 
Figure 2-1 and Figure 2-2 show the reaction between AKGA with HZ and MMH to form PCA 
and mPCA respectively. 
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 Figure 2-1: Reaction between AKGA and HZ (Mast, et al., 2009) 
 
Figure 2-2: Reaction between AKGA and MMH (Mast, et al., 2009) 
Oropeza (2011) reported that the reactions between AKGA with HZ and MMH yield 47.4% 
mPCA, and 82.9 % PCA when using a 1:1 solution by mass and 63.9% mPCA, 106% PCA when 
using a 2:1 solution. Other formation yields for these reactions are found in the literature 
including 50% formation yield of PCA (Evans, et al. 1945), 88% and 56.5% formation yield of 
PCA and mPCA respectively (Kline, et al., 1961) when using a 1:1 ratio of AKGA to HZ/MMH.   
In order for AKGA to be an appropriate substitute to citric acid in hydrazine waste treatment, the 
by-products, PCA and mPCA, should be safe for disposal to the wastewater treatment plant. 
Current literature fails to address the toxicity and biodegradability of mPCA and limited 
information is available on PCA. According to LaRue and Child (1979), a species of 
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Pseudomonas isolated from a soil sample can use PCA as source of N and C for growth, 
indicating that this specific specie has the ability to degrade PCA by cleaving its N-N bond. 
Bacterial growth was maintained on a media containing a concentration of 5.0 g/L of PCA 
indicating that PCA at this concentration is nontoxic to this organism. 
NASA conducted toxicity tests on AKGA and HZ or MMH mixtures. Bioassay tests using the 
freshwater species Ceriodaphnia dubia (invertebrate), Cyprinella leedsi, (vertebrate) and the 
saltwater species Mysidopsis bahia (invertebrate) and Menidia beryllina (vertebrate) were used 
to test for acute toxicity of three simulated waste streams containing the following three 
compositions: 
1. 1M AKGA diluted to 0.002M with water and adjusting the pH to 8 using NaOH 
2. 1M AKGA + 1M HZ diluted to 0.002M with water and adjusting the pH to 8 using 
NaOH 
3. 1M AKGA + 1M MMH diluted to 0.002M with water and adjusting the pH to 8 using 
NaOH 
The toxicity of these solutions was found to be mild to not acute for all the species but C. dubia. 
Solution (3) caused 100% mortality on this organism when it was exposed to the 0.002 M 
solution. The Johnson Space Center (JSC) toxicology group recommended that all the solutions 
should be diluted to 0.001 M or 50 % of the 0.002 M solution for effluent disposal (Oropeza, 
2011). 
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Toxicity Testing 
Toxicity tests can be classified by their duration. Acute toxicity tests examine the effect of a 
toxicant in a relatively short period of time. In the case of fish and crustaceans acute toxicity tests 
usually last 24, 48 or 96 hours. Endpoints in acute toxicity test are usually the estimate of the 
concentration that is lethal to the 50% of the population (LC50) in a prescribed time period, or the 
highest concentration at which survival is not significantly different from the control (No-
observed-effect concentration, NOEC) (USEPA, 2002). Chronic toxicity tests last for a 
significant portion of the organism’s life expectancy. Chronic tests on fish and crustaceans 
usually measure the effect on survival, growth, and reproduction. Results are presented using 
values determined by hypothesis tests for parameters such as the NOEC, LOEC (Lowest-
observed-effect concentration), LC50, or EC50 (effect concentration). 
Aquatic Toxicity Test on Vertebrates and Invertebrates 
Bioassays like the one conducted by JSC are used to find the acute toxicity for fish and 
crustaceans and provide important information about the possible effect of a test substance if it is 
released into the environment. Acute toxicity tests are usually performed using multiple 
concentrations of a test substance (at least five) and a control. These types of tests can help 
identify the concentration of a test substance that is lethal to 50% of the organisms (LC50) and 
help find dose-response relationships. 
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Effects of Toxic Substances on Wastewater Treatment 
Before discharging a chemical compound into the sewage system, it is important to understand 
the effect that it might have on the wastewater treatment plant efficiency where this waste will 
end up. A brief discussion about the wastewater treatment process is presented next to better 
understand how toxic compounds can adversely affect the biological treatment of a wastewater 
treatment plant. 
Wastewater Treatment 
Wastewater is the liquid waste or water-carried waste produced after water has been used. It 
comes from different applications and sectors including residences, institutions, and commercial 
and industrial establishments. These wastewaters are collected and transported through a system 
of pipes (the collection system) to the wastewater treatment plant for treatment before being 
release into the environment (Bitton, 2005; Tchobanoglous et al., 2003). 
The wastewater treatment process can be divided into four different steps:  
Preliminary:  Removal of materials that could negatively impact the operation and 
maintenance of unit operations and processes found downstream. 
 Primary:  Removal of a portion of suspended materials from the wastewater. 
Secondary:  Removal of biodegradable organic matter and suspended solids, usually 
performed by microorganisms. 
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Tertiary: Removal of additional suspended solids. Disinfection is typically 
performed at this step. 
The secondary treatment stage is discussed in more detail since this part of the treatment process 
usually is carried out by microorganisms that could be adversely affected by toxic substances 
found in the wastewater. 
Activated Sludge 
Activated Sludge (AS) is a suspended-growth process that has been widely adopted around the 
world as a secondary treatment for domestic wastewaters (Wong, 1997). The main objectives of 
this system is the oxidation of the biodegradable organic matter from the wastewater (occurs in 
aeration tanks) and later the separation of the newly formed biomass from the treated effluent 
(clarifiers or settling tanks) (Bitton, 2005). Activated sludge flocs contain a wide diversity of 
prokaryotic and eukaryotic microorganisms. Bacteria, fungi, algae, protozoa, and rotifers are 
some of the microbes of interest. Bacteria are the microorganisms with the highest population in 
the wastewater treatment plant (Davis, 2010), and they are the organism who biodegrade the 
wastewater organics.  
Conventional Activated Sludge 
A conventional activated sludge system consists of an aeration tank where the aerobic oxidation 
of organic matter occurs. Enough aeration is provided to the aeration tank using a system of 
diffusers to keep the mixed liquor (i.e. the biomass) under suspension. The influent is mixed with 
Return Activated Sludge (RAS) from the subsequent settling tank forming the mixed liquor (i.e. 
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the biomass). A portion of the biomass in the clarifier is wasted or removed daily to maintain an 
adequate food to mass ration of microorganisms (F/M) and growth rate. This process is shown in 
Figure 2-3.  
 
Figure 2-3: Conventional Activated Sludge 
Modified Activated Sludge  
Conventional activated sludge systems can be modified to encourage nitrogen and phosphorous 
removal. These modified systems include the A2/O (anaerobic/anoxic/aerobic), Five Stage 
Bardenpho, UCT (University of Cape Town, South Africa), and VIP (Virginia Initiative 
Process), among others. 
As previously mentioned, the microbial population in activated sludge is a heterogeneous 
community where the growth rate is controlled via the waste activated sludge (WAS) removal 
rate. This characteristic allows the biological treatment process to be flexible, within certain 
limits, to accommodate changes in the flow, temperature, and wastewater composition, etc. 
Toxicants however, can affect the activity of the activated sludge organisms adversely. In such a 
case, the treatment efficiency will be negatively impacted with the potential of causing effluent 
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violations and environmental damage (Gutiérrez, et al., 2002). According to Bitton (2005), “the 
major effects of toxicants on activated sludge are reduced BOD and COD removal, reduced 
efficiency in solids separation, and modification of sludge compaction properties.” 
Aerobic bacteria depend on respiration for survival. Thus respiration inhibition is an important 
measure to assess the ecotoxicological risk of chemicals in water and wastewater (Gutiérrez, et 
al., 2002). Respirometry methods have been used extensively and several standardized test have 
been developed and used for several years (Ren, 2004). Some examples of these methods include 
the Organization for Economic Cooperation and Development method (OECD, 2010), the 
Environmental Protection Agency method (EPA, 2012), and the International Organization for 
Standardization method (ISO, 2007). Respirometry methods compared to other toxicity methods 
of wastewater such as Microtox® bioluminescence assay are more representative of the actual 
conditions of activated sludge bacterial communities (Gutiérrez, et al., 2002) making them more 
appropriate for assessing impacts on an AS treatment plant. 
Respirometric Methods  
The basis of the respirometric methods to determine inhibition on activated sludge is that after 
exposing the microorganisms to a toxic substance, its respiration rate can be affected. The 
toxicity can be estimated by calculating the specific oxygen uptake rate (SOUR) of an activated 
sludge sample exposed to a test substance and a readily biodegradable compound; then it is 
compared to the SOUR of the same activated sludge sample in the absence of the test substance.  
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These measurements are relatively easy to perform by measuring the decrease of dissolved 
oxygen in a test vessel containing the sludge sample for some minutes. There is a linear 
relationship between the amount of oxygen consumed versus time; the oxygen uptake rate 
(OUR) is quantified by determining the slope of the curve (HagMan et al., 2007). The total and 
heterotrophic respiration can be determined from SOUR measurements using an activated sludge 
sample in the presence and absence of a nitrification inhibitor. The oxygen consumption due to 
nitrification is further estimated by subtracting the heterotrophic respiration from the total 
respiration (OECD, 2010).  
Oxygen Consumption for Biodegradation Tests 
Oxygen consumption is also used to determine if a chemical compound can be degraded by 
activated sludge bacteria. Biodegradation tests using fresh activated sludge samples are similar to 
Biochemical Oxygen Demand (BOD) tests. These tests are a preliminary approach to understand 
the fate of chemicals during wastewater treatment. Usually biodegradation tests use the 
compound of interest as the sole substrate for microbial growth (Grady, 1990). Several 
standardized protocols have been developed using respirometric techniques by various national 
and international organizations such as OECD (1992) and USEPA (1998). If the chemical 
composition of a test substance is known or the chemical oxygen demand (COD) is determined, 
the percentage degradation can be found by measuring the oxygen consumed in a 28-day period 
using the closed bottle method. In this method, a solution of a test substance in mineral water is 
inoculated by a relatively small number of microorganisms from a mixed population and kept in 
completely full, closed BOD (or similar) bottles in the dark at constant temperature. The amount 
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of oxygen taken up by the microbial population during the biodegradation of the test substance, 
corrected for uptake by the blank inoculum bottle run in parallel, is expressed as a percentage of 
the theoretical oxygen demand or its COD (EPA, 1998). This percentage represents the percent 
biodegradation of the test substance 
Aerobic Decomposition 
The type of decomposition in the wastewater treatment process is determined by the electron 
acceptor available. Aerobic, anoxic and anaerobic paths for decomposition may be present in 
wastewater treatment. 
In aerobic decomposition oxygen must be present; it works as the electron acceptor of the 
oxidation reduction reaction. When oxygen is present it is almost the only terminal electron 
acceptor used. The end products of this reaction are mainly carbon dioxide and new cell mass. 
Since these products are no longer in the effluent water, the effluent can be safely discharged 
without affecting the environment. A significant amount of organic matter can be oxidized in AS 
processes.  
𝑂𝑟𝑔𝑎𝑛𝑖𝑐 𝑚𝑎𝑡𝑡𝑒𝑟 + 𝑂𝑥𝑦𝑔𝑒𝑛 → 𝐶𝑂2 + 𝑁𝑒𝑤 𝑐𝑒𝑙𝑙𝑠 𝑚𝑎𝑠𝑠 + 𝐸𝑛𝑒𝑟𝑔𝑦 Equation (2-1)  
Endogenous respiration occurs when the organic matter present in the wastewater has been used 
completely, then, cells begin to use their own cell tissue to obtain energy for cell maintenance 
(Davis, 2010). 
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𝐶𝑒𝑙𝑙𝑠 + 𝑂2 → 𝐶𝑂2 + 𝑁𝐻3 + 𝐸𝑛𝑒𝑟𝑔𝑦 Equation (2-2) 
Nitrification 
Nitrification is the main process for nitrogen removal in wastewater treatment. It is a two-step 
process carried out by autotrophic bacteria such as nitrifying bacteria which requires the 
presence of oxygen to oxidize ammonia to nitrate. First, ammonia is oxidized to nitrite by 
Nitrosomonas, and then nitrite is converted to nitrate by Nitrobacter. The following equations 
describe the nitrification process: 
1. 𝑁𝐻4
+ + 1.5 𝑂2 → 𝑁𝑂2− + 𝐻2𝑂 + 2𝐻+ 
2. 𝑁𝑂2
− + 0.5 𝑂2 → 𝑁𝑂3− Equation (2-3) Equation (2-4) 
Overall reaction 
3. 𝑁𝐻4
+ + 2.0 𝑂2 → 𝑁𝑂3− + 𝐻2𝑂 + 2𝐻+ Equation (2-5) 
The most toxic compounds to the nitrification process are cyanide, thiourea, phenol, anilines, and 
heavy metals such as silver, mercury, nickel, chromium, copper, and zinc (David, 2010). In the 
secondary stage of wastewater treatment, nitrification has an important role in the removal of 
substances that could impact the effluent quality. 
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Anoxic Decomposition 
In the absence of dissolved oxygen, some microorganisms can use nitrate (𝑁𝑂3−) as the terminal 
electron acceptor. The decomposition process through this path is called denitrification. The end 
products of this reaction are nitrogen gas, carbon dioxide, water and new cell mass. 
Denitrification is of great importance in wastewater treatment to reduce the amount of nitrogen 
discharged into receiving water bodies. 
𝑂𝑟𝑔𝑎𝑛𝑖𝑐 𝑀𝑎𝑡𝑡𝑒𝑟 + 𝑁𝑂3− → 𝐶𝑂2 + 𝑁2 + 𝑁𝑒𝑤 𝐶𝑒𝑙𝑙 𝑚𝑎𝑠𝑠 + 𝐸𝑛𝑒𝑟𝑔𝑦 Equation (2-6) 
Anaerobic Decomposition 
For anaerobic decomposition to occur, dissolved oxygen and nitrite should not be present. In this 
case, sulfate, carbon dioxide, and organic compounds that can be reduced are used as the electron 
acceptors. The major end products of these reactions include carbon dioxide, methane, water, 
sulfide and hydrogen. Anaerobic processes are usually used when treating concentrated wastes. It 
is not practical for dilute (e.g. domestic) wastewater (David, 2010). 
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3. MATERIALS AND METHODS 
Overview 
This chapter provides information about the methods, materials and procedures used in this 
study. It is divided in three major sections. The first section describes the method and procedure 
used in the toxicity test on fish and crustaceans. The second section describes the process used to 
quantify the respiration inhibition for activated sludge and the evaluation of microbial viability. 
The third section describes the method used for assessing the biodegradation of the substances of 
interest using microbes commonly found in wastewater. 
Testing Procedures 
Acute Toxicity on Fish and Crustaceans 
Four separated 96 hours static tests with renewal at 48-hours were conducted. In static renewal 
tests, the test organisms are exposed to a fresh solution of the test substance every 48 hours. The 
test organisms selected for this study are among those recommended by EPA for acute toxicity 
testing. The freshwater species Ceriodaphnia dubia method 2002.0, and Pimephales promelas 
(Fathead minnows) method 2000.0 are acceptable test species for this toxicity test since they are 
indigenous to the waters of Florida. Each organism was tested for acute toxicity for both PCA 
and mPCA. 
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The lethal concentration was determined when possible following the recommended statistical 
methods referenced in EPA Methods for Measuring the Acute Toxicity of Effluents and 
Receiving Waters to Freshwater and Marine Organisms, fifth edition 2002 (EPA-821-R-02-012). 
Procedure 
Moderately hard synthetic dilution water also called diluted mineral water (DMW) was prepared 
by mixing 4 L of Perrier ® water and 16 L of deionized water. The dilution water was aerated for 
24 hours before test initiation to stabilize the medium.  
Before test initiation all materials that came in contact with the dilution water were soaked at 
least 15 minutes in tap water, and scrubbed with detergent.  Then, they were rinsed three times 
with tap water and soaked overnight in 10 percent hydrochloric acid. On test day, the test 
materials were rinsed three times with deionized water and twice with dilution water afterwards. 
Each test chamber was labeled with a number representing a test concentration (1-6) followed by 
a letter representing the replicate name (A-D). A randomization chart was used to ensure all the 
chambers were randomly distributed around the lab (Appendix A). Test organisms were obtained 
from Marinco Bioassay Laboratory (MBL) located in Sarasota, Florida and delivered the same 
day of test initiation.   
Test Solution Preparation: PCA and mPCA  
The test species were exposed to test sample concentrations of 0.50, 0.75, 1.0, 1.25 and 1.50 g/L 
of PCA and mPCA for a 96-hours period. The different test concentrations were prepared 
separately diluting PCA and mPCA into dilution water using a stirring plate and magnetic bars. 
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Mortality due to pH may occur if the pH of the test substance does not fall within the 6.0 to 9.0 
pH range. Due to the low pH of the prepared samples, 1N sodium hydroxide was used to adjust 
the pH to 8.0±0.3 prior to introducing the test organism. The prepared solutions were also 
allowed to equalize with the ambient lab temperature before adding the test organisms. In 
addition to the daily water quality measurements (Table 3-1), alkalinity and hardness were also 
measured at test initiation and test renewal in the highest concentration of test solution and in the 
dilution water.  
Table 3-1: Water Quality Parameters, Measurement Intervals 
Parameter 
Measurement interval 
Test Initiation Before Test Renewal After Test Renewal Daily 
Temperature Yes Yes Yes Yes 
Conductivity Yes Yes Yes Yes 
pH Yes Yes Yes Yes 
Dissolved Oxygen Yes Yes Yes Yes 
Alkalinity Yes No Yes No 
Hardness Yes No Yes No 
Ceriodaphnia dubia (Test Method 2002.0) 
The 96-hour static renewal test using C. dubia was initiated using neonates < 24 hours old from a 
healthy mother who produced at least eight young in her third brood. PCA and mPCA were 
tested using four replicates of 5 neonates each in 30 mL plastic medicine cups with 20 mL of the 
solutions containing PCA and mPCA. The test organisms were carefully loaded one at a time to 
the different vessels in random order using a plastic pipette. In total, 20 organisms were used for 
each test concentration. The test duration was 96 hours. After 48 hours since the test initiation, 
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fresh solutions of the same concentration were prepared and the organisms were carefully 
transferred to the fresh solutions. C. dubia was fed with a mixture of Yeast, Cerophyll, and Trout 
chow (YCT) and green alga, Selenastrum capricornutum, for two hours in a holding tank before 
test initiation and before test renewal at 48 hours. Both YCT and S. capricornutum were obtained 
from Marinco Bioassay Laboratory (MBL) located in Sarasota Florida. Light exposure was 
controlled using a light timer providing 16 hours of light and 8 hours of darkness. The room 
temperature was kept constant at 25±1 ˚C and was monitored throughout the duration of the test 
using a Dickson (Addison, IL) temperature chart recorder (Model SL4). Dissolved oxygen, pH 
and conductivity were measured at the beginning of the test, at 48 hours, and 96 hours. Organism 
survival was recorded daily. 
Pimephales promelas (Test method 2000.0) 
The 96-hour static renewal test using P. promelas was initiated using organisms 10±1 days old. 
PCA and mPCA were tested using four replicates with 10 fish each in 600 mL glass beakers with 
200 mL of the test solutions containing PCA and mPCA. The test organisms were carefully 
loaded one at a time to the different vessels in random order using a large-bore glass pipette.  In 
total, 40 organisms were used on each test concentration. The test duration was 96 hours. After 
48 hours since the test initiation, fresh solutions of the same concentration were prepared. About 
80% of the old test solution was removed and the fresh solution was poured slowly down the 
side of the test vessel to avoid excess turbulence and to prevent damage to the fish. P. promelas 
was fed with Arthemia nauplii for two hours in a holding tank before test initiation and before 
test renewal at 48 hours. A. nauplii was obtained from San Francisco Bay Brand Inc. (Newark, 
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CA). Light exposure was controlled using a light timer providing 16 hours of light and 8 hours of 
darkness. The room temperature was kept constant at 25±1 ˚C and was monitored throughout the 
duration of the test using a Dickson (Addison, IL) temperature chart recorder (Model SL4). 
Dissolved oxygen, pH, temperature, and conductivity were measure daily as well as organism 
survival. 
 
Figure 3-1: Setup Pimephales Promelas Toxicity Test 
Quality Assurance 
A laboratory standard operating procedure (SOP) was written for this study. It was followed 
strictly to reduce the variability of the results among the different tests. The organisms used in 
this study were purchased from Marinco Bioassay Laboratory (MBL). MBL is a certified 
laboratory by the Florida Department of Agriculture & Consumer Services, Aquaculture 
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Certificate #AQ0668007. Control charts showing the sensitivity of the test species were 
requested from MBL to verify the health of the organisms used in this research. Additionally, the 
health of the organism was evaluated from the control treatments on each test. For a test to be 
considered acceptable, test organisms survival in the control treatment must be greater or equal 
to 90%.  
Test precision was estimated by first creating a control chart for the LC50 values obtained from 
reference tests. These reference tests consisted of the same organisms, and same lab conditions 
used in PCA and mPCA tests but instead of using these test substances, reference tests used 
sodium chloride, a substance known to be toxic to fathead minnows and C. dubia.  
 Then the coefficient of variation (CV) which measures the relative variation of a set of data was 
determined using the following equation: 
𝐶𝑉 = 𝑠
𝑚
∗ 100 Equation (3-1) 
Where s represents the standard deviation, and m the mean of the LC50 values from the reference 
tests. The laboratory CV was then compared to the distribution of laboratory CVs reported 
nationally for reference toxicant testing. Table 3-2 summarizes the percentiles (P25, P50, P75, 
and P90) of the inter-laboratory CVs. The P50 column shows the 50 percentile (median value) of 
the CVs found across the 21 and 23 laboratories that reported their CV values after using 
methods 2000 and 2002 respectively. In other words, this table reports the typical range of lab 
test method variation between different independent labs (USEPA, 2000). 
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Table 3-2: Percentiles of the Within-Laboratory Values of CV for LC50 
Test Method 
Test 
Method 
No. 
Endpoint No. of Labs 
Percent CV 
P25 P50 P75 P90 
Fathead Minnow 
Larval Survival 2000 Survival 21 10% 16% 19% 33% 
Ceriodaphnia (Cd) 
Survival 2002 Survival 23 11% 19% 29% 34% 
Adapted from Table B-2 (USEPA, 2000) 
Seven reference tests were performed on the fish and on C. dubia. The estimated CVs from these 
toxicity tests were 11% for the fish and 17% on C. dubia. Comparing the obtained CVs from the 
reference tests performed in this study to the CVs reported in the in Table 3-2, it is observed that 
the CVs from the fish and C. dubia experiments are within the P50 for this type of tests. EPA 
recommends comparing the CV of the LC50 to the P75 of the CVs nationally reported. If the CV 
of the laboratory exceeds the P75, the laboratory should use the P75 and P90 to calculate the 
warning and control limits, respectively, and steps should be taken to reduce the variability of the 
method. Appendix A contains the raw data for the toxicity test on fish and crustaceans, the 
standard operating procedures used in these experiments and the most recent report for the 
standard toxicant reference tests. 
Microbe Treatment Efficiency Including Nitrification Inhibition Test 
The effect of PCA and mPCA on the biological treatment efficiency of a wastewater treatment 
plant was evaluated according to the method described in EPA OCSPP 850.3300: Modified 
Activated Sludge, Respiration Inhibition Test, January 2012 (EPA 712-C-014). There are three 
main test designs used to estimate the total respiration inhibition; they are the range-finding test, 
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the limit test, and the definitive test. The range-finding test is used to determine an appropriate 
range of concentrations to be used in the definitive test. This test consists of at least three widely 
spaced concentrations of the test substance and there is no need for replication. The limit test is 
used to determine if the IC50 is above a given concentration. If the IC50 is not observed below 
this concentration a definitive test is not necessary. The limit test is performed using three 
replicates of the limit concentration plus blank controls. Lastly, the definitive test is a multi-
concentration test using at least five different concentrations of the test substance in addition to 
blank controls. The objective of this test is to find the IC50 value for microbial respiration. 
Standard Test Conditions for the Total Respiration and Nitrification Inhibition Tests  
The effect of a chemical compound in the treatment efficiency of a WWTF can be estimated by 
measuring the respiration rate of an activated sludge sample exposed to a test substance and 
comparing it to the same batch of activate sludge in absence of the chemical. The total, 
heterotrophic and also due to nitrification respiration inhibition can be evaluated after finding the 
respiration rate of the activated sludge microbes. The following test standard conditions applied 
to the respiration inhibition tests performed in this research. 
Room Temperature 
The room temperature was kept constant at 21±1 ˚C and was monitored throughout the duration 
of the test using a Dickson (Addison, IL) temperature chart recorder (Model SL4). 
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Synthetic wastewater 
A fresh stock solution of synthetic wastewater was prepared for each test. The stock solution was 
composed of 16 g peptone, 11 g meat extract, 3 g urea (CO(NH2)2), 0.7 g sodium chloride 
(NaCl), 0.4 g calcium chloride dihydrate (CaCl2.2H2O), 0.2 g magnesium sulfate heptahydrate 
(MgSO4.7H2O), and 2.8 g dipotassium hydrogen phosphate (K2HPO4) diluted to one liter using 
deionized water.  
Inoculum 
An activated sludge sample was collected from an extended aeration plant using a closed loop 
reactor. (CLR, i.e. similar to a racetrack/oxidation ditch) operated for nitrification/denitrification.  
The sample was taken from the effluent of the reactor after reaeration in the CLR splitter box 
located before the clarifiers. The wastewater treatment facility (WWTF) is located at Cape 
Canaveral Air Force Station (Cape Canaveral, FL). The AS sample was collected in plastic 
containers and transported in coolers from the WWTF to the University of Central Florida. After 
arrival at the lab, the AS mixed liquor sample was homogenized in a blender for 20 seconds. 
Then, it was allowed to settle for about 20-min and a portion of the supernatant was removed to 
increase the concentration of the suspended solids. Later, a 20 mL sample was taken to analyze 
its mixed liquor suspended solids (MLSS) concentration.  After concentrating the suspended 
solids (SS) by removing a portion of the supernatant, and knowing the final concentration of 
MLSS inoculum, a determined volume of inoculum was added to each vessel and diluted with 
the test substance, synthetic wastewater (16 mL), and deionized water to make a final 
concentration closed to 1.6 g/L SS in a final sample volume of 500 mL. The volume of deionized 
26 
water and inoculum added to obtain the 1.6 g/L concentration of SS varied on each experiment 
depending on the concentration of the SS on each batch of inoculum prepared. 
Stock Solutions 
Stock solutions of PCA and mPCA were prepared the day of the test. mPCA was readily soluble 
in deionized water while PCA was fully dissolved after the pH was increased. The pH in the 
stock solutions was adjusted to 7.5±0.5 using 1N sodium hydroxide. 
Blank Controls 
Blank controls were prepared at the beginning and at the end of each experiment. Each set of 
blank controls were prepared in triplicate when measuring total respiration and in single reactors 
when measuring the heterotrophic respiration. The difference between blank controls from the 
total and the heterotrophic respiration was the addition of a nitrification inhibitor (N-
allylthiourea, ATU) in the controls measuring the heterotrophic respiration.   
Abiotic Oxygen Uptake 
Before initializing the respiration inhibition tests using PCA and mPCA, a set of abiotic controls 
were prepare and the oxygen uptake was measured in this controls. The objective of using abiotic 
controls is to determine if the test substances would cause measurable abiotic oxygen 
consumption. The experiment layout consisted of duplicates for each test substance diluted in 16 
ml of synthetic wastewater plus deionized water to make a final test substance concentration of 
1.5 g/L of mPCA or PCA in a 500 mL volume solution. pH was adjusted to 7.5 ± 0.5 using 
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sodium hydroxide. The test vessels were aerated for 180 min, followed by dissolved oxygen 
measurements for ten minutes at 1 minute intervals. 
Oxygen depletion was not noticed for any of the two test chemicals at the end of the exposure 
period from the aerated solution. Thus, no additional abiotic controls were used in the 
experiments. 
Cleaning Test Chambers and other Glassware  
Before test initiation, all glassware was scrubbed with a detergent solution. Then, they were 
rinsed three times with tap water and once with a 1:1 hydrochloric acid solution. The following 
day, they were triple rinse using deionized water. 
Total Respiration Inhibition 
Range finding tests and limit tests were performed to determine the total respiration of AS 
microbes exposed to mPCA and PCA. Three concentrations of the test substances were used 15, 
150 and 1,500 mg/L. The largest concentration was used as a limit concentration and it was 
prepared in triplicate (limit test), for the two lower concentrations no replication was used. In 
addition, an initial and a final set of black controls were prepared on each test; these blank 
controls did not contain any test substance and were prepared in triplicate. The sensitivity for 
each batch of activated sludge used as inoculum was evaluated using 3,4 dichlorophenol (3,4-
DCP). This is a reference substance known to inhibit the respiration of microbes.  
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Heterotrophic and Nitrification Respiration Inhibition 
Side experiments were performed concurrently to the Total Respiration Inhibition Range Finding 
Tests to estimate the effect that mPCA and PCA might have on nitrifying bacteria from the AS 
mixed liquor sample. This test consisted of initial and final blank controls plus one test chamber 
per concentration of the mPCA or PCA being evaluated in the concurrent Total Respiration 
Inhibition Range Finding Test. The test chambers were prepared in the same way as in the Total 
Respiration Inhibition Range Finding Test, but in this test a nitrification inhibitor (ATU) was 
used at 11.6 mg/L to inhibit nitrogenous oxygen demand. Knowing the Total and Heterotrophic 
respiration rates (nitrification inhibitor added), the nitrogenous oxygen demand can be estimated. 
Equation (3-3) can be used to determine the Total Respiration Inhibition,  
Equation (3-3) can be used to find the Nitrification Respiration Inhibition, 
𝐼𝑁 = �1 − 𝑅𝑇 − 𝑅𝐻𝑅𝑇𝐵 − 𝑅𝐻𝐵�𝑋100%   Equation (3-3) 
and Equation (3-4) is used to find the Heterotrophic Respiration Inhibition 
Where 𝑅𝑇 represents the total rate of respiration at a given concentration of the test substance 
(PCA, mPCA, and 3,4-DCP),  𝑅𝑇𝐵 represents the average rate of respiration form the initial and 
final blank controls; 𝑅𝐻 represents the rate of respiration in a given concentration of the test 
𝐼𝑇 = �1 − 𝑅𝑇𝑅𝑇𝐵� 𝑋100%   Equation (3-2) 
𝐼𝐻 = �1 − 𝑅𝐻𝑅𝐻𝐵� 𝑋100%   Equation (3-4) 
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substances from a sample containing a nitrification inhibitor (ATU); 𝑅𝐻𝐵 represents the average 
rate of respiration between the initial and final blank controls containing ATU. The relationship 
between total, heterotrophic and nitrification respiration is given in Equation (3-5): 
Where 𝑅𝑁 is the rate of respiration due to nitrification. 
Table 3-3 summarizes the composition of the different types of test vessels used in the 
respiration inhibition tests performed in this study. Table B-1 to   
𝑅𝑁 = 𝑅𝑇 − 𝑅𝐻 Equation (3-5) 
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Table B-3 in Appendix B show the volume of the activated sludge and the concentration of the 
test substances used on each test chamber. 
Table 3-3: Test Chambers Composition to Determine Respiration Inhibition 
Type of Vessel Inoculum Deionized Water 
Synthetic 
Wastewater PCA/mPCA 3,4-DCP ATU* 
Blank Controls – Total 
Respiration YES YES YES NO NO NO 
Blank Controls – 
Heterotrophic Respiration YES YES YES NO NO YES 
Abiotic Controls NO YES YES YES NO NO 
Reference Substance YES YES YES NO YES NO 
Test Chambers – Total 
Respiration  YES YES YES YES NO NO 
Test Chambers –
Heterotrophic Respiration YES YES YES YES NO YES 
ATU: N-allylthiourea; 3,4-DCP: 3,4-dichlorophenol 
Procedure for Total Respiration and Nitrification Inhibition Tests  
All test vessels were prepared before test initiation in 1000 mL glass beakers withholding the 
inoculum. The preparation consisted of 16 mL of synthetic wastewater stock solution, different 
volumes of mPCA/PCA stock solutions or of the reference substance (3,4-DCP) diluted in 
deionized water to a volume of 260-290 mL. After all the test vessels were prepared, the test was 
initiated by adding 210-250 mL of inoculum into the set of initial blank control beakers (the 
volume of inoculum and deionized water added depended on the concentration of MLSS in the 
concentrated inoculum prepared at the beginning of the experiments). After 15 minutes, the 
following set of beakers containing an initial concentration of the test substance was inoculated. 
The following vessels containing different concentrations of the test substance were prepared at 
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15-min intervals. After all the test concentrations had been initiated, a second set of blank control 
vessels was prepared by adding the inoculum. The test vessels were incubated for 180-min. 
Aeration was provided through the duration of the incubation period using oil-free air at a rate of 
about 0.5 to 1.0 L per minute. The contents in the vessels were maintained in suspension using 
magnetic stirrers.  
The specific oxygen uptake rate (SOUR) was measured after 30 and 180-min of incubation. The 
SOUR was determined by measuring the dissolved oxygen (DO) at 1-min intervals for 10-min 
and dividing it by the concentration of MLSS of the inoculum used. Only the values found in the 
linear part of the graph of the oxygen concentration versus time were used to calculate the 
SOUR. 
The percent inhibition of the test substances and reference substance on the activated sludge was 
determined by comparing the SOUR from the different test concentrations to the average SOUR 
of the initial and final sets of controls. Then, if possible, the IC50 was calculated using the 
Trimmed Spearman Karber (TSK) method (Hamilton et al., 1977) using the Trimmed Spearman-
Karber (TSK) Program Version 1.5 (USEPA, 1990).   
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 Figure 3-2: Setup Respiration Inhibition Test 
Quality Assurance 
A reference substance, 3,5-dichlorophenol (3,5-DCP), known to be inhibitory to AS, was used to 
assure that the lab technique, test method, test conditions and sensitivity of each batch of AS 
tested were all adequate. Three concentrations of 3,5-DCP (1, 10, and 100 mg/L) were prepared 
from a 1.0 g/L stock solution. The reference test setup was similar to the range finding test, 
consisting of an initial blank control followed by three different exposure concentrations to the 
reference substance and a final blank control. The IC50 was determined measuring the SOUR 
from each test concentration compared to the average SOUR from the blank controls. For an 
acceptable definitive test using 3,5-DCP, the 3-hour IC50 for the total respiration should be 
within the range between 5 to 30 mg/L according to EPA (USEPA, 2012) or 2 mg/L to 25 mg/L 
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Organization for Economic Development and Cooperation (OECD) Method 209 (OECD, 2010), 
and the International Organization for Standardization (ISO) Method 8192 (ISO, 2007). 
Test Validity Criteria 
For a respiration inhibition test to be considered valid, the following conditions must be satisfied. 
1. The difference between the respiration rate of the initial and the final control should be ≤ 
15%. 
2. The IC50 after a 3-hr exposure using 3-5-DCP should fall within the accepted range of 5 
to 30 mg/L. 
3. All test chambers should be identical and contain the same concentration of AS and 
synthetic wastewater.  
Microbial Viability (HPC) Test 
The microbial viability after exposing AS microorganisms to mPCA and PCA was analyzed 
using heterotrophic plate counts (HPCs). This test was performed according to the Standard 
Methods for the Examination of Water and Wastewater Method 9215 (APHA, 2005). 
One HPC test was performed using samples collected at the end of the respiration inhibition 
range finding test performed on November 30th, 2012. These samples were used to analyze the 
viability of heterotrophic organisms after exposing them for at least 180-min to mPCA and PCA. 
The samples were randomly selected from one of the triplicate reactors from the final set of 
blank controls, from one of the triplicate reactors using 750 mg/L mPCA, and from the single 
reactor containing 750 mg/L PCA prepared during this test. The organisms were exposed for at 
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least 240-min to the test chemicals under continuous aeration before they were spread-plated in 
petri dishes using a sterile medium of R2A agar. Serial dilutions of 10-3, 10-4, and 10-5 were 
prepared and then 0.1 mL of sample was plated to yield final factors of 10-4, 10-5, and 10-6 to find 
a dilution which would grow from 30 to 300 colony forming units (CFU).  All the prepared 
dilutions from the samples collected were analyzed using duplicate petri dishes per dilution and 
incubated for 7 days at 28 °C. On day seven, the colonies from each petri dish were counted to 
determine if exposure to the test chemicals had an effect in the viability of the heterotrophic 
organisms. 
Procedure for Microbial Viability Test 
Twenty four hours before test initiation, 18.2 grams of R2A agar were diluted in 1 liter deionized 
water following the manufacturer’s specifications. Then it was placed in an autoclave for 15-min 
at 121°C. Autoclave tape was used to ensure that autoclaving was completed. The liquid R2A 
media was allowed to cool down to around 45°C inside a Biosafety Cabinet before pouring 15 to 
20 mL of the liquid agar into sterile 100 X 15 mm petri dishes. Once the agar had hardened, the 
petri dishes were placed upside down to prevent moisture from falling into the agar.  
The following day 0.1 percent peptone solution was prepared by diluting 200 mg of peptone into 
200 mL deionized water. This solution was sterilized in an autoclave for 15-min at 121°C. After 
the previously mentioned Respiration Inhibition Range Finding Test was concluded on 
November 30th, 2012, 10 mL samples from the final blank control, 750 mg/L mPCA, and 750 
mg/L PCA beakers were collected into sterile plastic test tubes. Then, 10-3, 10-4, and 10-5 
dilutions were prepared for each one of the samples collected using the 0.1% peptone water. 
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Each plate was marked with the sample name, dilution factor, and the date the test was 
performed. A 0.1 mL volume was used from each dilution prepared to inoculate the agar; then, it 
was spread covering the surface of the agar using sterile disposable plastic L-Shaped Cell 
Spreaders. By using 0.1 mL inoculum, the final dilutions in the petri dishes were 10-4, 10-5, and 
10-6. 
After inoculation, the petri dishes were placed upside down in an incubator at 28±1 °C for 7 
days. On day 7, the dishes were removed from the incubator and placed in a Quebec colony 
counter, for manual counting. 
The bacterial count per milliliter was computed using the following equation: 
𝐶𝐹𝑈
𝑚𝐿
= 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
𝑎𝑐𝑡𝑢𝑎𝑙 𝑣𝑜𝑙.  𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒 𝑖𝑛 𝑑𝑖𝑠ℎ,𝑚𝐿 ∗ 1𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟  Equation (3-6) 
Quality Assurance 
As part of the quality assurance of this experiment the following actions were taken to ensure the 
quality of the results: 
1. A set of R2A (blank) controls per batch of R2A media prepared was incubated for the 
duration of the experiment to verify that the media was sterile.   
2. A 0.1 mL sample of the diluent (0.1% peptone water) was spread and incubated using the 
media to verify if the diluent was sterile. 
3. Each plate was counted twice. Both counts should have not differed by more than five 
percent. 
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Biodegradation of PCA and mPCA 
The biotic degradability of PCA and mPCA was evaluated based on the method described in 
EPA OPPTS 835.3110 Ready Biodegradability- Closed Bottle Test, January 1998 (EPA 712-C-
98-076).  This test consists of a test substance diluted in a mineral solution which is then 
inoculated using wastewater microbes and incubated under aerobic conditions in the dark at 20 
˚C for 28 days. To prevent limitations on the microbial activity due to low levels of oxygen in 
the sample, the dissolved oxygen (DO) concentration has to be greater than 0.5 mg/L at the end 
of the test. To achieve this objective in this study, the concentrations of the test substances were 
determined using their theoretical oxygen demand (ThOD). Since the chemical formula for 
mPCA (C6H8N2O3) and PCA (C5H6N2O3) were known, their ThODs were calculated using to the 
following equation: 
CCHhClclNnNanaOoPpSs 
𝑇ℎ𝑂𝐷𝑁𝑂3 = 16 �2𝑐 + (ℎ − 𝑐𝑙)2 + 5𝑛2 + 3𝑠 + 5𝑝2 + 𝑛𝑎2 − 𝑜� �𝑚𝑔𝑚𝑔�𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡    Equation (3-7) 
 
Where 𝑇ℎ𝑂𝐷𝑁𝑂3 is the theoretical oxygen demand of the substance accounting for nitrification. 
The 𝑇ℎ𝑂𝐷𝑁𝑂3 for mPCA and PCA were determined as 1.84 and 1.69 mg O2 per mg of test 
substance, respectively.  
The ThOD assuming that nitrification does not occur was determined from the following 
equation: 
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𝑇ℎ𝑂𝐷𝑁𝐻3 = 16 �2𝑐 + (ℎ − 𝑐𝑙 − 3𝑛)2 + 3𝑠 + 5𝑝2 + 𝑛𝑎2 − 𝑜� �𝑚𝑔𝑚𝑔�𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡    Equation (3-8) 
 
The 𝑇ℎ𝑂𝐷𝑁𝐻3  for mPCA and PCA were calculated as 1.025 and 0.788 mg O2 per mg of test 
substance, respectively. 
The concentration of oxygen consumed at a given day in the test was calculated as follows: 
𝐵𝑂𝐷𝑛, 𝑚𝑔 𝑂2𝑚𝑔 𝑡𝑒𝑠𝑡 𝑠𝑢𝑏𝑠𝑡𝑎𝑛𝑐𝑒 = (𝐷𝑂𝑠0 − 𝐷𝑂𝑠𝑛) − (𝐷𝑂𝑐0 − 𝐷𝑂𝑐𝑛)𝑚𝑔 𝑜𝑓 𝑡𝑒𝑠𝑡 𝑠𝑢𝑏𝑠𝑡𝑎𝑛𝑐𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑏𝑜𝑡𝑡𝑙𝑒 Equation (3-9) 
Where, n represents the number of days after test initiation; DOs0 is the average dissolved 
oxygen at test initiation in the bottles containing the test substance; DOsn is the dissolved oxygen 
after n days in the test substance; DOc0 is the average dissolved oxygen at test initiation for the 
inoculated control bottles; and DOcn represents the dissolved oxygen after n days for the 
inoculated control bottles. 
Knowing the BOD and the theoretical oxygen demand, the percent degradation was calculated in 
the following way: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 = (𝐵𝑂𝐷 ,𝑚𝑔 𝑂2)/𝑚𝑔 )(𝑇ℎ𝑂𝐷,𝑚𝑔 𝑂2)/𝑚𝑔) 𝑥 100   Equation (3-10) 
Two biodegradation tests were performed in this research. Both tests are explained below. 
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Standard Biodegradation Test Conditions 
Before test initiation, all BOD bottles were filled with a detergent solution for one hour. Then, 
they were triple rinse with tap water. After rinsing the bottles with tap water, the bottles were 
filled about half full with deionized water and 1 mL of a 10% solution of hydrochloric acid was 
added. Additional deionized water was added to fill them to the top. The bottles were left 
overnight in this solution. The following day, they were triple rinsed using deionized water. 
Inoculum 
New activated sludge samples were collected for each biodegradation test the day each 
experiment was performed. The activated sludge mixed liquor sample was extracted from an 
extended aeration plant using a closed loop reactor. (CLR, i.e. similar to a racetrack/oxidation 
ditch) operated for nitrification/denitrification.  The sample was taken from the effluent of the 
reactor after reaeration in the CLR splitter box located before the clarifiers. The wastewater 
treatment facility (WWTF) is located at Cape Canaveral Air Force Station (Cape Canaveral, FL). 
The AS mixed liquor samples were collected in a large plastic container and transported in a 
cooler from the WWTF to the University of Central Florida. The mixed liquor sample was 
allowed to settle for one hour. Then a portion of the supernatant was decanted and kept under 
aerobic conditions for a maximum time of two hours until it was needed as inoculum. Two mL 
of the inoculum was used on each bottle of Test 1 and 0.6 mL per bottle on Test 2. 
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Dilution Water 
Dilution water (DW) was prepared using Hach BOD Nutrient Buffer pillows (Hach Company, 
Loveland, CO) by adding one Nutrient Buffer pillow to 4 liters of deionized water. The DW 
provides trace elements needed by the microorganisms.  The DW was strongly aerated for 30 
minutes and allowed to stand for 24 hours at 20±1˚C. The DO from the DW was measured as 
8.51 mg/L and 9.10 mg/L on Test 1 and 2, respectively, before the tests were initiated. One batch 
of DW was used to prepare all the samples on each biodegradation test.  
Biodegradation Test # 1 
Nine groups of BOD bottles were prepared as described in Table 3-4. DO measurements were 
taken from duplicate bottles from all test groups, but from the blank control group only one 
measurement was taken. DO readings were taken at test initiation and at multiple times such as 
4, 7, 12, 14, 21, and 28 days (see Table 3-4). The DO in all groups was not measured the same 
day; it varied according to the number of bottles used and the objective of the test group. Nitrate 
and nitrite concentrations were measured on the samples to correct for nitrification (See test 
method used in Error! Reference source not found.). Nitrite and nitrate were measured at days 
14, 21 and 28 in the BOD bottles in which a significant oxygen demand was observed compared 
to the inoculated control. 
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Table 3-4: Biodegradation Test #1, Test Description 
Group ID TS Conc. TS, mg/L 
Volume 
Inoculum, mL 
No. 
Bottles 
DO measurements, 
day Description 
A None 0 2 14 0, 4, 7, 12, 14, 21, 28 Inoculated Control Group 
B mPCA 2 2 10 0, 7, 14, 21, 28 Biodegradation Test 
C mPCA 5 2 14 0, 4, 7, 12, 14, 21, 28 Biodegradation Test 
D PCA 2 2 10 0, 7, 14, 21, 28 Biodegradation Test 
E PCA 5 2 14 0, 4, 7, 12, 14, 21, 28 Biodegradation Test 
F KHP 3.4 2 14 0, 4, 7, 12, 14, 21, 28 Reference Test 
G KHP & mPCA 3.4 & 5 2 4 0, 7 Inhibition Test 
H KHP & PCA 3.4 & 5 2 4 0, 7 Inhibition Test 
I None 0 0 7 0, 4, 7, 12, 14, 21, 28 Blank Control 
TS: Test Substance 
KHP: Potassium Hydrogen Phthalate 
Biodegradation Test # 2 
Seven groups of BOD bottles were prepared as described in Table 3-5. Besides using a different 
batch of inoculum, the main differences between procedures from Test #1 and Test #2 were the 
use of a nitrification inhibitor (Formula 2533, Hach Co., Loveland, CO) instead of measuring 
nitrate and nitrite to account for nitrification, and the use of an smaller volume of inoculum, 0.6 
mL instead of 2 mL per BOD bottle. In this test a smaller volume was used to reduce the amount 
of readily biodegradable material that could be contained in the AS sample added as inoculum. 
DO measurements were taken from duplicate bottles from all test groups. DO readings were 
collected at test initiation and at 7, 14, 21, and 27 days. DO measurements were not collected at 
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day 4 and 12 on Test 2, since it would have required 28 more BOD bottles in addition to the 75 
already used causing the experiment to become unwieldy due to the amount of bottles and 
materials  required. The information obtained from measuring the DO at the given time intervals 
in Table 3-5 meets the requirements from the method. 
Table 3-5: Biodegradation Test 2, Test Description 
Group 
ID 
Test 
Substance 
Conc. 
TS, 
mg/L 
Volume 
Inoculum, 
mL 
No. 
Bottles 
Nitrification 
Inhibitor 
DO 
measurements, 
day 
Description 
A None 0 0.6 10 NO 0, 7, 14, 21, 27 Inoculated Ctrl Group 
B None 0 0.6 10 YES 0, 7, 14, 21, 27 Inoculated Ctrl Group + NI 
C mPCA 2 0.6 10 NO 0, 7, 14, 21, 27 Biodegradation Test 
D mPCA 2 0.6 10 YES 0, 7, 14, 21, 27 Biodegradation Test + NI 
E PCA 2 0.6 10 NO 0, 7, 14, 21, 27 Biodegradation Test 
F PCA 2 0.6 10 YES 0, 7, 14, 21, 27 Biodegradation Test + NI 
G KHP 3.4  0.6 10 NO 0, 7, 14, 21, 27 Reference Test 
H None 0 0 7 NO 0, 7, 14, 21, 27 Blank Control 
NI: Nitrification Inhibitor (Formula 2533, Hach Co., Loveland, CO) 
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Preparation 
In total, 91 BOD bottles were used to prepare the 9 groups used in the biodegradation Test 1 and 
75 bottles in Test 2. Each group was prepared by adding the test substances (mPCA, PCA and 
KHP) from freshly prepared stock solutions into large glass containers; then a portion of the 
BOD buffer solution was carefully added avoiding air bubbles formation in the container. Once 
the test substance was diluted, the inoculum was added. Later, the container was filled with 
additional BOD buffer solution to make the desired concentration. Lastly, all BOD bottles were 
filled with their corresponding sample from the solution prepared in the large containers and 
incubated at 20 ˚C in the dark. At the pre-established time intervals dissolved oxygen depletion 
was determined.  
 
Figure 3-3: Biodegradation Test, BOD bottles 
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Test Validity Criteria 
The EPA method used in this biodegradation study recommends the following validity criteria 
for a test to be considered valid:  
1. The difference in biodegradation between replicate values at the plateau (section of the 
degradation versus time graph were degradation has finished) at the end of the test or at 
the end of the 14-day window has to be less than 20%. The 14-day window begins when 
biodegradation has reached 10% of the ThOD of the test substance. The day when the 
10% degradation is achieved can be obtained by finding the equation of the curve from 
the graph of % degradation versus time.  
2. For ready biodegradability, the percent biodegradability should be higher than 60% of the 
ThOD. The 60% biodegradation has to occur within the 28 day experiment duration and 
within a 14-day window after the initial 10% degradation occurs. 
Methods, Materials and Equipment Used to Determine Water Quality Parameters 
The methods, materials and equipment used to determine the different water quality parameters 
presented in this chapter are summarized in Table 3-6. 
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Table 3-6 Methods and Equipment Used in Water Quality Determinations 
Parameter Method and/or Equipment 
pH HQ40d Portable pH, Conductivity, Dissolved Oxygen, ORP Multi-Parameter Meter, Probe IntelliCAL PHC101 (Hach Company, Loveland, CO) 
Temperature HQ40d Portable pH, Conductivity, Dissolved Oxygen, ORP Multi-Parameter Meter (Hach Company, Loveland, CO) 
Conductivity HQ40d Portable pH, Conductivity, Dissolved Oxygen, ORP Multi-Parameter Meter, Probe IntelliCAL CDC401 (Hach Company, Loveland, CO) 
Dissolved Oxygen HQ40d Portable pH, Conductivity, Dissolved Oxygen, ORP Multi-Parameter Meter, Probe IntelliCAL LBOD 101(Hach Company, Loveland, CO) 
Total Alkalinity Standard Method: 2320 B. Titration Method * 
Total Hardness Hach Method 8226 (Hach Company, Loveland, CO) 
Nitrate Hach Method 8171 (Hach Company, Loveland, CO) 
Nitrite Hach Method 8507 (Hach Company, Loveland, CO) 
*Standard Methods for the Examination of Water and Wastewater (APHA, 2005) 
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4. RESULTS AND DISCUSSION 
Overview 
In this research the byproducts of the reaction between AKGA and MHZ and HZ are analyzed 
for acute toxicity using fish and crustaceans as well as their effect on wastewater treatment 
efficiency and viability using AS microbes and their biodegradability by AS organisms. The 
analyses were carried out following standard methods by EPA (USEPA 1998, 2012a) and the 
Standard Methods for the examination of water and wastewater (APHA, 2005) 
Acute Toxicity on Fish and Crustaceans 
The acute toxicity of mPCA and PCA was analyzed to estimate the effect that these test 
substances might have on fish and crustaceans. For acute toxicity tests the lethal concentration 
that would kill the 50 percent of a population (LC50) and the non-observable effect concentration 
(NOEC) are commonly reported. From the acute toxicity tests performed using mPCA on C. 
dubia; the LC50 was estimated at 0.77 ± 0.6 g/L (with a 95% confidence level) using the 
Trimmed Spearman-Karber method (Hamilton et al., 1977). The NOEC was estimated at 0.5 g/L 
by the hypothesis testing following the Dunnett procedure (Dunnett, 1955). On the other hand 
the mortality of the minnows was not high enough to determine the LC50, but it was noticed that 
starting at 0.5 g/L, mPCA had an effect on the behavior of the fish. Abnormal behavior observed 
included loss of equilibrium and curved spine. The NOEC on the minnows was estimated at 0.75 
g/L using the Dunnett procedure. The type of method used to determine the NOEC of a 
substance depends on the characteristics of the data obtained. If the different concentrations 
evaluated for mortality on each test have the same number of replicates, the data is tested for 
46 
homogeneity of variance and for normal distribution. If the data passes the normality and 
homogeneity tests, the parametric method Dunnett’s Procedure is used (Dunnett, 1955), 
otherwise the nonparametric test Steel’s Many-one Rank Test (Steel, 1959) is used. These 
hypothesis tests were performed using the Whole Effluent Toxicity (WET) Analysis Spreadsheet 
found in the EPA website (USEPA, 2012b). 
The toxicity tests using PCA did not exhibit a significant effect on fish and crustaceans. There 
was not mortality at any of the concentrations used on the minnows and only 20 percent 
mortality was observed on the C. dubia at 1.25 and 1.50 g/L. The NOEC for both species was 
estimated at 1.50 g/L since it was the largest concentration tested. The Steel’s Many-one Rank 
Test (Steel, 1959) was used to estimate the NOEC in the C. dubia. Even thought there was 20% 
mortality at the two highest concentrations, from hypothesis testing it was found that the 
mortality at these concentrations was not significantly different from the control. Table 4-1 
summarizes the results from the acute toxicity tests performed in this study. This data can also be 
visualized in Figure A-1, Figure A-2 and Figure A-3 from the Appendix A. 
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Table 4-1: Organism Percent Survival and Lethal Concentrations 
Chemical 
Mass 
Chemical Percent Survival 
g/L Ceriodaphnia dubia Pimephales promelas 
PCA + NaOH 
Control 100 100 
0.50 100 100 
0.75 100 100 
1.00 100 100 
1.25 80 100 
1.50 80 100 
NOEC 1.5 g/L 1.5 g/L 
LC50 >1.5 g/L >1.5 g/L 
mPCA + 
NaOH 
Control 100 97.5 
0.50 100 97.5 
0.75 55 95 
1.00 15 60 
1.25 0 55 
1.50 0 62.5 
NOEC 0.5 g/L 0.75 g/L 
LC50 0.77 g/L >1.5 g/L 
Microbe Treatment Efficiency and Viability 
Three respiration inhibition tests were performed using activated sludge samples collected from 
Cape Canaveral Air Force Station Wastewater Treatment Facility (CCAFS WWTF) to estimate 
the effect that mPCA and PCA might have on the microorganisms used for biological treatment 
at this wastewater treatment facility. 
The rate of respiration of the activated sludge was measured at 30 and 180 minutes. The 
sensitivity of each batch of AS used was tested with 3,4-Dichlorophenol (3,4-DCP), a known 
respiration inhibitor to microbes. According to the test method by EPA (USEPA, 2012), for a test 
to be valid, the IC50 or the Inhibition Concentration should be within the 5 to 30 mg/L range for 
3,4-DCP range. In addition to the reference tests, range finding tests were performed to find the 
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concentrations of the test substances at which the IC50 could be found concurrently to a Limit 
Test. From the limit tests it was estimated that the IC50 for mPCA and PCA are above 1,500 
mg/L. For this reason, it was not necessary to perform a definitive test for mPCA and PCA. 
Table 4-2, summarizes the results from the three respiration inhibition test performed using 
mPCA and PCA and their respective reference test results.  
Table 4-2: Percentage of the Total Respiration Inhibition of mPCA and PCA on AS 
Relative to the Blank Controls 
Test Substance 
Concentration 
% Inhibition 
Test Type 
PCA mPCA-1 mPCA-2 
11/2/2012 11/9/2012 11/30/2012 
30-min 180-min 30-min 180-min 30-min 180-min 
3,4 DCP - 1 mg/L 21% – C1 21% – C1 26% 22% 29% 26% 
Reference Test 3,4 DCP - 10 mg/L 54%  – C1 54% – C1 66% 63% 63% 64% 
3,4 DCP - 100 mg/L 90% – C2 90% – C2 93% 92% 92% 90% 
IC50 mg/L 7.33 7.33 4.06 5.05 4.18 4.41 3, 4 – DCP 
15 mg/L  14% – C2 17% – C2 3% 0% - - 
Range Finding   
150 mg/L  13% – C2 17% – C2 -1% -1% - - 
375 mg/L* - - - - -7% -2% 
750 mg/L* - - - - -10% -12% 
1,500 mg/L* 12% – C2 9%– C2 8% 19% 3% 8% Range Finding & 
Limit Test IC50 g/L > 1.5 > 1.5 > 1.5 > 1.5 > 1.5 > 1.5 
*These concentrations were prepared using three replicates to meet the requirements of a limit test. It also meets the 
criteria to be part of the range finding test. 
C1: Percent Inhibition determined based on the initial control 
C2: Percent inhibition determined based on the final control 
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Total Respiration Inhibition 
PCA Test 
The total respiration inhibition test performed using PCA consisted of an initial set of blank 
controls prepared at the beginning of the experiment (time zero) and a final set of blank controls 
prepared after all the other test chambers had been initiated (by adding the inoculum). Initial and 
final controls were prepared in triplicate. After starting the initial set of controls, three sets of the 
reference substance (3,4–DCP ) using concentrations of 1, 10 and 100 mg/L were prepared, all of 
them in triplicate. After the reference substance reactors were started, three concentrations of the 
PCA (15, 150 and 1,500 mg/L) were initiated. The two lowest concentrations worked as a guide 
using one reactor per concentration (15 and 150 mg/L) to estimate the range where the IC50 
might be located, and the largest concentration (1,500 mg/L)  was prepared in triplicate reactors 
and worked as a limit test. The same blank controls were used to determine the percent inhibition 
of the 3,4-DCP and PCA to the AS microorganism. 
The average specific oxygen uptake rates (SOURs) from reactors containing 1,500 mg/L PCA 
after 30-min and 180-min of exposure were 12% and 9% different from the average SOUR of the 
final set of controls (without PCA). This difference represents the percentage inhibition of PCA 
on AS organisms after 30-min and 180-min of exposure, respectively. Because 1,500 mg/L of 
PCA is the limit concentration in this study, and the IC50 of the microbes was not observed below 
this concentration, it was not required to perform additional testing on PCA to find the IC50.  
The reference test for this batch of inoculum showed that as the concentration of the reference 
toxicant increased (3,4-DCP), the inhibition of the respiration also increased. Using the statistical 
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method Trimmed Spearman-Karber (Hamilton et al., 1977) for interpolation, the IC50 for the 
reference substance was determined as 7.33 mg/L 3-4-DCP after 30-min and also at 180-min. 
According to the EPA validity criteria (5 to 30 mg/L), these IC50 values are adequate for this type 
of test. On the other hand, the difference between the average of the initial and final controls was 
larger than the recommended 15% by EPA. In this case the difference between the controls was 
21% and 19% after 30 and 180-min of exposure, respectively. The difference was found to be 
caused by temperature differences between the two sets of blank controls (Table B-4, Table B-8 
from Appendix B).  The initial set of blank controls was aerated using an air source from outside 
the lab and the final set of blank controls used air provided by air pumps located inside the 
laboratory which aerated the reactors with air at room temperature causing the difference in 
temperature in the reactors. Due to the nature of the organisms used in this test, the respiration 
was expected to increase as the temperature increased. To avoid incorrect values from the 
determinations of the percentage respiration inhibition, the percent respiration inhibition on the 
different test chambers was determined based on the control that used the same aeration source 
(Table B-6 and Table B-10). This method to determine the percent inhibition and the use of the 
activated sludge inoculum at 1.21 g/L in the reactors instead of at 1.6 g/L were the only variation 
made from the method by EPA. Figure 4-1 and Figure 4-2 show the variance of the SOURs of 
the 1,500 mg/L PCA sample compared to the SOURs in the blank control samples after 30 and 
180-min of exposure. 
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 Figure 4-1: SOURs from the 1,500 mg/L PCA Samples Compared to the SOURs in the 
Initial and Final Sets of Controls after 30-min of Exposure 
 
Figure 4-2: SOURs from the 1,500 mg/L PCA Samples Compared to the SOURs in the 
Initial and Final Sets of Controls After 180-min of Exposure 
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mPCA – 1   
The setup of the test using mPCA was similar to the previously mentioned test for PCA. In this 
test, there was a small difference between the average respiration rate in the highest 
concentration of mPCA (1,500 mg/L) compared to the average respiration in the two sets of 
controls. Using this compound the estimated percent inhibition was 8% and 19% after 30 and 
180-min of exposure, respectively. Although the IC50 could not be determined using these 
concentrations, an additional test for mPCA (mPCA-2) was performed to obtain additional 
information about the toxicity of mPCA on AS. In this initial mPCA test, using the statistical 
method Trimmed Spearman-Karber (Hamilton et al., 1977) for interpolation, the IC50 for the 
reference substance was calculated as 4.06 and 5.05 mg/L of 3,4–DCP after 30 and 180-min of 
exposure and the difference between the initial and final sets of controls was 1% after the two 
exposure times, meeting both EPA validity criteria. Figure 4-3 and Figure 4-4 shows the variance 
of the SOURs of the 1,500 mg/L mPCA sample compared to the SOURs in the blank control 
samples after 30 and 180-min of exposure. 
 
Figure 4-3: SOURs from the 1,500 mg/L mPCA Samples Compared to the SOURs in the 
Initial and Final Sets of Controls After 30-min of Exposure 
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 Figure 4-4: SOURs from the 1,500 mg/L mPCA Samples Compared to the SOURs in the 
Initial and Final Sets of Controls After 180-min of Exposure 
mPCA – 2  
The objective of this test was to verify the information obtained in mPCA – 1, since there were 
some variations within the SOURs obtained from the different replicates in the set of reactors 
containing 1,500 mg/L of mPCA after 180-min of exposure (Table B-18 from the Appendix B). 
If the 19% inhibition observed in mPCA-1 after 180-min was lower than it should have been, by 
testing additional concentrations of mPCA in test mPCA-2 a concentration that does not produce 
a toxic effect on activated sludge could be identify. This test consisted of a reference substance, 
two sets of controls (initial and final) and three concentrations of mPCA (375, 750, and 1,500 
mg/L) all of them in triplicate. From this test, the respiration inhibition of AS at 1,500 mg/L was 
estimated as 8 % compared to 19% inhibition from the previous test after the same exposure time 
of 180-min. The other two concentrations did not show any respiration inhibition. Relative to the 
reference test on this batch of inoculum the IC50 for 3,4-DCP was determined as 4.18 and 4.41 
mg/L after 30 and 180-min of exposure. This value is slightly below the validity range proposed 
by EPA, but it is within the validity range for similar methods such as the one by the 
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Organization for Economic Development and Cooperation (OECD) Method 209 (OECD, 2010), 
and the International Organization for Standardization (ISO) Method 8192. The latter 
organization performed interlaboratory trials in July 2004 to find and propose validity ranges for 
IC50 using domestic wastewater. Under these two methods, a test is considered valid if the IC50 is 
within the range between 2 to 25 mg/L 3,4–DCP for total respiration. Figure 4-5 and Figure 4-6 
shows the variance of the SOURs of the 375, 750 and 1,500 mg/L mPCA samples compared to 
the SOURs in the blank control samples after 30 and 180-min of exposure. 
 
Figure 4-5: SOURs from the 375, 750 and 1,500 mg/L mPCA Samples Compared to the 
SOURs in the Initial and Final Sets of Controls After 30-min of Exposure 
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 Figure 4-6: SOURs from the 375, 750 and 1,500 mg/L mPCA Samples Compared to the 
SOURs in the Initial and Final Sets of Controls After 180-min of Exposure 
Nitrification Inhibition Test 
The nitrification inhibition was evaluated by finding the heterotrophic respiration rate (also 
referred to in this study as carbonaceous respiration) by adding N-allylthiourea (ATU). Then the 
carbonaceous SOUR (CSOUR) was subtracted from the total respiration rate (SOUR in the 
preceding sections or, in this section, TSOUR) of the sample to obtain the nitrogenous SOUR 
(NSOUR). Table 4-3 summarizes the respiration rates of the samples. It can be observed in this 
table that the TSOURs of the samples containing PCA appear to be lower than the TSOUR of its 
control.  There was not enough data to conduct robust statistical conformation of this, but by 
using the variability of the replicates (some parameters were run in triplicate), it was possible to 
determine if the values +/- the standard deviation of the control and experimental TSOURs of the 
samples containing PCA, overlapped.  In this context the only TSOUR that was lower or greater 
than the corresponding control was observed the 1,500 mg/L PCA sample at 30-min.  The 
control was 7.91 mg O2/g-h +/-0.54 and the 1,500 mg/L PCA TSOUR was 6.93+/-0.21 mg O2/g-
h.  The standard deviations did not overlap which suggests that the decrease in TSOUR was due 
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to the presence of PCA, and not just due to the variability of the SOUR test.  This analysis was 
also conducted for the CSOUR values and again only the 1,500 mg/L PCA tests (this time at 
both 30 and 180 minutes) showed the possibility of not overlapping.  Unfortunately no replicates 
were run for the 1,500 mg/L PCA CSOURs so it is only by looking at the variability for the 
overall test (i.e. the samples where replicates were run), and the very low variability of the 
CSOUR control tests (4.67+/-0.10 and 4.3+/-0.06 for the 30 and 180-min tests respectively) that 
we can conclude that there probably was a real difference in the CSOUR at 1,500 mg/L PCA.    
However in this case the CSOUR was higher than the control values, not lower. 
Therefore there are two major observations: 1) the 1,500 mg/L PCA TSOUR was lower than the 
control TSOUR at 30-min, but not at 180-min.  It is notable that this was also true at 15 and 150 
mg/L PCA (although no replicates were run at those concentrations).  The real question is why 
the TSOUR control values were so high at both 30 and 180-min.  This may have been due to 
temperature differences between the samples but unfortunately no temperature data was obtained 
for all the replicates in the control (the few temperature measurements in the control for TSOUR 
were higher than in the samples containing PCA).  The second observation was 2). The 1,500 
mg/L PCA CSOUR was higher than the CSOUR in the controls at both 30 and 180-min.  This 
may have been because the CSOUR at 1,500 mg/L PCA and 30-min was run at a temperature of 
22.9 °C compared to 20.8 °C for the control.  Or this may have been because PCA interacted 
with ATU in some way to prevent inhibition of nitrifiers.  A third possibility is that PCA 
biodegraded enough to exert an additional carbonaceous oxygen demand.  If this third hypothesis 
is true then the low calculated NSOURs may have been due to inhibition of nitrification due to 
PCA.   
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For mPCA the 1,500 mg/L TSOURs were always the lowest average TSOUR values observed.  
However in all cases the standard deviation overlapped between the 1,500 mg/L TSOURs and 
the controls.  CSOURs were not lower however.  Thus the calculated NSOURs at 1,500 mg/L 
mPCA were much lower than the controls or the 15 and 150 mg/L mPCA samples. 
Overall it is important to acknowledge that the NSOUR values have high cumulative errors since 
they are based on both the observed TSOUR and CSOUR, and may be artifacts due to the 
variability of the measurements they are calculated from.  It is notable however that the NSOUR 
values were low for all of the 1,500 mg/L PCA and mPCA samples tested, both for 30 and 180-
min. So it may be that at high concentrations PCA and mPCA are inhibitory for nitrifiers, though 
this conclusion is tenuous at best.  In contrast no sign of carbonaceous/heterotrophic inhibition 
was observed for either PCA or mPCA at any of the concentrations tested. 
Taking into account the 750 mg/L TSOURs for both PCA and mPCA in the mPCA-2 
experiments it can be concluded that there was no inhibition of TSOURs at 750 mg/L or less for 
either compound.  For mPCA there was no apparent inhibition of either heterotrophs or nitrifiers 
below 750 mg/L.  With PCA the elevated control TSOURs in the PCA experiments makes it less 
certain that there was not some nitrification inhibition.  However the TSOUR observed at 750 
mg/L PCA suggests that the difference between the 15 and 150 mg/L PCA TSOURs and the 
control was due to experimental error (e.g. temperature differences or etc.). 
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Table 4-3: Respiration Rates of AS Exposed for 30 and 180-min to PCA and mPCA 
Test 
Substance 
Conc., 
mg/L 
SOUR, mg O2/g-h & Temperature Measurements 
30-min 180-min 
TSOUR CSOUR NSOUR TSOUR CSOUR NSOUR 
PCA 
Final 
Control 7.91 21.5°C* 4.67 20.8°C* 3.24 8.14 22.6°C* 4.3 21.3°C 3.84 
15 6.77 20.0°C 4.89 21.2°C 1.88 6.76 21.0°C 4.99 22.3°C 1.77 
150 6.87 N/A 4.40 N/A 2.47 6.74 N/A 4.00 N/A 2.74 
1,500 6.93 21.0°C* 5.81 22.9°C* 1.12 7.38 N/A 6.67 N/A 0.71 
mPCA-1 
Avg. 
Controls 6.18 21.2°C 3.48 N/A 2.70 5.74 21.4°C 3.67 21.3°C 1.87 
15 6.01 21.3°C 3.42 N/A 2.59 5.76 21.6°C 3.45 21.5°C 2.31 
150 6.23 21.6°C 3.87 N/A 2.36 5.78 21.8°C 3.34 21.1°C 2.44 
1,500 5.67 21.6°C 3.75 N/A 1.92 4.67 22.0°C 3.63 21.9°C 1.04 
mPCA-2 
Avg. 
Controls 6.95 21.0°C 3.51 20.7°C 3.44 6.80 20.7°C 3.18 21.7°C 3.62 
375 7.10 21.8°C 3.44 21.1°C 3.66 6.92 21.1°C 3.25 22.0°C 3.67 
750 7.62 22.2°C 4.25 21.3°C 3.37 7.61 21.3°C 3.77 22.5°C 3.84 
1,500 6.75 21.2°C 3.99 21.1°C 2.76 6.23 21.1°C 3.73 22.3°C 2.50 
750 mg/L 
PCA 7.61 21.4 °C N/A N/A N/A 7.32 20.7°C N/A N/A N/A 
N/A: Initially the laboratory temperature was maintained at 21±1°C and the temperature in the samples was 
collected only from random reactors for the PCA experiment; for this reason, the temperature is not available for all 
the samples in the PCA experiment. After identifying the variance in temperature between the reactors, temperature 
measurements were collected for all the reactors in the following mPCA tests with the exemption of the samples 
used to find the CSOUR in mPCA-1 test at 30-min.  
Since the temperature was collected from random reactors in the PCA test, the temperature values followed by a 
symbol “*” represent the temperature of one reactor and not the average from the group. 
NSOUR: Specific Oxygen Uptake Rate due to nitrogenous respiration (calculated as TSOUR – CSOUR where 
CSOUR is the SOUR of the samples containing the nitrification inhibitor, i.e. ATU) 
CSOUR: Specific Oxygen Uptake Rate due to carbonaceous respiration 
TSOUR: Total Specific Oxygen Uptake Rate 
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Viability 
One viability test was made after an AS sample used as inoculum was exposed for at least 4 
hours to mPCA and PCA. The samples were spread on petri dishes containing R2A agar to 
analyze if mPCA and PCA might have an effect on the viability of heterotrophic bacteria 
compared to a control. Table 4-4, summarizes the heterotrophic plate counts for this experiment. 
The number of colonies on each dish was estimated by selecting 7 horizontal and 6 vertical 
squares from the colony counter containing a representative colony distribution. Then they were 
multiplied by 4.365 (area of the dish, 56.75 cm2 divided by 13 cm2, area of the squares where the 
colonies were counted) to find the total colony count in the dish. 
The estimated counts from the mPCA and PCA plates did not differ significantly from the 
control plates. The viability of the heterotrophic organisms found in the AS sample used in this 
experiment was not affected after 4 hours of incubation at concentrations of 750 mg/L PCA and 
mPCA. 
Table 4-4: Results of the HPC Analysis on AS Bacteria Exposed to mPCA and PCA 
Sample ID Dilution Vol Sample Used, mL 
Replicate 
A 
Replicate 
B Average 
Total 
Count CFU/mL 
Control 10-4 0.1 56 58 57.0 249 2.5E+07 
mPCA - 750mg/L 10-4 0.1 61 55 58.0 253 2.5E+07 
PCA - 750mg/L 10-4 0.1 57 60 58.5 255 2.6E+07 
Sterile Control - 0.1 1 0 0.5 1 5.00 
Blank Control - 0.1 1 1 1.0 1 - 
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Biodegradation 
Two closed bottle biodegradation tests were performed to estimate the degradation of mPCA and 
PCA by AS organisms after 28 days. Test one was carried out between October 26th, 2012 and 
November 23rd, 2012. This test consisted of nine groups of BOD bottles. Group A was the 
inoculated control group. Groups B to E contained mPCA and PCA at 2 mg/L and 5 mg/L 
concentrations. Group F was used as a reference to verify the lab technique and the activity of 
the inoculum, with a KHP concentration of 3.4 mg/L. Groups G & H contained the reference 
substance from group F in addition to mPCA (Group G) and PCA (Group H). The objective of 
these two groups was to verify if mPCA and PCA were toxic to the inoculum; and Group I was 
used as a blank control for quality control purposes. The sample bottles in this group only 
contained the BOD buffer solution with no inoculum to verify that no significant oxygen 
depletion was caused by contaminated BOD buffer solution or unclean BOD bottles. All the 
dissolved oxygen measurements from this test can be found in Table C-1 in the Appendix C. 
Table 4-5 shows the average oxygen depletion for each set of BOD bottles relative to the oxygen 
depleted in the inoculated control. Since groups G and H did not show a reduction in the activity 
of the microbes at day 7 compared to group F, this indicates that mPCA and PCA were not toxic 
or inhibitory at 5 mg/L to the AS sample used as inoculum.  
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Table 4-5: Average Oxygen Depletion Subtracting the Average Oxygen Consumed in the 
Inoculated Control Set of Test 1 
Group ID Description 
Dissolved Oxygen, mg/L O2 
 Day 4  Day 7  Day 11  Day 14  Day 21 Day 28 
B 2 mg/L mPCA N/A -0.26 N/A -0.22 0 0.07 
C 5 mg/L mPCA -0.03 -0.25 -0.31 -0.27 -0.21 0.01 
D 2 mg/L PCA N/A -0.23 N/A 1.44 2.03 2.46 
E 5 mg/L PCA -0.05 -0.21 0.86 3.27 4.59 5.43 
F 3.4 mg/L KHP 2.67 2.85 3.09 3.1 3.08 3.32 
G 3.4 mg/L KHP + 5 mg/L mPCA N/A 2.81 N/A N/A N/A N/A 
H 3.4 mg/L KHP + 5 mg/L PCA  N/A 3.72 N/A N/A N/A N/A 
The oxygen depletion after 28 days of incubation in samples B and C was not different to the 
depletion observed in the inoculated control. This is represented by the values near to zero after 
28-days of incubation in Table 4-5. The low values indicate that the microbes were not able to 
use mPCA as an alternative source of energy or grow within the experiment incubation period. 
This does not necessarily represent that activated sludge is not capable of using mPCA as a 
source of energy. Microorganisms might be able to use mPCA as a carbon source after an 
adaptation period longer than 28 days or under a different type of test conditions such us using a 
higher concentration of the mixed liquor volatile suspended solid (MLVSS). Adding PCA did 
increase the oxygen depletion in the BOD bottles. In the samples containing 2 mg/L and 5 mg/L 
of PCA, 2.46 and 5.43 mg/L of O2, respectively, was consumed. Comparing these values to their 
theoretical oxygen demand (ThOD) calculated using Equation (3-7), the percentage degradation 
for PCA at 2 and 5 mg/L was 67% and 59% respectively. Please see sample calculations in 
Appendix D.  The ThOD values are presented in Table 4-9. In the sample containing 3.4 mg/L of 
KHP (ThOD 4.0 mg/L O2) the percent degradation was 83% based on its ThOD. Table 4-6 
summarizes the percent degradation of mPCA, PCA, and KHP after 28 days of incubation. 
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Table 4-6: Percent Degradation mPCA, PCA and KHP Relative to their ThOD 
Group 
ID 
Test 
Substance 
% Degradation 
 Day 0 Day 4  Day 7 Day 11 Day 14 Day 21 Day 28 
B 2 mg/L mPCA  0% N/A 0% N/A 0% 2% 0% 
C 5 mg/L mPCA  0% 0% -3% -4% -3% -2% 0% 
D 2 mg/L PCA  0% N/A -6% N/A 39% 55% 67% 
E 5 mg/L PCA  0% -1% -2% 9% 35% 50% 59% 
F 3.4 mg/L KHP  0% 67% 71% 77% 78% 77% 83% 
These results can be visualized in Figure 4-7. The double solid line represents the degradation of 
KHP after time. The graph shows that KHP degrades to about 76% of its ThOD at day 10 which 
is above the 60% required at the same number of days to demonstrate that the inoculum used has 
an acceptable activity and that the technique used in this study was correct. Also, the 
measurements taken on the PCA samples (represented by the dotted lines), shows that 67% 
degradation occurs in the 2 mg/L PCA sample and about 59% degradation occurs in the 5 mg/L 
sample after 28 days. On the other hand, mPCA (dotted lines) did not degrade after 28 days of 
incubation. 
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 Figure 4-7:  Degradation of mPCA, PCA and KHP 
Nitrate and nitrite were measured in the samples in which a significant oxygen demand relative 
to the inoculated control was observed (Groups A, D, and E) starting at day 14. Table C-3 in the 
Appendix C summarizes the nitrite and nitrate concentrations measured on samples from groups 
A, D and E in addition to the calculation of the oxygen consumed due to changes in the 
concentration of nitrate and nitrite. Oxygen consumption from converting the nitrogen in the 
PCA and mPCA compounds to nitrate was not observed from day 14 to the 28. Since the nitrate 
and nitrite concentrations were measured only the last 14 days of the incubation it is not possible 
to determine if most of the oxygen depleted the initial 14 days of incubation was due to the 
nitrification of ammonia present in the dilute AS sample used as the inoculum in the test or due 
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to the present of other readily biodegradable material. Most of the oxygen consumption in the 
inoculated control occurred the first 14-days of incubation (2.44 mg/L O2) and a small fraction of 
the oxygen was depleted the last 14 days (0.51 mg/L O2). 
Biodegradation Test Using a Nitrification Inhibitor 
During the second biodegradation test performed to determine if mPCA and PCA were readily 
biodegradable, similar biodegradation trends were observed on mPCA and PCA compared to the 
test 1. This test consisted of eight groups of BOD bottles labeled them from 1 to 8. Groups 
labeled with even numbers with the exemption of Group 8 contained a nitrification inhibitor 
(NI). Group 1 and 2 were the inoculated control groups; Groups 3 and 4 contained mPCA, 
Groups 5 and 6 contained PCA; Group 7 contained KHP with a concentration of 3.4 mg/L; and 
Group 8 was used as a blank control. The results from this test are summarized in Table 4-8, and 
are visualized in Figure 4-8 and Figure 4-9 . 
Table 4-7: Average Oxygen Depletion Subtracting the Average Oxygen Consumed in the 
Inoculated Control Set of Test 2 
Group ID Test Substance 
Oxygen Demand, mg/L O2 
Day 7 Day 14 Day 20 Day 27 
7 3.4 mg/L KHP 2.5 2.8 2.9 2.9 
3 2 mg/L mPCA 0 0.2 0 0 
5 2 mg/L PCA 0 0.5 1.1 1.4 
4 2 mg/L PCA + Nitrification Inhibitor -0.1 0 0.2 1.6 
2 2 mg/L mPCA + Nitrification Inhibitor  0 0 0.1 0.1 
The results from Table 4-7 were divided in the groups containing the nitrification inhibitor 
(Groups 7, 3, 5) and the groups without it (Groups 2, 4). The oxygen consumption after 27 days 
of incubation was similar in the groups containing PCA with and without NI (1.6 and 1.4 mg/L, 
respectively). On the other hand, the addition of mPCA did not affect the amount of oxygen 
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depleted with respect to the inoculated controls. Based on the ThOD the percentage degradation 
was estimated. Table 4-8 presents the percent degradation of the test substances after the oxygen 
depletion in the controls were subtracted from the oxygen consumed on each samples. Please 
note that groups 3 and 5 are repeated in this table, this is due to the fact that the percentage 
degradation was determined based on two different ThOD values, the one in the top used the 
total ThOD and the other the carbonaceous ThOD. 
Table 4-8: Percentage Degradation of mPCA, PCA and KHP With and Without a 
Nitrification Inhibitor Relative to Their ThOD 
Group 
ID 
Test 
Substance 
% Degradation 
% Degradation 
Based on  
Day 0 Day 7 Day 14 Day 20 Day 27 
% Degradation in samples without nitrification inhibitor 
Total ThOD 
7 KHP 3.4 mg/L 0% 63% 70% 71% 72% 
3 mPCA 2 mg/L  0% 1% 5% 0% 1% 
5 PCA 2 mg/L 0% 0% 15% 32% 41% 
% Degradation in samples with nitrification inhibitor 
Carbonaceous 
ThOD 
2 mPCA 2 mg/L - NI  0% -2% -1% 3% 5% 
4 PCA mg/L -NI 0% -4% 0% 16% 102% 
% Degradation in samples without nitrification inhibitor 
3 mPCA 2 mg/L  0% 2% 8% 0% 1% 
5 PCA 2 mg/L 0% 0% 31% 69% 89% 
NI: Nitrification Inhibitor 
The degradation observed in the KHP sample (> 60% degradation after 10 days) confirms that 
the activity of the inoculum was acceptable. Also, the groups of BOD bottles containing PCA 
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with and without the nitrification inhibitor exhibited 41% and 102%, degradation, respectively. 
The large difference in the percentage degradation of PCA from the groups is due to the 
assumptions made in the calculation of the percent degradation. When the nitrification inhibitor 
was added, it was assumed that the nitrogen in the test substances formed ammonia (𝑇ℎ𝑂𝐷𝑁𝐻3) 
and this ammonia could not be converted into nitrate because of the inhibition to the nitrification. 
If no nitrification inhibitor is added, the ammonia can form nitrite and later nitrate, this reaction 
requires additional oxygen and the ThOD is higher (𝑇ℎ𝑂𝐷𝑁𝑂3 ). If the same ThOD is used to 
determine the percent degradation of the compounds, similar percentage degradations are 
observed 102% and 89% in the PCA samples with and without NI, respectively. Table 4-9 
summarizes the total ThOD (𝑇ℎ𝑂𝐷𝑁𝑂3 ) and the carbonaceous ThOD (𝑇ℎ𝑂𝐷𝑁𝐻3) values for 
mPCA and PCA.  
For the sample groups containing mPCA, no impact on the oxygen consumption was observed. 
This implies that mPCA was not readily biodegradable under the conditions of this study.  
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 Figure 4-8: Degradation of PCA, mPCA and KHP 
Table 4-9: Theoretical Oxygen Demand of mPCA, and PCA 
Test Substance 𝑻𝒉𝑶𝑫𝑵𝑯𝟑 ,𝒎𝒈 𝑶𝟐𝒎𝒈 𝑻𝑺 𝑻𝒉𝑶𝑫𝑵𝑶𝟑 ,𝒎𝒈 𝑶𝟐𝒎𝒈 𝑻𝑺 
mPCA 1.02 1.84 
PCA 0.79 1.69 
KHP 1.175 - 
TS: Test Substance  
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 Figure 4-9: Degradation of mPCA and PCA in the Presence of a Nitrification Inhibitor 
  
-20%
0%
20%
40%
60%
80%
100%
120%
0 5 10 15 20 25 30
%
 D
eg
ra
da
tio
n 
Days 
PCA 2mg/L+NI mPCA 2 mg/L+NI
69 
5. CONCLUSIONS 
Finding safer and more economical methods for treatment of hydrazine (HZ) and 
monomethylhydrazine (MMH) wastes are of great interest to NASA and more specifically to the 
Kennedy Space Center (KSC) because these wastes are the major hazardous wastes streams 
produced there. A new method using alpha ketoglutaric acid (AKGA) was proposed to treat HZ 
and MMH wastes. From the reaction of AKGA with HZ and MMH two products are formed, 
1,4,5,6-tetrahydro-6-oxo-3-pyridazinecarboxylic acid (PCA) and l-methyl-1,4,5,6-tetrahydro-6-
oxo-3-pyridazinecarboxylic (mPCA), respectively. In order to find if PCA and mPCA can be 
safely disposed of into the Cape Canaveral Air Force Station Wastewater Treatment Plant 
(CCAFS WWTP), the toxicity of these compounds were studied using bioassays on fish 
(Pimephales promelas) and crustaceans (Ceriodaphnia dubia).  In addition, respiration inhibition 
tests using activated sludge (AS) samples from the CCAFS WWTP and viability tests using 
heterotrophic plate counts (HPCs) were performed. Also, biodegradation test were conducted to 
observe if PCA and mPCA could be decomposed by AS organisms. 
The highest concentration of PCA and mPCA used in this research was 1.5 g/L. From the 
bioassay studies performed using mPCA, the lethal concentration that would kill 50 percent of 
the population (LC50) of C. dubia was determined at 0.77 g/L ±0.06 (with a 95% confidence 
level) and with a non-observable effect concentration (NOEC) estimated at 0.50 g/L after 96 
hours of exposure. The LC50 could not be identified on P. promelas, so the value must exceed 
1.5 g/L.  However at mPCA concentrations of 0.5 g/L and above, effects in the behavior and 
their physical appearance were observed. These effects included curved spines and loss of 
equilibrium. The NOEC on the fish was estimated at 0.75 g/L. On the other hand, the 
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mortality/immobilization caused by exposing C. dubia to PCA (for 96 hours) was low compared 
to mPCA with 100% survival at 1.0 g/L and below, and 80% survival at 1.25 and 1.5 g/L. No 
effect on the mortality and the behavior of the fish was observed after exposing them to 
concentrations of up to 1.5 g/L of PCA. 
The effect on the treatment efficiency was evaluated by measuring the respiration rate of an 
activated sludge sample from CCAFS WWTP exposed to mPCA and PCA and comparing it to 
the respiration of a portion of the same batch of AS that was not exposed to the chemicals. The 
differences in temperature caused by using two different air sources for the aeration of the PCA 
test in addition and the tendency of the stirring plates used in this experiment to increase their 
temperature after time, made firm conclusions difficult. In addition replicate measurements 
showed that the variability of the values obtained could be significant.  Overall the effect of PCA 
and mPCA on total respiration rates was small and only observed at 1,500 mg/L if at all.  Further 
this effect was apparently caused by the inhibition of nitrification rather than by heterotrophic 
inhibition.  However it cannot be firmly concluded that PCA or mPCA at a concentration of 
1,500 mg/L was inhibitory to nitrification.  But it can be concluded that there was probably no 
significant inhibition of either nitrification or heterotrophic (carbonaceous) respiration for either 
PCA or mPCA. 
The viability of heterotrophic organisms after exposing them for 4 hours to PCA and mPCA was 
estimated with HPCs. By comparing the number of colonies formed after 7-days of incubation, 
there was not a significant difference between the number of colonies in the control (2.5x107 
CFU/mL)  and  the number of colonies from the samples containing PCA (2.6x107 CFU/mL)  
and mPCA (2.5x107 CFU/mL).   
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Based on the results from the biodegradation tests, the samples of AS organisms used were 
capable of biodegrading up to 67% of PCA (with respect to its total theoretical oxygen demand) 
after 28 days of incubation using a concentration of 2.0 mg/L PCA. On the other hand, 
biodegradation of mPCA was not observed over 28 days of incubation. It can be concluded that 
under the conditions of this test PCA was biodegradable while mPCA was not.  This may imply 
that significant amounts of mPCA might not be removed in the AS plant but the biomass in this 
test was much more dilute than the MLVSS concentration in the plant, and that may make a 
difference. 
The results of this research show that mPCA is significantly more toxic than PCA.  However 
neither mPCA nor PCA was inhibitory to heterotrophic AS organisms although it is possible that 
both PCA and mPCA could inhibit nitrification at a concentration of 1.5 g/L. No effect on 
nitrification was observed on mPCA at 0.75 g/L. PCA was not evaluated at 0.75 g/L for 
nitrification inhibition. Both compounds could not be completely degraded by dilute AS biomass 
during a 28 day incubation period using 2 and 5 mg/L concentrations in BOD-like 
biodegradation tests.  mPCA did not show significant degradation at all.   Additional analyses are 
required to identify if mPCA can be biodegraded under different types of test conditions such as 
in an anaerobic environment and with a more concentrated biomass.  In addition it needs to be 
determined if PCA can be completely biodegraded if the concentration of biomass is higher (and 
thus more representative of actual AS MLVSS concentrations).  It is well known that some 
compounds may not be degradable, or may be inhibitory, in a BOD test while still being 
biodegradable in an actual reactor with high MLVSS concentrations (Vázquez-Rodríguez, et al., 
2011, Van Ginkel, et al., 1995). 
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APPENDIX A: 
ACUTE TOXICITY TESTS 
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Standard Operating Procedure for Pimephales promelas and Ceriodaphnia dubia Acute Toxicity 
Tests 
Pimephales promelas Acute Toxicity Method 
Materials 
1. 600 mL beakers 
2. 25 mL wide bored glass pipet 
3. 2.5 gallon aquarium 
4. Separatory funnel 
5. Air pumps 
6. 150 µm screen 
7. 1000 mL volumetric flasks 
8. Timer 
9. Test tubes 
10. Perrier ® water 
 
Materials and dilution medium preparation 
1. Prepare moderately hard synthetic dilution water by mixing 4 L of Perrier ® water and 16 
L of deionized water. Aerate the medium for 24 hours before test initiation to stabilize it.  
2. Clean all materials that come in contact with the dilution water and the dilutions 
containing the test substance following process described below: 
a. Soak at least 15 minutes in tap water, and scrub with detergent 
b. Rinse three times with tap water  
c. Carefully rinse once with 10 percent solution of hydrochloric acid 
d. Rinse three times with deionized water 
e. Allow all materials to air dry 
Food preparation and collection 
1. In a separatory funnel add 1 L of 20 percent dilution water; add 1 teaspoon of Artemia 
nauplii (brine shrimp) eggs and two tablespoons of aquarium salt. 
2. Place an airline inside the separatory funnel and provide aeration from the bottom of the 
funnel. Air bubbles will keep the Artemia circulating inside the container.  
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3. At 25˚ to 28 ˚C, the Artemia will begin to hatch in 24 hours. 
4. To collect the Artemia for feeding, remove the air supply and allow unhatched cysts to 
settle to the bottom of the funnel for about 5-min. 
5. Live brine shrimp will settle to the bottom of the funnel creating an orange layer.  
6. Remove the brine shrimp using a wide-bore pipette.  
7. Rinse the Artemia with dilution water before feeding using the 150 µm screen. 
Test initiation 
1. Upon arrival to the lab, measure the temperature of the fish media to determine if the fish 
were subject to thermal stress. 
2. Carefully transfer the fish from shipping container to the 2.5 gallon aquarium.  
3.  Feed the test organisms with Artemia for two hours in the holding tank before the test 
starts. 
4. Label the 600 mL test chambers using numbers from “1” to “6”. Each number represents 
a different test concentration, “2” being the lowest and 6 the highest concentration. After 
the number write a letter from A to D to represent each replicate. Chambers labeled as 
number 1 are used as controls. The media should only contain dilution water without test 
substance. In total, 24 test containers are prepared. 
5. Calibrate pH, conductivity, and dissolve oxygen (DO) meters following the manufacturer 
recommendations. 
6. Fill a test tube with dilution water and measure its pH, dissolved oxygen, temperature, 
and conductivity. Record all these readings on the bench sheets. 
7. Measure the desired masses of the test substance to prepare five different test 
concentrations (Minimum required for definitive tests). 
8. Dilute the test substances in 1000 mL volumetric flasks. 
a. If the solution has a pH outside the range of 6.0 to 9.0, first dilute the chemical in 500 mL 
of dilution water and adjust the pH to 8.0 ± 0.3 using a solution of 1N sodium hydroxide 
or 1N hydrochloric acid. Then add dilution water to make a final volume of 1000 mL. 
9. Pour 200 mL from each test solution concentration into their corresponding replicates. 
Set aside the additional solution to measure pH, conductivity, temperature, and DO 
measurements. 
75 
10. After the two hour feeding period, using a wide-bore pipette, load two test organisms at a 
time into each test chamber. Repeat this process until there are ten fish in each test vessel. 
11. Verify that 10 organisms were loaded into each chamber. 
12. Place the test vessels in random order across the table using a randomization chart.  
13. Measure alkalinity, and hardness in the dilution water (control or concentration 1) and on 
the highest concentration of the test substance (concentration 6). 
a. Alkalinity: Standard Methods for the Examination of Water and Wastewater, 
Method 2320.  
b. Hardness: Use Hach (Hach Company, Loveland, CO) kit. Hach Method 8226. 
14. Record daily the number of surviving organisms per vessel. In addition, measure pH, 
conductivity, DO, and temperature on one replicate per concentration. If there is any 
organism showing behavior associated with considerable suffering they should be 
removed and humanely euthanized.  
Test renewal: 48 hours after test initiation 
15. Add 0.2 mL of concentrated Artemia at least two hours prior to test renewal on each test 
chamber. 
16. Within this two hour period, prepare fresh solutions of the test substance. 
17. At the end of the feeding period, collect one aliquot per test concentration from any 
replicate. Measure pH, conductivity, temperature, and DO 
18. Carefully remove about 80% of the old test solution using a large pipette. Pour the new 
solution slowly down the side of the test vessel to avoid excessive turbulence and to 
prevent damage to the fish. 
19. Measure alkalinity and hardness on the new test media. 
Test termination: 96-hr after test initiation 
20. Count the number of surviving fish in each chamber. 
21. Collect one aliquot from each test concentration. Measure pH, conductivity, temperature, 
and DO. 
22. If using hazardous samples, remove the fish from the solutions and collect the test media 
in amber glass bottles. Dispose as required by local authorities. 
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23. All test organisms should be humanely euthanized and disposed of in an appropriate 
manner. 
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Summary of Test Conditions for Pimephales promelas Acute Toxicity Test using PCA and 
mPCA  
(EPA Test Method 2000.0) 
1. Test type      Static-renewal 
2. Test duration      96- hours 
3. Age of test organisms     1-14 days old 
4. Test chamber size     600 mL 
5. Test solution volume     200 mL 
6. Renew of test solution    After 48 hours 
7. Photoperiod      16 hours light, and 8 hours darkness 
8. Number of organisms per chamber   Ten 
9. Number of replicates per concentration  Four 
10. Number of organisms per concentration  Forty 
11. Test Concentrations     Five and a control 
12. Test substance      PCA and mPCA 
13. Test concentrations     0.5, 0.75, 1.0, 1.25, and 1.5 g/L  
14. Dilution water      Moderately hard dilution water 
15. Feeding:       Artemia nauplii during holding and  
two hours prior to solution renewal 
16. Temperature      25 ±1˚C  
17. End Point       Mortality 
18. Test acceptability     90 percent or greater survival in  
                                                            controls 
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Ceriodaphnia dubia Acute Toxicity Method 
Materials 
1. 30 mL plastic medicine cups 
2. Transfer pipettes 
3. 2.5 gallon aquarium 
4. Air pump 
5. 500 and 100 mL volumetric flasks 
6. Timer 
7. Test tubes 
8. 2 L Beaker 
9. DO, pH, conductivity meters 
10. Plastic tray 
11. Perrier ® water 
 
Materials and dilution medium preparation 
1. Prepare moderately hard synthetic dilution water by mixing 4 L of Perrier ® water and 16 
L of de-ionized water. Aerate the medium for 24 hours before test initiation to stabilize it.  
2. Clean all materials that come in contact with the dilution water and the dilutions 
containing the test substance following the process described below: 
a. Soak at least 15 minutes in tap water, and scrub with detergent 
b. Rinse three times with tap water  
c. Carefully rinse once with 10 percent solution of hydrochloric acid 
d. Rinse three times with deionized water 
e. Allow all materials to air dry 
Test initiation 
1. Upon arrival to the lab, measure the temperature of the C. dubia media to determine if the 
organisms were subject to thermal stress. 
2. Carefully transfer the fish from shipping container to the 2 L beaker.  
3. Feed the test organisms with a mixture of Yeast, Cerophyll, and Trout chow (YCT) and 
green alga, Selenastrum capricornutum for two hours in the holding tank before the test 
starts. 
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4. Label the 30 mL test chambers using numbers from “1” to “6”. Each number represents a 
different test concentration, “2” being the lowest and 6 the highest concentration. After 
the number write a letter from A to D to represent each replicate. Chambers labeled as 
number 1 are used as controls. The media should only contain dilution water without test 
substance. In total, 24 test containers are prepared. 
5. Calibrate pH, conductivity, and dissolve oxygen (DO) meters following the manufacturer 
recommendations. 
6. Fill a test tube with dilution water and measure its pH, DO, temperature, and 
conductivity. Record all these readings on the bench sheets. 
7. Measure the desired masses of the test substance to prepare five different test 
concentrations (Minimum required for definitive tests). 
8. Dilute the test substances in 500 mL or 100 mL volumetric flasks. 
a. If the solution has a pH outside the range of 6.0 to 9.0, first dilute the chemical in 200 or 
50 mL of dilution water and adjust the pH to 8.0 ± 0.3 using a solution of 1N sodium 
hydroxide or 1N hydrochloric acid. Then add dilution water to the mark indicating the 
volume of the volumetric flask (500 or 100 mL). 
9. Pour 20 mL from each test solution concentration into their corresponding replicates. Set 
aside the additional solution to measure pH, conductivity, temperature, and DO 
measurements. 
10. After the two hour feeding period, using a transfer plastic pipette, load two test organisms 
at the time into each test chamber. Repeat this process until there are 5 C. dubia in each 
test vessel. 
11. Verify that 5 organisms were loaded into each chamber. 
12. Place the test vessels in random order across a plastic tray using a randomization chart.  
13. Measure alkalinity, and hardness in the dilution water (control or concentration 1) and on 
the highest concentration of the test substance (concentration 6). 
a. Alkalinity: Standard Methods for the Examination of Water and Wastewater, 
Method 2320.  
b. Hardness: Use Hach pillows (Hach Company, Loveland, CO) kit. Hach Method 
8222. 
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14. Record daily the number of surviving organisms per vessel. In addition, measure pH, 
conductivity, DO, and temperature if there is a test chamber with 100 % of their organism 
immobile.  
Test renewal: 48 hours after test initiation 
1. Add 0.1 mL of YCT and 0.1 mL of green alga, S. capricornutum at least two hours prior 
to test renewal on each test chamber. 
2. Within this two hour period, prepare fresh solutions of the test substance. 
3. At the end of the feeding period, collect one aliquot per test concentration from any 
replicate. Measure pH, conductivity, temperature, and DO. 
4. Carefully remove and transfer each organism into the fresh solutions using a transfer 
pipette. 
5. Measure alkalinity and hardness on the new test media. 
Test termination: 96-hr after test initiation 
24. Count the number of surviving organisms in each chamber. 
25. Collect one aliquot from each test concentration. Measure pH, conductivity, temperature, 
and DO. 
26. If using hazardous samples, remove the fish from the solutions and collect the test media 
in amber glass bottles. Dispose as required by local authorities. 
References 
1) Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to 
Freshwater and Marine Organisms, USEPA, 5th Edition, 2002. 
2) Ceriodaphnia dubia Acute Toxicity Testing Methods, TA-07.01-7.15, Florida Department of 
Environmental Protection, 2012.  
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Summary of Test Conditions for Ceriodaphnia dubia Acute Toxicity Test using PCA and 
mPCA 
 (EPA Test Method 2002.0) 
1. Test type      Static-renewal 
2. Test duration      96- hours 
3. Age of test organisms     Less than 24 hours 
4. Test chamber size     30 mL 
5. Test solution volume     20 mL 
6. Renew of test solution    After 48 hours 
7. Photoperiod      16 hours light, and 8 hours darkness 
8. Number of organisms per chamber   Five 
9. Number of replicates per concentration  Four 
10. Number of organisms per concentration  Twenty 
11. Test Concentrations     Five and a control 
12. Test substance      PCA and mPCA 
13. Test concentrations     0.5, 0.75, 1.0, 1.25, and 1.5 g/L  
14. Dilution water      Moderately hard synthetic dilution                 
        water  
15. Feeding      YCT, Selenastrum c. during holding  
       and two hours prior to test renewal                                                                       
16. Temperature      25 ±1˚C  
17. End Point       Mortality 
18. Test acceptability     90 percent or greater survival in  
controls  
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RANDOMIZATION CHART 
 
Replicate Position of the Test Solution 
A 3 5 2 6 1 4 
B 1 4 5 3 2 6 
C 2 6 3 1 4 5 
D 5 1 6 4 3 2 
The numbers from 2 to 6 represents a different concentration of the test solution, 1 represents the 
position of the mineral dilution water.  
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Raw Data Acute Toxicity Tests 
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 Figure A-1: mPCA Toxicity on Pimephales promelas at 96 hours, Dose – Response Curve 
Pimephales promelas - mPCA (96 hours Acute Toxicity) 
Concentrations Control 0.5 g/L 0.75 g/L 1.0 g/L 1.25 g/L 1.5 g/L 
Survival Count 
10 10 10 7 7 5 
9 9 9 5 4 6 
10 10 10 5 6 8 
10 10 9 7 5 6 
mean 9.75 9.75 9.5 6 5.5 6.25 
Std. Dev. 0.50 0.50 0.58 1.15 1.29 1.26 
% Mortality 2.5% 2.5% 5.0% 40.0% 45.0% 37.5% 
% Std. Dev. 5.0% 5.0% 5.8% 11.5% 12.9% 12.6% 
% Survival 97.5% 97.5% 95.0% 60.0% 55.0% 62.5% 
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 Figure A-2: mPCA Toxicity on Ceriodaphnia dubia at 96-hours, Dose - Response Curve 
Ceriodaphnia dubia - mPCA (96 hours Acute Toxicity) 
Concentrations Control 0.5 g/L 0.75 g/L 1.0 g/L 1.25 g/L 1.5 g/L 
Survival Count 
5 5 4 1 0 0 
5 5 1 0 0 0 
5 5 2 1 0 0 
5 5 4 1 0 0 
mean 5 5 2.75 0.75 0 0 
Std. Dev. 0.00 0.00 1.50 0.50 0.00 0.00 
% Mortality 0.0% 0.0% 45.0% 85.0% 100.0% 100.0% 
% Std. Dev. 0.0% 0.0% 30.0% 10.0% 0.0% 0.0% 
% Survival 100.0% 100.0% 55.0% 15.0% 0.0% 0.0% 
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 Figure A-3: PCA Toxicity on Ceriodaphnia dubia at 96-hours, Dose - Response Curve 
Ceriodaphnia dubia - PCA (96 hours Acute Toxicity) 
Concentrations Control 0.5 g/L 0.75 g/L 1.0 g/L 1.25 g/L 1.5 g/L 
Survival Count 
5 5 5 5 5 3 
5 5 5 5 3 4 
5 5 5 5 3 4 
5 5 5 5 5 5 
mean 5 5 5 5 4 4 
Std. Dev. 0.00 0.00 0.00 0.00 1.15 0.82 
% Mortality 0% 0% 0% 0% 20% 20% 
% Std. Dev. 0% 0% 0% 0% 23% 16% 
% Survival 100.0% 100.0% 100.0% 100.0% 80.0% 80.0% 
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Statistical Analysis from the Whole Effluent Toxicity Spreadsheet 
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Although the 
spreadsheet can 
determine the LC50 
for the acute toxicity 
test using the 
graphical method, the 
TKS method is more 
appropriated for this 
data. LC50 are 
reported using the 
TKS method in the 
body of the study. 
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Although the 
spreadsheet can 
determine the LC50 
for the acute toxicity 
test using the 
graphical method, the 
TKS method is more 
appropriated for this 
data. LC50 are 
reported using the 
TKS method in the 
body of the study. 
115 
116 
  
Although the 
spreadsheet can 
determine the LC50 
for the acute toxicity 
test using the 
graphical method, the 
TKS method is more 
appropriated for this 
data. LC50 are 
reported using the 
TKS method in the 
body of the study. 
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Standard Reference Toxicity Tests 
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Figure A-4: Standard Reference Toxicant Control Chart for Pimephales promelas Acute 
Toxicity Test 
The LC50 line represents the actual LC50 calculated for the test. 
The LC50 means represents the cumulative mean from the LC50 values determined from all tests. 
Data plotted in this figure was taken from Table A-1 
  
119 
Table A-1: Control Limit Determination, Standard Reference Toxicant for P. promelas 
Test # Test ID Test Date LC50 Cumulative LC50 
Standard 
Deviation 
LC 50 
Upper 
Limit 
(Mean 
+2 Std. 
Dev.) 
LC 50 
Lower 
Limit 
(Mean -
2 Std. 
Dev.) 
Statistical 
Method 
Used to 
determine 
LC 50 
%CV 
Value 
1 030912 3/9/2012 7.04         TSK   
2 031612 3/16/2012 6.12 6.58 0.65 7.88 5.28 TSK 0.10 
3 032112 3/21/2012 5.49         Probit*   
4 042812 4/28/2012 6.57 6.58 0.46 7.50 5.66 TSK 0.07 
5 050312 5/3/2012 8.27 7.00 0.93 8.85 5.15 TSK 0.13 
6 060112 6/1/2012 7.92 7.18 0.90 8.99 5.38 TSK 0.13 
7 062812 6/28/2012 7.02 7.16 0.81 8.77 5.54 TSK 0.11 
TSK: Trimmed Spearman-Karber Method 
* The LC50 value of Test #3 was determined using the Probit Method of interpolation because it did not satisfy the 
requirements of the TSK method. Since all the LC50 used to generate the Standard Reference Toxicant (SRT) control 
chart must be calculated using the same statistical method, Test #3 was not included in the determination of the 
control limits for the SRT control chart for P. promelas. 
LC50 values calculated using the TSK method were determined using the EPA Trimmed Spearman-Karber (TSK) 
Program Version 1.5. 
LC50 values calculated using the Probit method were determined using the EPA Probit Analysis program Version 
1.5. 
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 Figure A-5: Coefficient of Variance Pimephales promelas Acute LC50 
Data plotted in this figure was taken from Table A-1 
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 Figure A-6: Standard Reference Toxicant Control Chart for Ceriodaphnia dubia Toxicity 
Test 
The LC50 line represents the actual LC50 calculated for the test. 
The LC50 means represents the cumulative mean from the LC50 values determined from all tests. 
Data plotted in this figure was taken from Table A-2  
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Table A-2: Control Limits Determination, Standard Reference Toxicant for C. dubia 
Test 
# Test ID Test Date LC50 
Cumulative 
LC50 Means 
Standard 
Deviation 
LC50 
Upper 
Limit 
(Mean 
+2 Std. 
Dev.) 
LC50 
Lower 
Limit 
(Mean -2 
Std. 
Dev.) 
Statistical 
Method 
Used to 
determine 
LC50 
%CV 
Value 
1 050312 5/3/2012 1.30 - - - - TSK - 
2 051812 5/18/2012 1.70 1.50 0.28 2.07 0.93 TSK 19% 
3 052412 5/24/2012 1.40 1.47 0.21 1.88 1.05 TSK 14% 
4 060512 6/5/2012 1.35 1.44 0.18 1.80 1.08 TSK 13% 
5 071312 7/13/2012 1.75 1.50 0.21 1.92 1.08 TSK 14% 
6 072012 7/20/2012 2.00 1.58 0.28 2.14 1.03 TSK 17% 
7 072612 7/26/2012 1.88 1.63 0.28 2.18 1.07 TSK 17% 
TSK: Trimmed Spearman-Karber Method 
LC50 values calculated using the TSK method were determined using the EPA Trimmed Spearman-Karber (TSK) 
Program Version 1.5 
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 Figure A-7: Coefficient of Variance Ceriodaphnia dubia Acute LC50 
Data plotted in this figure was taken from Table A-2  
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APPENDIX B: 
MICROBIAL TREATMENT EFFICIENCY AND VIABILITY TEST RESULTS 
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Table B-1: PCA Test Preparation 
Test Substance Test Substance Concentration, mg/L 
Conc. MLSS of 
the Inoculum, 
g/L 
Volume 
inoculum, mL 
Final 
Concentration in 
500 mL, g/L 
Conc. 
ATU, 
mg/L 
PCA 
15 2.43 250 1.21 0 
150 2.43 250 1.21 0 
1500 2.43 250 1.21 0 
PCA + ATU 
15 2.43 250 1.21 11.6 
150 2.43 250 1.21 11.6 
1500 2.43 250 1.21 11.6 
3,4-DCP 
1 2.43 250 1.21 0 
10 2.43 250 1.21 0 
100 2.43 250 1.21 0 
Initial and final 
Controls 0 2.43 250 1.21 0 
Initial and final 
Controls + ATU 0 2.43 250 1.21 11.6 
 
ATU: N-allylthiourea; 3,4-DCP: 3,4-dichlorophenol 
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Table B-2: mPCA-1 Test Preparation 
Test Substance Test Substance Concentration, mg/L 
Conc. MLSS of 
the Inoculum, 
g/L 
Volume 
inoculum, 
mL 
Final 
Concentration in 
500 mL, g/L 
Conc. 
ATU, 
mg/L 
mPCA 
15 3.80 210 1.60 0 
150 3.80 210 1.60 0 
1500 3.80 210 1.60 0 
mPCA + ATU 
15 3.80 210 1.60 11.6 
150 3.80 210 1.60 11.6 
1500 3.80 210 1.60 11.6 
3,4-DCP 
1 3.80 210 1.60 0 
10 3.80 210 1.60 0 
100 3.80 210 1.60 0 
Initial and final 
Controls 0 3.80 210 1.60 0 
Initial and final 
Controls + ATU 0 3.80 210 1.60 11.6 
ATU: N-allylthiourea; 3,4-DCP: 3,4-dichlorophenol 
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Table B-3: mPCA-2 Test Preparation 
Test Substance Test Substance Concentration, mg/L 
Conc. MLSS 
of the 
Inoculum, 
g/L 
Volume 
inoculum 
used, mL 
Final 
Concentration in 
500 mL, g/L 
Conc. ATU, mg/L 
mPCA 
375 3.38 240 1.62 0 
750 3.38 240 1.62 0 
1500 3.38 240 1.62 0 
mPCA + ATU 
375 3.38 240 1.62 11.6 
750 3.38 240 1.62 11.6 
1500 3.38 240 1.62 11.6 
3,4-DCP 
1 3.38 240 1.62 0 
10 3.38 240 1.62 0 
100 3.38 240 1.62 0 
Initial and final 
Controls 0 3.38 240 1.62 0 
Initial and final 
Controls + 
ATU 
0 3.38 240 1.62 11.6 
ATU: N-allylthiourea; 3,4-DCP: 3,4-dichlorophenol 
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Table B-4: PCA – Raw Data Collected After 30-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., °C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A   8.85 8.69 8.60 8.48 8.37 8.24 8.12 8.00 7.89 7.76 7.64 N/A 
C1B   8.65 - 8.71 8.74 - - 8.49 8.55 8.41 8.28 8.14 N/A 
C1C   8.64 8.54 8.49 8.37 8.25 8.11 7.97 7.84 7.69 7.56 7.43 N/A 
R1A-1mg/L   9.7 9.57 9.47 9.36 9.27 9.18 9.07 8.98 8.88 8.76 8.65 16.9 
R1B-1mg/L   8.72 8.96 9.00 8.91 8.81 8.73 8.66 8.56 8.45 8.35 8.24 N/A 
R1C-1mg/L   10.38 10.51 10.51 10.42 10.33 10.22 10.10 9.97 9.85 9.76 9.65 N/A 
R2A-10mg/L   9.51 9.45 9.39 9.34 9.28 9.26 9.15 9.09 9.03 8.98 8.92 N/A 
R2B-10mg/L   8.57 8.84 8.82 - - - - 8.53 8.68 8.68 - N/A 
R2C-10mg/L   9.47 9.40 9.33 9.28 9.23 9.17 9.11 9.07 9.00 8.94 8.87 18.0 
R3A-100mg/L   8.84 8.79 8.74 8.69 8.65 8.83 8.85 8.85 8.84 8.82 8.80 N/A 
R3B-100mg/L   - - - - - - 8.26 - 8.72 8.71 8.68 N/A 
R3C-100mg/L   9.25 9.20 9.19 9.18 9.17 9.15 9.14 9.13 9.11 9.10 9.09 N/A 
PCA1A-15mg/L   8.71 8.58 8.45 8.31 8.17 8.03 7.89 7.76 7.61 7.48 7.34 20.0 
PCA2A-150mg/L   7.06 6.89 6.76 6.62 6.48 6.36 6.22 6.08 5.94 5.81 5.67 N/A 
PCA3A-1500mg/L   7.62 7.52 7.38 7.24 7.09 6.96 6.82 6.68 6.61 6.42 6.28 N/A 
PCA3B-1500mg/L   8.6 8.45 8.31 8.17 8.02 7.88 7.73 7.58 7.44 7.28 7.15 21.0 
PCA3C-1500mg/L   7.51 7.33 7.19 7.05 6.91 6.77 6.64 6.50 6.36 6.21 6.09 N/A 
C2A   8.73 8.59 8.44 8.27 8.12 7.95 7.79 7.62 7.46 7.28 7.13 N/A 
C2B   8.52 8.33 8.18 8.00 7.83 7.65 7.44 7.23 7.15 6.98 6.81 21.5 
C2C   7.54 7.38 7.24 7.08 6.94 6.78 6.64 6.49 6.35 6.20 6.05 N/A 
Control1N +ATU   8.87 8.81 8.73 8.63 8.53 8.42 8.37 8.32 8.14 8.04 7.94 20.7 
PCA1AN-15mg/L+ATU   8.44 8.33 8.22 8.14 8.03 7.93 7.84 7.74 7.64 7.54 7.45 21.2 
PCA2AN-150mg/L+ATU   7.32 7.26 7.14 7.06 6.97 6.88 6.79 6.71 6.61 6.52 6.43 N/A 
PCA3AN-1500mg/L+ATU   8.32 8.14 8.00 7.88 7.76 7.64 7.52 7.41 7.30 7.18 7.06 22.9 
Control2N+ATU   8.64 8.53 8.49 8.34 8.25 8.16 8.06 7.96 7.87 7.78 7.68 20.9 
ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls   
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Table B-5: PCA – Valid DO Concentration Measurements After 30-min Exposure at 1 minute Intervals 
Sample ID 
Dissolved Oxygen Concentration, mg/L 
R2 
Minutes in the 
Linear Section of 
the Curve 
Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A 8.85 8.69 8.60 8.48 8.37 8.24 8.12 8.00 7.89 7.76 7.64 0.9993 10 
C1B 8.65 - 8.71 8.74 - - 8.49 8.55 8.41 8.28 8.14 0.9995 3 
C1C 8.64 8.54 8.49 8.37 8.25 8.11 7.97 7.84 7.69 7.56 7.43 0.9924 8 
R1A-1mg/L 9.70 9.57 9.47 9.36 9.27 9.18 9.07 8.98 8.88 8.76 8.65 0.9988 10 
R1B-1mg/L 8.72 8.96 9.00 8.91 8.81 8.73 8.66 8.56 8.45 8.35 8.24 0.9968 8 
R1C-1mg/L 10.38 10.51 10.51 10.42 10.33 10.22 10.10 9.97 9.85 9.76 9.65 0.9976 8 
R2A-10mg/L 9.51 9.45 9.39 9.34 9.28 9.26 9.15 9.09 9.03 8.98 8.92 0.9945 10 
R2B-10mg/L 8.57 8.84 8.82 - - - - 8.53 8.68 8.68 - 0.1013 8 
R2C-10mg/L 9.47 9.40 9.33 9.28 9.23 9.17 9.11 9.07 9.00 8.94 8.87 0.9981 10 
R3A-100mg/L 8.84 8.79 8.74 8.69 8.65 8.83 8.85 8.85 8.84 8.82 8.80 0.9797 3 
R3B-100mg/L - - - - - - 8.26 - 8.72 8.71 8.68 0.9231 2 
R3C-100mg/L 9.25 9.20 9.19 9.18 9.17 9.15 9.14 9.13 9.11 9.10 9.09 0.9943 9 
PCA1A-15mg/L 8.71 8.58 8.45 8.31 8.17 8.03 7.89 7.76 7.61 7.48 7.34 0.9999 10 
PCA2A-150mg/L 7.06 6.89 6.76 6.62 6.48 6.36 6.22 6.08 5.94 5.81 5.67 0.9996 10 
PCA3A-1500mg/L 7.62 7.52 7.38 7.24 7.09 6.96 6.82 6.68 6.61 6.42 6.28 0.9981 9 
PCA3B-1500mg/L 8.60 8.45 8.31 8.17 8.02 7.88 7.73 7.58 7.44 7.28 7.15 0.9999 10 
PCA3C-1500mg/L 7.51 7.33 7.19 7.05 6.91 6.77 6.64 6.50 6.36 6.21 6.09 0.9993 9 
C2A 8.73 8.59 8.44 8.27 8.12 7.95 7.79 7.62 7.46 7.28 7.13 0.9996 10 
C2B 8.52 8.33 8.18 8.00 7.83 7.65 7.44 7.23 7.15 6.98 6.81 0.9974 10 
C2C 7.54 7.38 7.24 7.08 6.94 6.78 6.64 6.49 6.35 6.20 6.05 0.9999 10 
Control1N+ATU 8.87 8.81 8.73 8.63 8.53 8.42 8.37 8.32 8.14 8.04 7.94 0.9908 10 
PCA1AN-15mg/L+ATU 8.44 8.33 8.22 8.14 8.03 7.93 7.84 7.74 7.64 7.54 7.45 0.9996 10 
PCA2AN-150mg/L+ATU 7.32 7.26 7.14 7.06 6.97 6.88 6.79 6.71 6.61 6.52 6.43 0.9992 10 
PCA3AN-1500mg/L+ATU 8.32 8.14 8.00 7.88 7.76 7.64 7.52 7.41 7.30 7.18 7.06 0.9969 8 
Control2N+ATU 8.64 8.53 8.49 8.34 8.25 8.16 8.06 7.96 7.87 7.78 7.68 0.9978 10 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
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Table B-6: PCA – SOUR & Percentage Total Inhibition Calculations after 30-min Exposure  
Test Substance mg/L 
Total Respiration at 30 min SOUR 
mg O2/g-
h 
Average 
SOUR, mg 
O2/g-h 
% Total 
Inhibition Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.16 0.09 0.12 0.11 0.13 0.12 0.12 0.11 0.13 0.12 5.98 
6.43 - C1B 8.65 -8.71 -0.03 8.74 0.00 -8.49 -0.06 0.14 0.13 0.14 6.76 
C1C 0.10 0.05 0.12 0.12 0.14 0.14 0.13 0.15 0.13 0.13 6.55 
R1A-1mg/L 0.13 0.10 0.11 0.09 0.09 0.11 0.09 0.10 0.12 0.11 5.19 
5.07 21% Relative To Control 1 R1B-1mg/L -0.24 -0.04 0.09 0.10 0.08 0.07 0.10 0.11 0.10 0.11 4.70 
R1C-1mg/L -0.13 0.00 0.09 0.09 0.11 0.12 0.13 0.12 0.09 0.11 5.31 
R2A-10mg/L 0.06 0.06 0.05 0.06 0.02 0.11 0.06 0.06 0.05 0.06 2.92 
2.94 54% Relative To Control 1 R2B-10mg/L -0.27 0.02 8.82 0.00 0.00 0.00 -8.53 -0.15 0.00 8.68 52.96 
R2C-10mg/L 0.07 0.07 0.05 0.05 0.06 0.06 0.04 0.07 0.06 0.07 2.97 
R3A-100mg/L 0.05 0.05 0.05 0.04 -0.18 -0.02 0.00 0.01 0.02 0.02 0.82 
0.81 90% Relative To Control 2 R3B-100mg/L 0.00 0.00 0.00 0.00 0.00 -8.26 8.26 -8.72 0.01 0.03 0.99 
R3C-100mg/L 0.05 0.01 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.60 
PCA1A-15mg/L 0.13 0.13 0.14 0.14 0.14 0.14 0.13 0.15 0.13 0.14 6.77 6.77 14% Compared To Control 2 
PCA2A-150mg/L 0.17 0.13 0.14 0.14 0.12 0.14 0.14 0.14 0.13 0.14 6.87 6.87 13% Relative To Control 2 
PCA3A-1500mg/L 0.10 0.14 0.14 0.15 0.13 0.14 0.14 0.07 0.19 0.14 6.81 
6.93 12% Relative To Control 2 PCA3B-1500mg/L 0.15 0.14 0.14 0.15 0.14 0.15 0.15 0.14 0.16 0.13 7.17 
PCA3C-1500mg/L 0.18 0.14 0.14 0.14 0.14 0.13 0.14 0.14 0.15 0.12 6.81 
C2A 0.14 0.15 0.17 0.15 0.17 0.16 0.17 0.16 0.18 0.15 7.91 
7.91 - C2B 0.19 0.15 0.18 0.17 0.18 0.21 0.21 0.08 0.17 0.17 8.45 
C2C 0.16 0.14 0.16 0.14 0.16 0.15 0.15 0.14 0.15 0.15 7.37 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time. 
  
144 
Table B-7: PCA – SOUR & Percentage Heterotrophic Inhibition Calculations after 30-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration 
SOUR mg 
O2/g-h 
Average 
SOUR, mg 
O2/g-h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
Control1N+ATU 0.06 0.08 0.10 0.10 0.11 0.05 0.05 0.18 0.10 0.10 4.60 4.60  N/A 
PCA1AN-15mg/L+ATU 0.11 0.11 0.08 0.11 0.10 0.09 0.10 0.10 0.10 0.09 4.89 4.89 -5% 42% Relative To Control 2 
PCA2AN-150mg/L+ATU 0.06 0.12 0.08 0.09 0.09 0.09 0.08 0.10 0.09 0.09 4.40 4.40 -6% 24% Relative To Control 2 
PCA3AN-1500mg/L+ATU 0.18 0.14 0.12 0.12 0.12 0.12 0.11 0.11 0.12 0.12 5.81 5.81 -24% 65% Relative To Control 2 
Control2N+ATU 0.11 0.04 0.15 0.09 0.09 0.10 0.10 0.09 0.09 0.10 4.75 4.75 -1.59 N/A 
               
        
Average Between C1 and C2= 7.17 mg O2/g-h 
 
        
Difference Between Controls= 21% 
  
        
LC50 Reference Substance = 7.33 mg/L 3, 4-DCP 
 
        
Average Between C1N & C2N= 4.67 mg O2/g-h 
 
        
Difference Between C1N & C2N= 3% 
  
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured. 
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Table B-8: PCA – Raw Data Collected After 180-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., °C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A  8.29 8.15 8.02 7.86 7.70 7.55 7.39 7.26 7.13 7.01 6.85 19.8 
C1B  7.82 8.21 8.33 8.34 8.19 8.03 7.90 7.78 7.62 7.49 7.35 N/A 
C1C  8.18 8.29 8.16 8.04 7.92 7.78 7.67 7.54 7.41 7.30 7.20 19.4 
R1A-1mg/L  9.37 9.28 9.18 9.08 8.97 8.87 8.77 8.66 8.55 8.45 8.34 N/A 
R1B-1mg/L  8.57 8.57 8.45 8.33 8.21 8.10 7.98 7.87 7.77 7.65 7.52 N/A 
R1C-1mg/L  10.17 10.07 9.96 9.86 9.75 9.65 9.55 9.45 9.36 9.27 9.17 N/A 
R2A-10mg/L  9.20 9.14 9.08 9.02 8.97 8.92 8.87 8.81 8.75 8.68 8.62 N/A 
R2B-10mg/L  8.67 8.61 8.59 8.55 8.48 8.43 8.38 8.32 8.26 8.19 8.29 N/A 
R2C-10mg/L  8.9 8.84 8.76 8.69 8.62 8.55 8.47 8.40 8.34 8.28 8.21 N/A 
R3A-100mg/L  9.05 9.04 9.03 9.02 9.01 8.99 8.98 8.96 8.94 8.93 8.91 N/A 
R3B-100mg/L  8.67 8.81 8.84 8.85 8.85 8.82 8.82 8.82 8.79 8.77 8.75 N/A 
R3C-100mg/L  8.63 8.58 8.56 8.54 8.53 8.51 8.49 8.48 8.46 8.45 8.44 N/A 
PCA1A-15mg/L  8.43 8.22 8.08 7.94 7.81 7.67 7.52 7.40 7.27 7.14 6.99 21.0 
PCA2A-150mg/L  7.43 7.01 6.81 6.65 6.51 6.38 6.24 6.12 5.99 5.86 5.72 N/A 
PCA3A-1500mg/L  8.61 8.50 8.36 8.21 8.05 7.91 7.75 7.61 7.45 7.30 7.13 N/A 
PCA3B-1500mg/L  8.13 7.90 7.74 7.57 7.42 7.26 7.12 6.97 6.81 6.63 6.46 N/A 
PCA3C-1500mg/L  6.70 6.47 6.32 6.18 6.04 5.91 5.79 5.65 5.51 5.35 5.21 N/A 
C2A  8.45 8.27 8.10 7.92 7.77 7.60 7.45 7.28 7.11 6.92 6.74 N/A 
C2B  8.10 7.93 7.75 7.59 7.41 7.23 7.06 6.88 6.71 6.54 6.36 22.6 
C2C  7.12 6.95 6.78 6.65 6.51 6.36 6.22 6.06 5.92 5.78 5.63 N/A 
Control1N+ATU  8.70 8.62 8.53 8.45 8.35 8.26 8.22 8.13 8.02 7.93 7.84 21.4 
PCA1AN-15mg/L+ATU  8.13 8.02 7.92 7.82 7.73 7.62 7.52 7.43 7.31 7.22 7.12 22.3 
PCA2AN-150mg/L+ATU  7.12 7.04 6.98 6.89 6.83 6.75 6.68 6.60 6.48 6.41 6.31 N/A 
PCA3AN-1500mg/L+ATU  7.52 7.35 7.20 7.07 6.93 6.79 6.66 6.52 6.38 6.25 6.12 N/A 
Control2N+ATU  8.62 8.54 8.45 8.36 8.27 8.19 8.10 8.01 7.92 7.83 7.83 21.2 
 ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls 
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Table B-9: PCA – Valid DO Concentration Measurements After 180-min Exposure at 1 minute Intervals 
Sample ID 
Dissolve Oxygen Concentrations, mg/L 
R2 
Min. in the 
Linear Section 
of the Curve 
Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A 8.29 8.15 8.02 7.86 7.70 7.55 7.39 7.26 7.13 7.01 6.85 0.9989 10 
C1B 7.82 8.21 8.33 8.34 8.19 8.03 7.90 7.78 7.62 7.49 7.35 0.9991 7 
C1C 8.18 8.29 8.16 8.04 7.92 7.78 7.67 7.54 7.41 7.30 7.20 0.9993 9 
R1A-1mg/L 9.37 9.28 9.18 9.08 8.97 8.87 8.77 8.66 8.55 8.45 8.34 0.9996 10 
R1B-1mg/L 8.57 8.57 8.45 8.33 8.21 8.10 7.98 7.87 7.77 7.65 7.52 0.9996 9 
R1C-1mg/L 10.17 10.07 9.96 9.86 9.75 9.65 9.55 9.45 9.36 9.27 9.17 0.9993 10 
R2A-10mg/L 9.20 9.14 9.08 9.02 8.97 8.92 8.87 8.81 8.75 8.68 8.62 0.9984 10 
R2B-10mg/L 8.67 8.61 8.59 8.55 8.48 8.43 8.38 8.32 8.26 8.19 8.29 0.8677 8 
R2C-10mg/L 8.90 8.84 8.76 8.69 8.62 8.55 8.47 8.40 8.34 8.28 8.21 0.9991 10 
R3A-100mg/L 9.05 9.04 9.03 9.02 9.01 8.99 8.98 8.96 8.94 8.93 8.91 0.9869 10 
R3B-100mg/L 8.67 8.81 8.84 8.85 8.85 8.82 8.82 8.82 8.79 8.77 8.75 0.9888 3 
R3C-100mg/L 8.63 8.58 8.56 8.54 8.53 8.51 8.49 8.48 8.46 8.45 8.44 0.9925 9 
PCA1A-15mg/L 8.43 8.22 8.08 7.94 7.81 7.67 7.52 7.40 7.27 7.14 6.99 0.9997 9 
PCA2A-150mg/L 7.43 7.01 6.81 6.65 6.51 6.38 6.24 6.12 5.99 5.86 5.72 0.9963 8 
PCA3A-1500mg/L 8.61 8.50 8.36 8.21 8.05 7.91 7.75 7.61 7.45 7.30 7.13 0.9991 10 
PCA3B-1500mg/L 8.13 7.90 7.74 7.57 7.42 7.26 7.12 6.97 6.81 6.63 6.46 0.9994 9 
PCA3C-1500mg/L 6.70 6.47 6.32 6.18 6.04 5.91 5.79 5.65 5.51 5.35 5.21 0.9993 9 
C2A 8.45 8.27 8.10 7.92 7.77 7.60 7.45 7.28 7.11 6.92 6.74 0.9995 10 
C2B 8.10 7.93 7.75 7.59 7.41 7.23 7.06 6.88 6.71 6.54 6.36 0.9999 10 
C2C 7.12 6.95 6.78 6.65 6.51 6.36 6.22 6.06 5.92 5.78 5.63 0.9995 10 
Control1N+ATU 8.70 8.62 8.53 8.45 8.35 8.26 8.22 8.13 8.02 7.93 7.84 0.9975 10 
PCA1AN-15mg/L+ATU 8.13 8.02 7.92 7.82 7.73 7.62 7.52 7.43 7.31 7.22 7.12 0.9997 10 
PCA2AN-150mg/L+ATU 7.12 7.04 6.98 6.89 6.83 6.75 6.68 6.60 6.48 6.41 6.31 0.9960 10 
PCA3AN-1500mg/L+ATU 7.52 7.35 7.2 7.07 6.93 6.79 6.66 6.52 6.38 6.25 6.12 0.9999 8 
Control2N+ATU 8.62 8.54 8.45 8.36 8.27 8.19 8.10 8.01 7.92 7.83 7.83 0.9999 9 
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Table B-10: PCA – SOUR & Percentage Total Inhibition Calculations after 180-min Exposure 
Test Substance 
mg/L 
Total Respiration at 180 min SOUR 
mg O2/g-
h 
Average 
SOUR, 
mg O2/g-
h 
% Total 
Inhibition Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.14 0.13 0.16 0.16 0.15 0.16 0.13 0.13 0.12 0.16 7.12 
6.70 - C1B -0.39 -0.12 -0.01 0.15 0.16 0.13 0.12 0.16 0.13 0.14 6.99 
C1C -0.11 0.13 0.12 0.12 0.14 0.11 0.13 0.13 0.11 0.10 5.99 
R1A-1mg/L 0.09 0.10 0.10 0.11 0.10 0.10 0.11 0.11 0.10 0.11 5.09 
5.27 21% Relative To Control 1 R1B-1mg/L 0.00 0.12 0.12 0.12 0.11 0.12 0.11 0.10 0.12 0.13 5.77 
R1C-1mg/L 0.10 0.11 0.10 0.11 0.10 0.10 0.10 0.09 0.09 0.10 4.94 
R2A-10mg/L 0.06 0.06 0.06 0.05 0.05 0.05 0.06 0.06 0.07 0.06 2.87 
3.08 54% Relative To Control 1 R2B-10mg/L 0.06 0.02 0.04 0.07 0.05 0.05 0.06 0.06 0.07 -0.10 2.97 
R2C-10mg/L 0.06 0.08 0.07 0.07 0.07 0.08 0.07 0.06 0.06 0.07 3.41 
R3A-100mg/L 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.69 
0.78 90% Relative To Control 2 R3B-100mg/L -0.14 -0.03 -0.01 0.00 0.03 0.00 0.00 0.03 0.02 0.02 0.87 
R3C-100mg/L 0.05 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.01 0.77 
PCA1A-15mg/L 0.21 0.14 0.14 0.13 0.14 0.15 0.12 0.13 0.13 0.15 6.76 6.76 17% Relative To Control 2 
PCA2A-150mg/L 0.42 0.20 0.16 0.14 0.13 0.14 0.12 0.13 0.13 0.14 6.74 6.74 17% Relative To Control 2 
PCA3A-1500mg/L 0.11 0.14 0.15 0.16 0.14 0.16 0.14 0.16 0.15 0.17 7.32 
7.38 9% Relative To Control 2 PCA3B-1500mg/L 0.23 0.16 0.17 0.15 0.16 0.14 0.15 0.16 0.18 0.17 7.91 
PCA3C-1500mg/L 0.23 0.15 0.14 0.14 0.13 0.12 0.14 0.14 0.16 0.14 6.92 
C2A 0.18 0.17 0.18 0.15 0.17 0.15 0.17 0.17 0.19 0.18 8.45 
8.14 - C2B 0.17 0.18 0.16 0.18 0.18 0.17 0.18 0.17 0.17 0.18 8.60 
C2C 0.17 0.17 0.13 0.14 0.15 0.14 0.16 0.14 0.14 0.15 7.37 
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Table B-11: PCA – SOUR & Heterotrophic Inhibition Calculations after 180-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration SOUR 
mg 
O2/g-h 
Average 
SOUR, 
mg 
O2/g-h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
Control1N+ATU 0.08 0.09 0.08 0.10 0.09 0.04 0.09 0.11 0.09 0.09 4.25 4.25 1.02 - 
PCA1AN-15mg/L+ATU 0.11 0.10 0.10 0.09 0.11 0.10 0.09 0.12 0.09 0.10 4.99 4.99 -16.24 54% Relative To Control 2 
PCA2AN-150mg/L+ATU 0.08 0.06 0.09 0.06 0.08 0.08 0.08 0.12 0.07 0.10 4.00 4.00 6.78 29% Relative To Control 2 
PCA3AN-1500mg/L+ATU 0.17 0.16 0.13 0.14 0.14 0.13 0.14 0.14 0.13 0.13 6.67 6.67 -55.37 82% Relative To Control 2 
Control2N+ATU 0.08 0.09 0.09 0.09 0.08 0.09 0.09 0.09 0.09 0.00 4.34 4.34 -1.02 - 
               
        
Average Between C1 and C2= 7.42  mg O2/g-h 
 
        
Difference Between Controls= 19% 
  
        
LC50 of Reference Substance= 7.33 mg/L 3,4-DCP 
 
        
Average Between C1N & C2N= 4.30  mg O2/g-h 
 
        
Difference Between C1N & C2N= 2% 
  
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured. 
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Table B-12: mPCA#1 – R aw Data Collected After 30-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., 
°C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A  8.34 8.17 8.01 7.85 7.67 7.52 7.36 7.20 7.03 6.87 6.70 21.1 
C1B  8.51 8.36 8.20 8.04 7.86 7.70 7.53 7.35 7.18 7.00 6.83 21.7 
C1C  8.51 8.42 8.27 8.12 7.94 7.80 7.64 7.48 7.32 7.15 6.98 21.2 
R1A-1mg/L  8.48 8.35 8.23 8.11 7.98 7.86 7.74 7.62 7.50 7.38 7.27 21.0 
R1B-1mg/L  8.35 8.23 8.10 7.98 7.86 7.74 7.63 7.51 7.38 7.24 7.12 22.1 
R1C-1mg/L  8.73 8.61 8.49 8.36 8.24 8.12 8.01 7.89 7.76 7.64 7.53 21.4 
R2A-10mg/L  8.60 8.54 8.48 8.42 8.36 8.31 8.25 8.20 8.15 8.10 8.04 21.0 
R2B-10mg/L  8.70 8.62 8.57 8.52 8.47 8.42 8.37 8.32 8.26 8.20 8.14 21.6 
R2C-10mg/L  8.33 8.27 8.22 8.17 8.11 8.06 8.00 7.95 7.91 7.84 7.78 21.1 
R3A-100mg/L  8.94 8.93 8.92 8.90 8.90 8.88 8.87 8.86 8.85 8.83 8.82 20.9 
R3B-100mg/L  8.81 8.80 8.80 8.79 8.77 8.76 8.75 8.74 8.74 8.72 8.71 21.7 
R3C-100mg/L  8.85 8.85 8.84 8.82 8.81 8.80 8.79 8.77 8.76 8.75 8.74 21.4 
mP1A-15mg/L  8.54 8.43 8.26 8.10 7.93 7.77 7.62 7.46 7.30 7.14 6.99 21.3 
mP2A-150mg/L  8.14 8.00 7.85 7.66 7.47 7.32 7.15 6.99 6.82 6.66 6.48 21.6 
mP3A-1500mg/L  7.32 7.19 7.05 6.91 6.76 6.62 6.49 6.36 6.22 6.09 5.94 21.3 
mP3B-1500mg/L  7.78 7.57 7.39 7.21 7.04 6.87 6.70 6.57 6.35 6.18 6.01 22.7 
mP3C-1500mg/L  8.61 8.53 8.40 8.26 8.12 7.99 7.85 7.71 7.57 7.43 7.30 20.9 
C2A  7.83 7.69 7.54 7.37 7.21 7.06 6.89 6.74 6.58 6.41 6.25 20.9 
C2B  8.01 7.85 7.68 7.52 7.36 7.20 7.04 6.88 6.71 6.55 6.38 20.9 
C2C  8.13 7.96 7.79 7.61 7.44 7.27 7.09 6.92 6.74 6.57 6.38 21.4 
CAD  7.86 7.72 7.58 7.44 7.28 7.14 6.99 6.84 6.69 6.53 6.39 20.6 
CBD  7.94 7.73 7.51 7.30 7.10 6.90 6.69 6.48 6.28 6.08 5.88 23.7 
C1N+ATU  8.79 8.74 8.67 8.58 8.51 8.42 8.33 8.24 8.15 8.06 7.97 20.7 
mP1AN-15mg/L+ATU  8.42 8.33 8.24 8.15 8.06 7.97 7.88 7.79 7.69 7.60 7.51 N/A 
mP2AN-150mg/L+ATU   8.04 7.94 7.76 7.66 7.57 7.48 7.38 7.26 7.20 7.10 7.01 N/A 
mP3AN-1500mg/L+ATU  8.52 8.43 8.23 8.13 8.02 7.92 7.82 7.71 7.64 7.53 7.43 N/A 
C2N+ATU  8.15 7.94 7.71 7.61 7.50 7.40 7.30 7.19 7.11 7.01 6.91 N/A 
ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls 
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Table B-13: mPCA#1 – Valid DO Concentrations after 30-min Exposure at 1 minute Intervals 
Sample ID 
Dissolved Oxygen Concentration, mg/L 
R2 
Minutes in 
the linear 
Section of 
the curve 
Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A 8.34 8.17 8.01 7.85 7.67 7.52 7.36 7.20 7.03 6.87 6.70 0.9999 10 
C1B 8.51 8.36 8.20 8.04 7.86 7.70 7.53 7.35 7.18 7.00 6.83 0.9996 10 
C1C 8.51 8.42 8.27 8.12 7.94 7.80 7.64 7.48 7.32 7.15 6.98 0.9996 9 
R1A-1mg/L 8.48 8.35 8.23 8.11 7.98 7.86 7.74 7.62 7.50 7.38 7.27 0.9998 10 
R1B-1mg/L 8.35 8.23 8.10 7.98 7.86 7.74 7.63 7.51 7.38 7.24 7.12 0.9996 10 
R1C-1mg/L 8.73 8.61 8.49 8.36 8.24 8.12 8.01 7.89 7.76 7.64 7.53 0.9998 10 
R2A-10mg/L 8.60 8.54 8.48 8.42 8.36 8.31 8.25 8.20 8.15 8.10 8.04 0.9989 10 
R2B-10mg/L 8.70 8.62 8.57 8.52 8.47 8.42 8.37 8.32 8.26 8.20 8.14 0.9978 10 
R2C-10mg/L 8.33 8.27 8.22 8.17 8.11 8.06 8.00 7.95 7.91 7.84 7.78 0.9990 10 
R3A-100mg/L 8.94 8.93 8.92 8.90 8.90 8.88 8.87 8.86 8.85 8.83 8.82 0.9923 10 
R3B-100mg/L 8.81 8.80 8.80 8.79 8.77 8.76 8.75 8.74 8.74 8.72 8.71 0.9815 10 
R3C-100mg/L 8.85 8.85 8.84 8.82 8.81 8.80 8.79 8.77 8.76 8.75 8.74 0.9897 10 
mP1A-15mg/L 8.54 8.43 8.26 8.10 7.93 7.77 7.62 7.46 7.30 7.14 6.99 0.9995 9 
mP2A-150mg/L 8.14 8.00 7.85 7.66 7.47 7.32 7.15 6.99 6.82 6.66 6.48 0.9995 10 
mP3A-1500mg/L 7.32 7.19 7.05 6.91 6.76 6.62 6.49 6.36 6.22 6.09 5.94 0.9998 10 
mP3B-1500mg/L 7.78 7.57 7.39 7.21 7.04 6.87 6.70 6.57 6.35 6.18 6.01 0.9990 10 
mP3C-1500mg/L 8.61 8.53 8.40 8.26 8.12 7.99 7.85 7.71 7.57 7.43 7.30 0.9986 9 
C2A 7.83 7.69 7.54 7.37 7.21 7.06 6.89 6.74 6.58 6.41 6.25 0.9998 10 
C2B 8.01 7.85 7.68 7.52 7.36 7.20 7.04 6.88 6.71 6.55 6.38 0.9999 10 
C2C 8.13 7.96 7.79 7.61 7.44 7.27 7.09 6.92 6.74 6.57 6.38 0.9999 10 
CAD 7.86 7.72 7.58 7.44 7.28 7.14 6.99 6.84 6.69 6.53 6.39 0.9998 10 
CBD 7.94 7.73 7.51 7.30 7.10 6.90 6.69 6.48 6.28 6.08 5.88 0.9999 10 
C1N  8.79 8.74 8.67 8.58 8.51 8.42 8.33 8.24 8.15 8.06 7.97 0.9989 9 
mP1AN-15mg/L 8.42 8.33 8.24 8.15 8.06 7.97 7.88 7.79 7.69 7.60 7.51 0.9999 10 
mP2AN-150mg/L 8.04 7.94 7.76 7.66 7.57 7.48 7.38 7.26 7.20 7.10 7.01 0.9925 10 
mP3AN-1500mg/L 8.52 8.43 8.23 8.13 8.02 7.92 7.82 7.71 7.64 7.53 7.43 0.9990 8 
C2N 8.15 7.94 7.71 7.61 7.50 7.40 7.30 7.19 7.11 7.01 6.91 0.9993 8 
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Table B-14: mPCA#1 – SOUR & Total Percentage Inhibition Calculations after 30-min Exposure 
Test Substance 
mg/L 
Total Respiration at 30 min SOUR 
mg O2/g-
h 
Average 
SOUR, 
mg O2/g-
h 
% Total 
Inhibition Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.17 0.16 0.16 0.18 0.15 0.16 0.16 0.17 0.16 0.17 6.16 
6.16 - C1B 0.15 0.16 0.16 0.18 0.16 0.17 0.18 0.17 0.18 0.17 6.31 
C1C 0.09 0.15 0.15 0.18 0.14 0.16 0.16 0.16 0.17 0.17 6.01 
R1A-1mg/L 0.13 0.12 0.12 0.13 0.12 0.12 0.12 0.12 0.12 0.11 4.54 
4.56 26% R1B-1mg/L 0.12 0.13 0.12 0.12 0.12 0.11 0.12 0.13 0.14 0.12 4.62 
R1C-1mg/L 0.12 0.12 0.13 0.12 0.12 0.11 0.12 0.13 0.12 0.11 4.51 
R2A-10mg/L 0.06 0.06 0.06 0.06 0.05 0.06 0.05 0.05 0.05 0.06 2.10 
2.09 66% R2B-10mg/L 0.08 0.05 0.05 0.05 0.05 0.05 0.05 0.06 0.06 0.06 2.10 
R2C-10mg/L 0.06 0.05 0.05 0.06 0.05 0.06 0.05 0.04 0.07 0.06 2.06 
R3A-100mg/L 0.01 0.01 0.02 0.00 0.02 0.01 0.01 0.01 0.02 0.01 0.45 
0.41 93% R3B-100mg/L 0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.00 0.02 0.01 0.38 
R3C-100mg/L 0.00 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.41 
mP1A-15mg/L 0.11 0.17 0.16 0.17 0.16 0.15 0.16 0.16 0.16 0.15 6.01 6.01 3% 
mP2A-150mg/L 0.14 0.15 0.19 0.19 0.15 0.17 0.16 0.17 0.16 0.18 6.23 6.23 -1% 
mP3A-1500mg/L 0.13 0.14 0.14 0.15 0.14 0.13 0.13 0.14 0.13 0.15 5.18 
5.67 8% mP3B-1500mg/L 0.22 0.18 0.18 0.17 0.17 0.17 0.13 0.22 0.17 0.17 6.68 
mP3C-1500mg/L 0.08 0.13 0.14 0.14 0.13 0.14 0.14 0.14 0.14 0.13 5.13 
C2A 0.14 0.15 0.17 0.16 0.15 0.17 0.15 0.16 0.17 0.16 5.93 
6.21 - C2B 0.16 0.17 0.16 0.16 0.16 0.16 0.16 0.17 0.16 0.17 6.12 
C2C 0.17 0.17 0.18 0.17 0.17 0.18 0.17 0.18 0.17 0.19 6.57 
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Table B-15: mPCA#1 – SOUR & Heterotrophic Inhibition Calculations after 30-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration 
SOUR mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1N+ATU 0.05 0.07 0.09 0.07 0.09 0.09 0.09 0.09 0.09 0.09 3.21 3.21 8% -  
mP1AN-15mg/L+ATU 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.10 0.09 0.09 3.42 3.42 2% 4% 
mP2AN-150mg/L+ATU 0.10 0.18 0.10 0.09 0.09 0.10 0.12 0.06 0.10 0.09 3.87 3.87 -11% 12% 
mP3AN-1500mg/L+ATU 0.09 0.20 0.10 0.11 0.10 0.10 0.11 0.07 0.11 0.10 3.75 3.75 -8% 29% 
C2N+ATU 0.21 0.23 0.10 0.11 0.10 0.10 0.11 0.08 0.10 0.10 3.75 3.75 -8%  - 
 
         
Average Between C1 and C2= 6.18  mg O2/g-h 
 
         
Difference Between Controls= 1% 
  
         
LC50= 
  
4.06 mg/L 3,4 DCP 
 
         
Average Between C1N & C2N= 3.48  mg O2/g-h 
 
         
Difference Between C1N & C2N= 16% 
   
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured.  
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Table B-16: mPCA#1 – Raw Data Collected After 180-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., 
°C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A   8.63 8.48 8.33 8.19 8.04 7.90 7.75 7.60 7.46 7.31 7.17 20.7 
C1B   8.37 8.20 8.03 7.84 7.67 7.50 7.32 7.15 6.97 6.80 6.62 21.8 
C1C   8.38 8.25 8.12 7.97 7.83 7.69 7.55 7.40 7.26 7.12 6.98 21.0 
R1A-1mg/L   8.64 8.53 8.42 8.31 8.20 8.09 7.98 7.86 7.75 7.63 7.51 21.0 
R1B-1mg/L   8.23 8.09 7.95 7.81 7.68 7.55 7.43 7.29 7.15 7.01 6.88 22.8 
R1C-1mg/L   8.43 8.32 8.21 8.10 7.99 7.88 7.77 7.67 7.55 7.43 7.32 21.2 
R2A-10mg/L   8.96 8.90 8.85 8.80 8.76 8.70 8.66 8.59 8.53 8.47 8.41 20.7 
R2B-10mg/L   8.57 8.51 8.44 8.38 8.33 8.27 8.21 8.16 8.09 8.02 7.95 22.8 
R2C-10mg/L   8.62 8.56 8.51 8.46 8.41 8.36 8.31 8.25 8.20 8.13 8.07 21.1 
R3A-100mg/L   9.04 9.03 9.02 9.01 9.00 8.98 8.97 8.96 8.95 8.93 8.91 20.8 
R3B-100mg/L   8.98 8.98 8.98 8.96 8.96 8.95 8.93 8.93 8.91 8.90 8.88 21.1 
R3C-100mg/L   8.68 8.62 8.60 8.59 8.58 8.57 8.55 8.54 8.53 8.52 8.51 21.6 
mP1A-15mg/L   8.88 8.39 8.20 8.08 7.92 7.77 7.61 7.46 7.31 7.15 7.01 21.6 
mP2A-150mg/L   8.16 8.01 7.83 7.70 7.54 7.39 7.24 7.09 6.93 6.78 6.62 21.8 
mP3A-1500mg/L   8.32 8.23 8.12 8.05 7.94 7.85 7.74 7.63 7.52 7.40 7.29 21.2 
mP3B-1500mg/L   7.86 7.71 7.56 7.41 7.25 7.10 6.96 6.81 6.67 6.52 6.37 23.5 
mP3C-1500mg/L   8.16 8.04 7.92 7.80 7.68 7.56 7.43 7.31 7.19 7.07 6.95 21.2 
C2A   7.87 7.71 7.57 7.41 7.27 7.11 6.96 6.82 6.67 6.52 6.37 21.3 
C2B   8.14 7.97 7.82 7.67 7.52 7.36 7.21 7.06 6.91 6.77 6.61 21.2 
C2C   8.23 8.06 7.90 7.76 7.59 7.45 7.30 7.15 7.00 6.85 6.69 21.2 
CAD   7.50 7.31 7.10 6.90 6.70 6.52 6.33 6.14 5.95 5.76 5.57 21.3 
CBD   8.77 8.69 8.61 8.54 8.43 8.36 8.27 8.19 8.10 8.01 7.93 23.6 
C1N+ATU   8.77 8.69 8.61 8.54 8.43 8.36 8.27 8.19 8.10 8.01 7.93 20.7 
mP1AN-15mg/L+ATU   8.37 8.26 8.15 8.08 7.97 7.89 7.80 7.72 7.63 7.54 7.45 21.5 
mP2AN-150mg/L+ATU   8.61 8.53 8.44 8.34 8.26 8.17 8.08 7.99 7.90 7.81 7.72 21.1 
mP3AN-1500mg/L+ATU   8.34 8.20 8.09 8.00 7.90 7.81 7.72 7.62 7.52 7.43 7.33 21.9 
C2N+ATU   7.90 7.58 7.43 7.31 7.19 7.08 6.97 6.86 6.76 6.65 6.54 22.8 
ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls 
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Table B-17: mPCA#1 – Valid DO Concentrations after 180-min Exposure at 1 minute Intervals 
180 min 
Sample ID 
Dissolved Oxygen Concentration, mg/L 
R2 Minutes in the linear Section of the curve Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A 8.63 8.48 8.33 8.19 8.04 7.90 7.75 7.60 7.46 7.31 7.17 1.0000 10 
C1B 8.37 8.20 8.03 7.84 7.67 7.50 7.32 7.15 6.97 6.80 6.62 1.0000 10 
C1C 8.38 8.25 8.12 7.97 7.83 7.69 7.55 7.40 7.26 7.12 6.98 0.9999 10 
R1A-1mg/L 8.64 8.53 8.42 8.31 8.20 8.09 7.98 7.86 7.75 7.63 7.51 0.9998 10 
R1B-1mg/L 8.23 8.09 7.95 7.81 7.68 7.55 7.43 7.29 7.15 7.01 6.88 0.9998 10 
R1C-1mg/L 8.43 8.32 8.21 8.10 7.99 7.88 7.77 7.67 7.55 7.43 7.32 0.9998 10 
R2A-10mg/L 8.96 8.90 8.85 8.80 8.76 8.70 8.66 8.59 8.53 8.47 8.41 0.9969 10 
R2B-10mg/L 8.57 8.51 8.44 8.38 8.33 8.27 8.21 8.16 8.09 8.02 7.95 0.9985 10 
R2C-10mg/L 8.62 8.56 8.51 8.46 8.41 8.36 8.31 8.25 8.20 8.13 8.07 0.9981 10 
R3A-100mg/L 9.04 9.03 9.02 9.01 9.00 8.98 8.97 8.96 8.95 8.93 8.91 0.9888 10 
R3B-100mg/L 8.98 8.98 8.98 8.96 8.96 8.95 8.93 8.93 8.91 8.90 8.88 0.9532 10 
R3C-100mg/L 8.68 8.62 8.60 8.59 8.58 8.57 8.55 8.54 8.53 8.52 8.51 0.9926 9 
mP1A-15mg/L 8.88 8.39 8.20 8.08 7.92 7.77 7.61 7.46 7.31 7.15 7.01 0.9995 9 
mP2A-150mg/L 8.16 8.01 7.83 7.70 7.54 7.39 7.24 7.09 6.93 6.78 6.62 0.9998 10 
mP3A-1500mg/L 8.32 8.23 8.12 8.05 7.94 7.85 7.74 7.63 7.52 7.40 7.29 0.9976 10 
mP3B-1500mg/L 7.86 7.71 7.56 7.41 7.25 7.10 6.96 6.81 6.67 6.52 6.37 0.9999 10 
mP3C-1500mg/L 8.16 8.04 7.92 7.80 7.68 7.56 7.43 7.31 7.19 7.07 6.95 1.0000 10 
C2A 7.87 7.71 7.57 7.41 7.27 7.11 6.96 6.82 6.67 6.52 6.37 0.9999 10 
C2B 8.14 7.97 7.82 7.67 7.52 7.36 7.21 7.06 6.91 6.77 6.61 0.9998 10 
C2C 8.23 8.06 7.90 7.76 7.59 7.45 7.30 7.15 7.00 6.85 6.69 0.9997 10 
CAD 7.50 7.31 7.10 6.90 6.70 6.52 6.33 6.14 5.95 5.76 5.57 0.9998 10 
CBD 8.77 8.69 8.61 8.54 8.43 8.36 8.27 8.19 8.10 8.01 7.93 0.9994 10 
C1N+ATU 8.77 8.69 8.61 8.54 8.43 8.36 8.27 8.19 8.10 8.01 7.93 0.9994 10 
mP1AN-15mg/L+ATU 8.37 8.26 8.15 8.08 7.97 7.89 7.80 7.72 7.63 7.54 7.45 0.9986 10 
mP2AN-150mg/L+ATU 8.61 8.53 8.44 8.34 8.26 8.17 8.08 7.99 7.90 7.81 7.72 0.9999 10 
mP3AN-1500mg/L+ATU 8.34 8.20 8.09 8.00 7.90 7.81 7.72 7.62 7.52 7.43 7.33 0.9997 9 
C2N+ATU 7.90 7.58 7.43 7.31 7.19 7.08 6.97 6.86 6.76 6.65 6.54 0.9995 8 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
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Table B-18: mPCA#1 – SOUR & Total Percentage Inhibition Calculations after 180-min Exposure 
Test Substance 
mg/L 
Total Respiration at 180 min SOUR 
mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-
h 
% Total 
Inhibition Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.15 0.15 0.14 0.15 0.14 0.15 0.15 0.14 0.15 0.14 5.48 
5.77 - C1B 0.17 0.17 0.19 0.17 0.17 0.18 0.17 0.18 0.17 0.18 6.57 
C1C 0.13 0.13 0.15 0.14 0.14 0.14 0.15 0.14 0.14 0.14 5.26 
R1A-1mg/L 0.11 0.11 0.11 0.11 0.11 0.11 0.12 0.11 0.12 0.12 4.24 
4.49 22% R1B-1mg/L 0.14 0.14 0.14 0.13 0.13 0.12 0.14 0.14 0.14 0.13 5.07 
R1C-1mg/L 0.11 0.11 0.11 0.11 0.11 0.11 0.10 0.12 0.12 0.11 4.17 
R2A-10mg/L 0.06 0.05 0.05 0.04 0.06 0.04 0.07 0.06 0.06 0.06 2.06 
2.15 63% R2B-10mg/L 0.06 0.07 0.06 0.05 0.06 0.06 0.05 0.07 0.07 0.07 2.33 
R2C-10mg/L 0.06 0.05 0.05 0.05 0.05 0.05 0.06 0.05 0.07 0.06 2.06 
R3A-100mg/L 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.02 0.49 
0.44 92% R3B-100mg/L 0.00 0.00 0.02 0.00 0.01 0.02 0.00 0.02 0.01 0.02 0.38 
R3C-100mg/L 0.06 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.46 
mP1A-15mg/L 0.49 0.19 0.12 0.16 0.15 0.16 0.15 0.15 0.16 0.14 5.76 5.76 -0% 
mP2A-150mg/L 0.15 0.18 0.13 0.16 0.15 0.15 0.15 0.16 0.15 0.16 5.78 5.78 -1% 
mP3A-1500mg/L 0.09 0.11 0.07 0.11 0.09 0.11 0.11 0.11 0.12 0.11 3.87 
4.67 19% mP3B-1500mg/L 0.15 0.15 0.15 0.16 0.15 0.14 0.15 0.14 0.15 0.15 5.59 
mP3C-1500mg/L 0.12 0.12 0.12 0.12 0.12 0.13 0.12 0.12 0.12 0.12 4.54 
C2A 0.16 0.14 0.16 0.14 0.16 0.15 0.14 0.15 0.15 0.15 5.63 
5.72 - C2B 0.17 0.15 0.15 0.15 0.16 0.15 0.15 0.15 0.14 0.16 5.74 
C2C 0.17 0.16 0.14 0.17 0.14 0.15 0.15 0.15 0.15 0.16 5.78 
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Table B-19: mPCA#1 – SOUR & Heterotrophic Inhibition Calculations after 180-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration SOUR 
mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-
h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1N+ATU 0.08 0.08 0.07 0.11 0.07 0.09 0.08 0.09 0.09 0.08 3.15 3.15 14% - 
mP1AN-15mg/L+ATU 0.11 0.11 0.07 0.11 0.08 0.09 0.08 0.09 0.09 0.09 3.45 3.45 6% -11% 
mP2AN-150mg/L+ATU 0.08 0.09 0.1 0.08 0.09 0.09 0.09 0.09 0.09 0.09 3.34 3.34 9% -17% 
mP3AN-1500mg/L+ATU 0.14 0.11 0.09 0.10 0.09 0.09 0.10 0.10 0.09 0.10 3.63 3.63 1% 50% 
C2N+ATU 0.32 0.15 0.12 0.12 0.11 0.11 0.11 0.10 0.11 0.11 4.18 4.18 -14% - 
         
Average Between C1 and C2= 5.74  mg O2/g-h 
 
         
Difference Between Controls= 1% 
  
         
LC50= 
  
5.05 mg/L 3,4 DCP 
 
         
Average Between C1N & C2N= 3.67  mg O2/g-h 
 
         
Difference Between C1N & C2N= 28% 
  
 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured.  
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Table B-20: mPCA#2 – Raw Data Collected After 30-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., 
°C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A   8.42 8.24 8.05 7.85 7.67 7.48 7.29 7.09 6.91 6.71 6.52 20.5 
C1B   8.23 8.08 7.90 7.71 7.53 7.34 7.15 6.96 6.79 6.59 6.41 20.3 
C1C   7.78 7.65 7.48 7.31 7.14 6.94 6.76 6.58 6.39 6.21 6.04 20.5 
R1A-1mg/L   8.39 8.24 8.10 7.96 7.82 7.67 7.53 7.39 7.25 7.12 6.98 21.1 
R1B-1mg/L   7.40 7.26 7.13 7.00 6.87 6.73 6.60 6.47 6.34 6.22 6.08 20.5 
R1C-1mg/L   7.50 7.37 7.24 7.11 6.98 6.85 6.72 6.60 6.47 6.34 6.22 20.8 
R2A-10mg/L   8.79 8.72 8.64 8.57 8.49 8.41 8.33 8.26 8.18 8.10 8.03 21.4 
R2B-10mg/L   8.55 8.48 8.42 8.36 8.29 8.22 8.16 8.09 8.02 7.95 7.89 20.8 
R2C-10mg/L   8.08 8.00 7.93 7.86 7.80 7.73 7.66 7.61 7.54 7.48 7.41 20.9 
R3A-100mg/L   9.04 9.03 9.01 9.00 8.98 8.97 8.95 8.93 8.92 8.90 8.89 21.1 
R3B-100mg/L   8.39 8.38 8.37 8.35 8.33 8.32 8.30 8.29 8.28 8.26 8.24 22.6 
R3C-100mg/L   8.08 8.07 8.05 8.05 8.03 8.02 8.00 8.98 8.97 8.95 8.94 21.4 
mP1A-375mg/L   8.30 8.10 7.89 7.69 7.48 7.29 7.09 6.88 6.69 6.49 6.29 21.4 
mP1B-375mg/L   8.04 7.87 7.69 7.50 7.32 7.13 6.95 6.76 6.59 6.40 6.22 21.3 
mP1C-375mg/L   7.25 7.02 6.82 6.62 6.42 6.23 6.04 5.86 5.68 5.50 5.32 22.6 
mP2A-750mg/L   7.92 7.51 7.27 7.03 6.80 6.57 6.34 6.11 5.89 5.66 5.44 22.7 
mP2B-750mg/L   7.89 7.71 7.51 7.32 7.13 6.93 6.74 6.55 6.35 6.16 5.97 21.2 
mP2C-750mg/L   6.73 6.71 6.51 6.31 6.11 5.91 5.72 5.53 5.33 5.15 4.94 22.6 
mP3A-1500mg/L   7.80 7.62 7.44 7.24 7.09 6.90 6.72 6.56 6.37 6.20 6.03 21.0 
mP3B-1500mg/L   7.43 7.25 7.07 6.89 6.71 6.52 6.34 6.15 5.96 5.78 5.60 21.8 
mP3C-1500mg/L   7.04 6.86 6.66 6.47 6.28 6.10 5.91 5.78 5.53 5.35 5.16 20.9 
C2A   8.02 7.83 7.64 7.45 7.26 7.09 6.89 6.71 6.53 6.33 6.15 21.8 
C2B   7.93 7.71 7.51 7.30 7.08 6.88 6.68 6.47 6.25 6.04 5.84 21.5 
C2C   7.09 6.92 6.74 6.55 6.35 6.17 5.98 5.79 5.60 5.40 5.22 21.3 
PCA1A-1500mg/L   7.94 7.73 7.52 7.32 7.11 6.90 6.70 6.49 6.29 6.07 5.88 21.4 
C1N+ATU   8.41 8.33 8.25 8.15 8.05 7.96 7.87 7.78 7.68 7.59 7.44 20.7 
mP1AN-375mg/L+ATU   7.72 7.63 7.55 7.46 7.36 7.27 7.17 7.07 6.99 6.88 6.79 21.1 
mP2AN-750mg/L+ATU   8.40 8.30 8.20 8.10 7.94 7.78 7.67 7.57 7.46 7.35 7.25 21.3 
mP3AN-1500mg/L+ATU   8.11 8.01 7.91 7.81 7.66 7.52 7.42 7.33 7.22 7.13 7.03 21.1 
C2N+ATU   7.73 7.60 7.51 7.43 7.25 7.16 7.08 6.99 6.90 6.82 6.73 20.8 
ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls 
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Table B-21: mPCA#2 – Valid DO Concentrations after 30-min Exposure at 1 minute Intervals 
Sample ID 
30 min- mPCA 2--Dissolved Oxygen Concentration, mg/L 
R2 
Minutes in 
the linear 
Section of 
the curve 
Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A 8.42 8.24 8.05 7.85 7.67 7.48 7.29 7.09 6.91 6.71 6.52 0.9999 10 
C1B 8.23 8.08 7.90 7.71 7.53 7.34 7.15 6.96 6.79 6.59 6.41 0.9997 10 
C1C 7.78 7.65 7.48 7.31 7.14 6.94 6.76 6.58 6.39 6.21 6.04 0.9990 10 
R1A-1mg/L 8.39 8.24 8.10 7.96 7.82 7.67 7.53 7.39 7.25 7.12 6.98 0.9999 10 
R1B-1mg/L 7.40 7.26 7.13 7.00 6.87 6.73 6.60 6.47 6.34 6.22 6.08 0.9999 10 
R1C-1mg/L 7.50 7.37 7.24 7.11 6.98 6.85 6.72 6.60 6.47 6.34 6.22 0.9999 10 
R2A-10mg/L 8.79 8.72 8.64 8.57 8.49 8.41 8.33 8.26 8.18 8.10 8.03 0.9998 10 
R2B-10mg/L 8.55 8.48 8.42 8.36 8.29 8.22 8.16 8.09 8.02 7.95 7.89 0.9997 10 
R2C-10mg/L 8.08 8.00 7.93 7.86 7.80 7.73 7.66 7.61 7.54 7.48 7.41 0.9989 10 
R3A-100mg/L 9.04 9.03 9.01 9.00 8.98 8.97 8.95 8.93 8.92 8.90 8.89 0.9966 10 
R3B-100mg/L 8.39 8.38 8.37 8.35 8.33 8.32 8.30 8.29 8.28 8.26 8.24 0.9943 10 
R3C-100mg/L 8.08 8.07 8.05 8.05 8.03 8.02 8.00 7.98 7.97 7.95 7.94 0.9899 10 
mP1A-375mg/L 8.30 8.10 7.89 7.69 7.48 7.29 7.09 6.88 6.69 6.49 6.29 0.9999 10 
mP1B-375mg/L 8.04 7.87 7.69 7.50 7.32 7.13 6.95 6.76 6.59 6.40 6.22 0.9999 10 
mP1C-375mg/L 7.25 7.02 6.82 6.62 6.42 6.23 6.04 5.86 5.68 5.50 5.32 0.9989 10 
mP2A-750mg/L 7.92 7.51 7.27 7.03 6.80 6.57 6.34 6.11 5.89 5.66 5.44 0.9999 9 
mP2B-750mg/L 7.89 7.71 7.51 7.32 7.13 6.93 6.74 6.55 6.35 6.16 5.97 1.0000 10 
mP2C-750mg/L 6.73 6.71 6.51 6.31 6.11 5.91 5.72 5.53 5.33 5.15 4.94 0.9999 9 
mP3A-1500mg/L 7.80 7.62 7.44 7.24 7.09 6.90 6.72 6.56 6.37 6.20 6.03 0.9997 10 
mP3B-1500mg/L 7.43 7.25 7.07 6.89 6.71 6.52 6.34 6.15 5.96 5.78 5.60 0.9999 10 
mP3C-1500mg/L 7.04 6.86 6.66 6.47 6.28 6.10 5.91 5.78 5.53 5.35 5.16 0.9992 10 
C2A 8.02 7.83 7.64 7.45 7.26 7.09 6.89 6.71 6.53 6.33 6.15 0.9999 10 
C2B 7.93 7.71 7.51 7.30 7.08 6.88 6.68 6.47 6.25 6.04 5.84 0.9999 10 
C2C 7.09 6.92 6.74 6.55 6.35 6.17 5.98 5.79 5.60 5.40 5.22 0.9999 10 
PCA1A-750mg/L 7.94 7.73 7.52 7.32 7.11 6.90 6.70 6.49 6.29 6.07 5.88 1.0000 10 
C1N+ATU 8.41 8.33 8.25 8.15 8.05 7.96 7.87 7.78 7.68 7.59 7.44 0.9972 10 
mP1AN-375mg/L+ATU 7.72 7.63 7.55 7.46 7.36 7.27 7.17 7.07 6.99 6.88 6.79 0.9994 10 
mP2AN-750mg/L+ATU 8.40 8.30 8.20 8.10 7.94 7.78 7.67 7.57 7.46 7.35 7.25 0.9962 10 
mP3AN-1500mg/L+ATU 8.11 8.01 7.91 7.81 7.66 7.52 7.42 7.33 7.22 7.13 7.03 0.9966 10 
C2N+ATU 7.73 7.60 7.51 7.43 7.25 7.16 7.08 6.99 6.90 6.82 6.73 0.9930 10 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
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Table B-22: mPCA#2 – SOUR & Total Percentage Inhibition Calculations after 30-min Exposure 
Test Substance 
mg/L 
Total Respiration at 30-min SOUR 
mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-
h 
% Total 
Inhibition Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.18 0.19 0.20 0.18 0.19 0.19 0.20 0.18 0.20 0.19 7.02 
6.73 - C1B 0.15 0.18 0.19 0.18 0.19 0.19 0.19 0.17 0.20 0.18 6.73 
C1C 0.13 0.17 0.17 0.17 0.20 0.18 0.18 0.19 0.18 0.17 6.43 
R1A-1mg/L 0.15 0.14 0.14 0.14 0.15 0.14 0.14 0.14 0.13 0.14 5.21 
4.94 29% R1B-1mg/L 0.14 0.13 0.13 0.13 0.14 0.13 0.13 0.13 0.12 0.14 4.88 
R1C-1mg/L 0.13 0.13 0.13 0.13 0.13 0.13 0.12 0.13 0.13 0.12 4.73 
R2A-10mg/L 0.07 0.08 0.07 0.08 0.08 0.08 0.07 0.08 0.08 0.07 2.81 
2.57 63% R2B-10mg/L 0.07 0.06 0.06 0.07 0.07 0.06 0.07 0.07 0.07 0.06 2.44 
R2C-10mg/L 0.08 0.07 0.07 0.06 0.07 0.07 0.05 0.07 0.06 0.07 2.48 
R3A-100mg/L 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.55 
0.54 92% R3B-100mg/L 0.01 0.01 0.02 0.02 0.01 0.02 0.01 0.01 0.02 0.02 0.55 
R3C-100mg/L 0.01 0.02 0.00 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.52 
mP1A-375mg/L 0.20 0.21 0.20 0.21 0.19 0.20 0.21 0.19 0.20 0.20 7.43 
7.10 -7% mP1B-375mg/L 0.17 0.18 0.19 0.18 0.19 0.18 0.19 0.17 0.19 0.18 6.73 
mP1C-375mg/L 0.23 0.20 0.20 0.20 0.19 0.19 0.18 0.18 0.18 0.18 7.13 
mP2A-750mg/L 0.41 0.24 0.24 0.23 0.23 0.23 0.23 0.22 0.23 0.22 8.50 
7.62 -10% mP2B-750mg/L 0.18 0.20 0.19 0.19 0.20 0.19 0.19 0.20 0.19 0.19 7.10 
mP2C-750mg/L 0.02 0.20 0.20 0.20 0.20 0.19 0.19 0.20 0.18 0.21 7.27 
mP3A-1500mg/L 0.18 0.18 0.20 0.15 0.19 0.18 0.16 0.19 0.17 0.17 6.54 
6.75 3% mP3B-1500mg/L 0.18 0.18 0.18 0.18 0.19 0.18 0.19 0.19 0.18 0.18 6.76 
mP3C-1500mg/L 0.18 0.20 0.19 0.19 0.18 0.19 0.13 0.25 0.18 0.19 6.95 
C2A 0.19 0.19 0.19 0.19 0.17 0.20 0.18 0.18 0.20 0.18 6.91 
7.18 - C2B 0.22 0.21 0.21 0.22 0.20 0.20 0.21 0.22 0.21 0.20 7.72 
C2C 0.17 0.19 0.19 0.20 0.18 0.19 0.19 0.19 0.20 0.18 6.91 
PCA1A-750mg/L 0.21 0.21 0.20 0.21 0.21 0.20 0.21 0.20 0.22 0.19 7.61 7.61 -9% 
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Table B-23: mPCA#2 – SOUR & Heterotrophic Inhibition Calculations after 30-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration SOUR 
mg O2/g-
h 
Average 
SOUR, 
mg O2/g-
h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1N+ATU 0.08 0.08 0.10 0.10 0.09 0.09 0.09 0.10 0.09 0.15 3.58 3.58 -2%   
mP1AN-375mg/L+ATU 0.09 0.08 0.09 0.10 0.09 0.10 0.10 0.08 0.11 0.09 3.44 3.44 2% -6% 
mP2AN-750mg/L+ATU 0.10 0.10 0.10 0.16 0.16 0.11 0.10 0.11 0.11 0.10 4.25 4.25 -21% 2% 
mP3AN-1500mg/L+ATU 0.10 0.10 0.10 0.15 0.14 0.10 0.09 0.11 0.09 0.10 3.99 3.99 -14% 20% 
C2N+ATU 0.09 0.08 0.09 0.10 0.09 0.10 0.10 0.08 0.11 0.09 3.44 3.44 2%   
         
Average Between C1 and C2= 6.95  mg O2/g-h 
 
         
Difference Between Controls= 7% 
  
         
LC50 from Reference Substance= 4.18 mg/L 3,4 DCP 
 
         
Average Between C1N & C2N= 3.51  mg O2/g-h 
 
         
Difference Between C1N & C2N= 4% 
  
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured.  
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Table B-24: mPCA#2 – Raw Data Collected after 180-min Exposure 
Sample ID Start Time 
Dissolved Oxygen Concentration, mg/L 
Temp., 
°C Time, min 
0 1 2 3 4 5 6 7 8 9 10 
C1A   8.07 7.89 7.73 7.54 7.37 7.18 7.00 6.82 6.65 6.47 6.29 21.2 
C1B   7.99 7.83 7.67 7.50 7.33 7.16 6.99 6.83 6.66 6.49 6.31 20.9 
C1C   7.29 7.12 6.95 6.80 6.63 6.47 6.32 6.13 6.00 5.82 5.65 21.2 
R1A-1mg/L   7.81 7.67 7.53 7.38 7.23 7.09 6.94 6.79 6.65 6.50 6.36 22.2 
R1B-1mg/L   7.78 7.64 7.51 7.38 7.24 7.10 6.97 6.83 6.69 6.55 6.40 21.9 
R1C-1mg/L   6.88 6.76 6.64 6.51 6.39 6.27 6.14 6.02 5.90 5.77 5.65 21.7 
R2A-10mg/L   8.36 8.28 8.27 8.15 8.08 8.00 7.92 7.85 7.78 7.71 7.63 22.0 
R2B-10mg/L   8.13 8.07 8.00 7.94 7.87 7.81 7.73 7.66 7.59 7.53 7.46 21.7 
R2C-10mg/L   7.42 7.36 7.31 7.25 7.19 7.13 7.07 7.00 6.94 6.87 6.81 21.7 
R3A-100mg/L   8.72 8.70 8.68 8.66 8.64 8.63 8.61 8.60 8.59 8.56 8.55 - 
R3B-100mg/L   7.72 7.69 7.67 7.65 7.64 7.62 7.60 7.58 7.57 7.56 7.53 - 
R3C-100mg/L   7.62 7.59 7.57 7.56 7.54 7.53 7.51 7.50 7.48 7.46 7.43 - 
mP1A-375mg/L   7.86 7.68 7.49 7.30 7.11 6.93 6.74 6.55 6.37 6.19 6.00 22.4 
mP1B-375mg/L   7.43 7.25 7.06 6.87 6.69 6.51 6.32 6.14 5.95 5.77 5.58 22.3 
mP1C-375mg/L   6.23 6.02 5.83 5.64 5.45 5.26 5.07 4.80 4.69 4.51 4.32 24.0 
mP2A-750mg/L   - - - - 6.36 6.14 5.91 5.69 5.46 5.23 5.00 23.9 
mP2B-750mg/L   7.53 7.34 7.16 6.98 6.79 6.59 6.41 6.21 6.03 5.84 5.66 22.1 
mP2C-750mg/L   6.27 6.06 5.85 5.65 5.45 5.23 5.03 4.83 4.63 4.43 4.23 24.1 
mP3A-1500mg/L   8.05 7.88 7.71 7.54 7.37 7.20 7.02 6.86 6.69 6.51 6.33 22.4 
mP3B-1500mg/L   6.94 6.76 6.58 6.41 6.23 6.04 5.87 5.69 5.51 5.34 5.16 23.3 
mP3C-1500mg/L   6.54 6.37 6.22 6.07 5.93 5.77 5.61 5.46 5.30 5.15 4.98 22.6 
C2A   7.13 6.91 6.71 6.51 6.30 6.08 5.88 5.68 5.48 5.27 5.05 22.6 
C2B   6.77 6.57 6.36 6.16 5.96 5.75 5.55 5.35 5.15 4.95 4.75 22.5 
C2C   5.93 5.74 5.55 5.36 5.19 5.00 4.82 4.63 4.45 4.27 4.09 22.6 
PCA1A-1500mg/L   7.75 7.54 7.34 7.13 6.98 6.77 6.58 6.37 6.18 5.97 5.77 22.4 
C1N+ATU   8.20 8.11 8.03 7.94 7.87 7.78 7.69 7.60 7.51 7.42 7.33 21.5 
mP1AN-375mg/L+ATU   7.25 7.16 7.07 6.98 6.91 6.83 6.74 6.65 6.55 6.46 6.37 22.0 
mP2AN-750mg/L+ATU   8.09 8.00 7.89 7.79 7.69 7.58 7.48 7.38 7.27 7.17 7.07 22.5 
mP3AN-1500mg/L+ATU   7.66 7.56 7.45 7.35 7.25 7.15 7.05 6.94 6.84 6.75 6.65 22.3 
C2N+ATU   7.27 7.19 7.10 7.02 6.93 6.84 6.76 6.67 6.59 6.51 6.42 21.9 
ATU: allylthiourea; Sample IDs starting with “R” represent the Reference Substance 3,4-DCP, Sample IDs starting with “C” represent the Controls 
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Table B-25: mPCA#2 – Valid DO Concentrations after 30-min Exposure at 1 minute Intervals 
Sample ID 
Dissolved Oxygen Concentration, mg/L 
R2 Minutes in the linear Section of the curve Time, min 0 1 2 3 4 5 6 7 8 9 10 
C1A 8.07 7.89 7.73 7.54 7.37 7.18 7.00 6.82 6.65 6.47 6.29 0.9999 10 
C1B 7.99 7.83 7.67 7.50 7.33 7.16 6.99 6.83 6.66 6.49 6.31 0.9999 10 
C1C 7.29 7.12 6.95 6.80 6.63 6.47 6.32 6.13 6.00 5.82 5.65 0.9997 10 
R1A-1mg/L 7.81 7.67 7.53 7.38 7.23 7.09 6.94 6.79 6.65 6.50 6.36 0.9999 10 
R1B-1mg/L 7.78 7.64 7.51 7.38 7.24 7.10 6.97 6.83 6.69 6.55 6.40 0.9998 10 
R1C-1mg/L 6.88 6.76 6.64 6.51 6.39 6.27 6.14 6.02 5.90 5.77 5.65 1.0000 10 
R2A-10mg/L 8.36 8.28 8.27 8.15 8.08 8.00 7.92 7.85 7.78 7.71 7.63 0.9956 10 
R2B-10mg/L 8.13 8.07 8.00 7.94 7.87 7.81 7.73 7.66 7.59 7.53 7.46 0.9995 10 
R2C-10mg/L 7.42 7.36 7.31 7.25 7.19 7.13 7.07 7.00 6.94 6.87 6.81 0.9989 10 
R3A-100mg/L 8.72 8.70 8.68 8.66 8.64 8.63 8.61 8.60 8.59 8.56 8.55 0.9920 10 
R3B-100mg/L 7.72 7.69 7.67 7.65 7.64 7.62 7.60 7.58 7.57 7.56 7.53 0.9908 10 
R3C-100mg/L 7.62 7.59 7.57 7.56 7.54 7.53 7.51 7.50 7.48 7.46 7.43 0.9884 10 
mP1A-375mg/L 7.86 7.68 7.49 7.30 7.11 6.93 6.74 6.55 6.37 6.19 6.00 1.0000 10 
mP1B-375mg/L 7.43 7.25 7.06 6.87 6.69 6.51 6.32 6.14 5.95 5.77 5.58 1.0000 10 
mP1C-375mg/L 6.23 6.02 5.83 5.64 5.45 5.26 5.07 4.80 4.69 4.51 4.32 0.9984 10 
mP2A-750mg/L 0.00 0.00 0.00 0.00 6.36 6.14 5.91 5.69 5.46 5.23 5.00 0.9999 6 
mP2B-750mg/L 7.53 7.34 7.16 6.98 6.79 6.59 6.41 6.21 6.03 5.84 5.66 0.9999 10 
mP2C-750mg/L 6.27 6.06 5.85 5.65 5.45 5.23 5.03 4.83 4.63 4.43 4.23 0.9999 10 
mP3A-1500mg/L 8.05 7.88 7.71 7.54 7.37 7.20 7.02 6.86 6.69 6.51 6.33 0.9999 10 
mP3B-1500mg/L 6.94 6.76 6.58 6.41 6.23 6.04 5.87 5.69 5.51 5.34 5.16 1.0000 10 
mP3C-1500mg/L 6.54 6.37 6.22 6.07 5.93 5.77 5.61 5.46 5.30 5.15 4.98 0.9998 10 
C2A 7.13 6.91 6.71 6.51 6.30 6.08 5.88 5.68 5.48 5.27 5.05 0.9999 10 
C2B 6.77 6.57 6.36 6.16 5.96 5.75 5.55 5.35 5.15 4.95 4.75 1.0000 10 
C2C 5.93 5.74 5.55 5.36 5.19 5.00 4.82 4.63 4.45 4.27 4.09 0.9999 10 
PCA1A-750mg/L 7.75 7.54 7.34 7.13 6.98 6.77 6.58 6.37 6.18 5.97 5.77 0.9996 10 
C1N+ATU 8.20 8.11 8.03 7.94 7.87 7.78 7.69 7.60 7.51 7.42 7.33 0.9995 10 
mP1AN-375mg/L+ATU 7.25 7.16 7.07 6.98 6.91 6.83 6.74 6.65 6.55 6.46 6.37 0.9990 10 
mP2AN-750mg/L+ATU 8.09 8.00 7.89 7.79 7.69 7.58 7.48 7.38 7.27 7.17 7.07 0.9999 10 
mP3AN-1500mg/L+ATU 7.66 7.56 7.45 7.35 7.25 7.15 7.05 6.94 6.84 6.75 6.65 0.9998 10 
C2N+ATU 7.27 7.19 7.10 7.02 6.93 6.84 6.76 6.67 6.59 6.51 6.42 0.9999 10 
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
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Table B-26: mPCA#2 – SOUR & Total Percentage Inhibition Calculations after 180-min Exposure 
Test Substance 
mg/L 
Total Respiration at 180 min SOUR 
mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-
h 
% Total 
Inhibition Time, mins 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1A 0.18 0.16 0.19 0.17 0.19 0.18 0.18 0.17 0.18 0.18 6.58 
6.28 - C1B 0.16 0.16 0.17 0.17 0.17 0.17 0.16 0.17 0.17 0.18 6.21 
C1C 0.17 0.17 0.15 0.17 0.16 0.15 0.19 0.13 0.18 0.17 6.06 
R1A-1mg/L 0.14 0.14 0.15 0.15 0.14 0.15 0.15 0.14 0.15 0.14 5.36 
5.00 26% R1B-1mg/L 0.14 0.13 0.13 0.14 0.14 0.13 0.14 0.14 0.14 0.15 5.10 
R1C-1mg/L 0.12 0.12 0.13 0.12 0.12 0.13 0.12 0.12 0.13 0.12 4.55 
R2A-10mg/L 0.08 0.01 0.12 0.07 0.08 0.08 0.07 0.07 0.07 0.08 2.70 
2.48 64% R2B-10mg/L 0.06 0.07 0.06 0.07 0.06 0.08 0.07 0.07 0.06 0.07 2.48 
R2C-10mg/L 0.06 0.05 0.06 0.06 0.06 0.06 0.07 0.06 0.07 0.06 2.25 
R3A-100mg/L 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.03 0.01 0.63 
0.68 90% R3B-100mg/L 0.03 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.01 0.03 0.70 
R3C-100mg/L 0.03 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.03 0.70 
mP1A-375mg/L 0.18 0.19 0.19 0.19 0.18 0.19 0.19 0.18 0.18 0.19 6.87 
6.92 -2% mP1B-375mg/L 0.18 0.19 0.19 0.18 0.18 0.19 0.18 0.19 0.18 0.19 6.84 
mP1C-375mg/L 0.21 0.19 0.19 0.19 0.19 0.19 0.27 0.11 0.18 0.19 7.06 
mP2A-750mg/L 0.00 0.00 0.00 -6.36 0.22 0.23 0.22 0.23 0.23 0.23 8.38 
7.61 -12% mP2B-750mg/L 0.19 0.18 0.18 0.19 0.20 0.18 0.20 0.18 0.19 0.18 6.91 
mP2C-750mg/L 0.21 0.21 0.20 0.20 0.22 0.20 0.20 0.20 0.20 0.20 7.54 
mP3A-1500mg/L 0.17 0.17 0.17 0.17 0.17 0.18 0.16 0.17 0.18 0.18 6.36 
6.23 8% mP3B-1500mg/L 0.18 0.18 0.17 0.18 0.19 0.17 0.18 0.18 0.17 0.18 6.58 
mP3C-1500mg/L 0.17 0.15 0.15 0.14 0.16 0.16 0.15 0.16 0.15 0.17 5.76 
C2A 0.22 0.20 0.20 0.21 0.22 0.20 0.20 0.20 0.21 0.22 7.69 
7.32  C2B 0.20 0.21 0.20 0.20 0.21 0.20 0.20 0.20 0.20 0.20 7.46 
C2C 0.19 0.19 0.19 0.17 0.19 0.18 0.19 0.18 0.18 0.18 6.80 
PCA1A-750mg/L 0.21 0.20 0.21 0.15 0.21 0.19 0.21 0.19 0.21 0.20 7.32 7.32 -8% 
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Table B-27: mPCA#2 – SOUR & Heterotrophic Inhibition Calculations after 180-min Exposure 
Test Substance mg/L 
Heterotrophic Respiration 
SOUR mg 
O2/g-h 
Average 
SOUR, 
mg O2/g-
h 
% 
Heterotrophic 
Inhibition 
% 
Nitrification 
Inhibition  
Time, min 
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10 
C1N+ATU 0.09 0.08 0.09 0.07 0.09 0.09 0.09 0.09 0.09 0.09 3.22 3.22 -1%   
mP1AN-375mg/L+ATU 0.09 0.09 0.09 0.07 0.08 0.09 0.09 0.10 0.09 0.09 3.25 3.25 -2% -1% 
mP2AN-750mg/L+ATU 0.09 0.11 0.10 0.10 0.11 0.10 0.10 0.11 0.10 0.10 3.77 3.77 -19% -6% 
mP3AN-1500mg/L+ATU 0.10 0.11 0.10 0.10 0.10 0.10 0.11 0.10 0.09 0.10 3.73 3.73 -17% 31% 
C2N+ATU 0.08 0.09 0.08 0.09 0.09 0.08 0.09 0.08 0.08 0.09 3.14 3.14 1%   
         
Average Between C1 and C2= 6.80  mg O2/g-h 
 
         
Difference Between Controls= 15% 
  
         
LC50 from Reference Substance 4.41 mg/L 3,4 DCP 
 
         
Average Between C1N & C2N= 3.18  mg O2/g-h 
 
         
Difference Between C1N & C2N= 2% 
   
The crossed values were not in the linear part of the graph of the oxygen concentration versus time 
By adding allylthiourea (ATU), a known nitrification inhibitor, into the sample, the heterotrophic respiration can be measured. 
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Table B-28: Summary of the Variation in the PCA Test Results After 30 and 180-min of 
Exposure 
    30-min - mg O2/g-h 180-min - mg O2/g-h 
Sample Statistics PCA # replicates PCA # replicates 
Control 1 
mean 6.43 
3 
6.70 
3 std. dev. 0.40 0.62 
% CV 6% 9% 
1 mg/L 3,4 DCP 
mean 5.07 
3 
5.27 
3 std. dev. 0.33 0.44 
% CV 6% 8% 
10 mg/L 3,4 DCP 
mean 2.94 
2 
3.04 
3 std. dev. 0.03 0.32 
% CV 1% 11% 
100 mg/L 3,4 DCP 
mean 0.81 
3 
0.87 
3 std. dev. 0.19 0.25 
% CV 24% 28% 
15 mg/L PCA mean 6.77 1 6.76 1 
150 mg/L PCA mean 6.87 1 6.74 1 
1500 mg/L PCA 
mean 6.93 
3 
7.38 
3 std. dev. 0.21 0.50 
% CV 3% 7% 
Control 2 
mean 7.91 
3 
8.14 
3 std. dev. 0.54 0.67 
% CV 7% 8% 
Initial and final Controls 
mean 7.17 
3 each 
7.42 
3 each std. dev. 0.92 0.98 
% CV 13% 13% 
Control 1 + ATU mean 4.60 1 4.25 1 
15 mg/L PCA +ATU mean 4.89 1 4.99 1 
150 mg/L PCA +ATU mean 4.40 1 4.00 1 
1500 mg/L PCA +ATU mean 5.81 1 6.67 1 
Control 2 + ATU mean 4.75 1 4.34 1 
Initial and final Control + ATU  
mean 4.67 
1 each 
4.30 
1 each std. dev. 0.10 0.06 
% CV 2% 1% 
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Table B-29: Summary of the Variation of mPCA-1 and mPCA-2 Test Results After 30-min 
30-min - mg O2/g-h 
Sample Statistics mPCA-1 # replicates mPCA-2 # replicates 
Avg. Value of 
mPCA-1 and mPCA-
2 
Control 1 
mean 6.16 
3 
6.73 
3 
6.44 
std. dev. 0.15 0.30 0.38 
% CV 2% 4% 6% 
1 mg/L 3,4 DCP 
mean 4.56 
3 
4.94 
3 
4.75 
std. dev. 0.06 0.25 0.26 
% CV 1% 5% 6% 
10 mg/L 3,4 DCP 
mean 2.09 
3 
2.57 
3 
2.33 
std. dev. 0.02 0.20 0.30 
% CV 1% 8% 13% 
100 mg/L 3,4 DCP 
mean 0.41 
3 
0.54 
3 
0.48 
std. dev. 0.04 0.02 0.08 
% CV 9% 4% 16% 
15 mg/L mPCA mean 6.01 1 - - - 
150 mg/L mPCA mean 6.23 1 - - - 
375 mg/L mPCA 
mean - 
- 
7.10 
3 - std. dev. - 0.35 
% CV - 5% 
750 mg/L mPCA 
mean - 
- 
7.62 
3 - std. dev. - 0.77 
% CV - 10% 
1500 mg/L mPCA 
mean 5.67 
3 
6.75 
3 
6.21 
std. dev. 0.88 0.20 0.83 
% CV 16% 3% 13% 
Control 2 
mean 6.21 
3 
7.18 
3 
6.69 
std. dev. 0.33 0.47 0.64 
% CV 5% 7% 10% 
Initial and final Controls 
mean 6.18 
3 each 
6.95 
3 each 
6.57 
std. dev. 0.23 0.43 0.52 
% CV 4% 6% 8% 
Control 1 + ATU 
mean 3.21 1 3.58 1 3.40 
std. dev. - - - - 0.26 
% CV - - - - 8% 
15 mg/L mPCA +ATU mean 3.42 1 - - 
- 150 mg/L mPCA +ATU mean 3.87 1 - - 375 mg/L mPCA +ATU mean - - 3.44 1 
750 mg/L mPCA +ATU mean - - 4.25 1 
1500 mg/L mPCA +ATU 
mean 3.75 1 3.99 1 3.87 
std. dev. - - - - 0.17 
% CV - - - - 4% 
Control 2 + ATU mean 3.75 1 3.44 1 3.60 
    - 1 - 1 0.22 
    - 1 - 1 6% 
Initial and final Control + 
ATU  
mean 3.48 
1 each 
3.51 
1 each 
3.50 
std. dev. 0.38 0.10 0.02 
% CV 11% 3% 1% 
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Table B-30: Summary of the Variation of mPCA-1 and mPCA-2 Test Results After 180-
min 
180-min - mg O2/g-h 
Sample Statistics mPCA-1 # replicates mPCA-2 # replicates 
Avg. Value of 
mPCA-1 and 
mPCA-2 
Control 1 
mean 5.77 
3 
6.28 
3 
6.03 
std. dev. 0.70 0.27 0.55 
% CV 12% 4% 9% 
1 mg/L 3,4 DCP 
mean 4.49 
3 
5.00 
3 
4.75 
std. dev. 0.50 0.42 0.50 
% CV 11% 8% 10% 
10 mg/L 3,4 DCP 
mean 2.15 
3 
2.48 
3 
2.31 
std. dev. 0.15 0.22 0.25 
% CV 7% 9% 11% 
100 mg/L 3,4 DCP 
mean 0.44 
3 
0.68 
3 
0.56 
std. dev. 0.06 0.04 0.14 
% CV 13% 6% 25% 
15 mg/L mPCA mean 5.76 1 - - - 
150 mg/L mPCA mean 5.78 1 - - - 
375 mg/L mPCA 
mean - 
- 
6.92 
3 - std. dev. - 0.12 
% CV - 2% 
750 mg/L mPCA 
mean - 
- 
7.61 
3 - std. dev. - 0.74 
% CV - 10% 
1500 mg/L mPCA 
mean 4.67 
3 
6.23 
3 
5.45 
std. dev. 0.87 0.42 1.05 
% CV 19% 7% 19% 
Control 2 
mean 5.72 
3 
7.32 
3 
6.52 
std. dev. 0.08 0.46 0.92 
% CV 1% 6% 14% 
Initial and final Controls 
mean 5.74 
3 each 
6.80 
3 each 
6.27 
std. dev. 0.45 0.66 0.77 
% CV 8% 4% 12% 
Control 1 + ATU 
mean 3.15 1 3.22 1 3.18 
std. dev. - - - - 0.04 
% CV - - - - 1% 
15 mg/L mPCA +ATU mean 3.45 1 - - 
- 150 mg/L mPCA +ATU mean 3.34 1 - - 375 mg/L mPCA +ATU mean - - 3.25 1 
750 mg/L mPCA +ATU mean - - 3.77 1 
1500 mg/L mPCA +ATU 
mean 3.63 1 3.73 1 3.68 
std. dev. - - - - 0.07 
% CV - - - - 2% 
Control 2 + ATU mean 4.18 1.00 3.14 1 3.66 
    - 1 - 1 0.73 
    - 1 - 1 20% 
Initial and final Control + 
ATU  
mean 3.67 
1 each 
3.18 
1 each 
3.42 
std. dev. 0.72 0.05 0.34 
% CV 20% 2% 10% 
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Viability Test 
Table B-31: Colony Counts on Petri Dishes Using a Medium of R2A Agar after 7 Days 
Incubation 
Sample ID Dilution Vol. Sample Used, mL Replicate A Replicate B Average 
Total 
Count CFU/mL 
Control 10-3 0.10 >5700 >5700 - - - 
Control 10-4 0.10 56 58 57 250 2.5E+07 
Control 10-5 0.10 43 37 40 40 1.8E+07 
mPCA-750mg/L 10-3 0.10 >5700 >5700 - - - 
mPCA-750mg/L 10-4 0.10 61 55 58 254 2.5E+07 
mPCA-750mg/L 10-5 0.10 29 61 45 45 2.0E+07 
PCA-750mg/L 10-3 0.10 >5700 >5700 - - - 
PCA-750mg/L 10-4 0.10 57 60 58.5 257 2.6E+07 
PCA-750mg/L 10-5 0.10 - - - - - 
Sterile Ctrl - 0.10 1 0 0.5 1 5.00 
Close Ctrl - - 1 1 1 1  
 
  
169 
APPENDIX C: 
RAW DATA BIODEGRADATION TEST 
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Table C-1: Raw Data, Oxygen Concentrations (mg/L) - Biodegradation Test 1 
Day 0 4 7 11 14 21 28 
Date 10/26/2012 10/30/2012 11/2/2012 11/6/2012 11/9/2012 11/16/2012 11/23/2012 
Inoculated 
Control 
R 1 8.50 8.26 7.60 6.74 5.98 5.51 5.67 
R 2 8.52 8.27 7.67 6.86 6.17 5.40 5.47 
Mean 8.51 8.27 7.64 6.80 6.08 5.46 5.57 
2 mg/L mPCA 
R 1 8.54 N/A 7.91 N/A 6.24 5.39 5.50 
R 2 8.55 N/A 7.94  N/A 6.42 5.60 5.57 
Mean 8.55 N/A 7.93  N/A 6.33 5.50 5.54 
5 mg/L mPCA 
R 1 8.54 8.31 7.94 7.10 6.34 5.65 5.30 
R 2 8.53 8.33 7.87 7.18 6.39 5.73 5.87 
Mean 8.54 8.32 7.91 7.14 6.37 5.69 5.59 
2 mg/L PCA 
R 1 8.49 N/A 7.81 N/A 4.46 3.47 3.02 
R 2 8.49 N/A 7.89 N/A 4.78 3.35 3.16 
Mean 8.49 N/A 7.85 N/A 4.62 3.41 3.09 
5 mg/L PCA 
R 1 8.51 8.31 7.73 6.00 2.65 0.95 0.18 
R 2 8.51 8.33 7.95 5.88 2.97 0.79 0.11 
Mean 8.51 8.32 7.84 5.94 2.81 0.87 0.15 
KHP & MPCA 
R 1 8.51 N/A 4.85 N/A N/A N/A N/A 
R 2 8.53 N/A 4.82 N/A N/A N/A N/A 
Mean 8.52 N/A 4.84 N/A N/A N/A N/A 
KHP & PCA 
R 1 8.48 N/A 3.90 N/A N/A N/A N/A 
R 2 8.49 N/A 3.88 N/A N/A N/A N/A 
Mean 8.49 N/A 3.89 N/A N/A N/A N/A 
KHP 
R 1 8.52 5.55 4.82 3.65 2.89 2.46 1.89 
R 2 8.53 5.67 4.79 3.80 3.09 2.32 2.65 
Mean 8.53 5.61 4.81 3.73 2.99 2.39 2.27 
Blank Control   8.42 8.32 8.17 8.00 7.94 7.68 7.91 
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Table C-2: Raw Data, Oxygen Concentrations (mg/L) - Biodegradation Test 2 
Day 0 7 14 20 27 
Date 11/30/2012 12/7/2012 12/14/2012 12/20/2012 12/27/2012 
Inoculated Control 
R 1 9.08 8.76 8.05 6.88 6.75 
R 2 9.08 8.75 8.21 6.95 6.83 
Mean 9.08 8.76 8.13 6.92 6.79 
Inoculated Control 
+ NI 
R 1 9.08 8.84 8.71 8.62 8.50 
R 2 9.08 8.77 8.69 8.61 8.58 
Mean 9.08 8.81 8.70 8.62 8.54 
2 mg/L mPCA 
R 1 9.09 8.70 7.86 6.96 6.80 
R 2 9.08 8.72 8.07 6.88 6.73 
Mean 9.09 8.71 7.97 6.92 6.77 
2 mg/L mPCA + NI 
R 1 9.10 8.84 8.77 8.52 8.42 
R 2 9.10 8.89 8.73 8.64 8.50 
Mean 9.10 8.87 8.75 8.58 8.46 
2 mg/L PCA 
R 1 9.08 8.74 7.62 6.08 5.41 
R 2 9.08 8.76 7.65 5.57 5.37 
Mean 9.08 8.75 7.64 5.83 5.39 
2 mg/L PCA + NI 
R 1 9.08 8.86 8.76 8.60 6.84 
R 2 9.08 8.88 8.63 8.14 7.02 
Mean 9.08 8.87 8.70 8.37 6.93 
KHP 
R 1 9.02 6.24 5.22 3.95 3.82 
R 2 9.02 6.11 5.32 4.05 3.89 
Mean 9.02 6.18 5.27 4.00 3.86 
Blank Control  9.07 8.82 8.70 8.45 8.40 
NI: Nitrification Inhibitor 
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Table C-3: Nitrate and Nitrite Measurements: Correction for Nitrification of the Test Substance 
Day 14 Day 21 Day 28 
Sample ID Blank 5 PCA 5 PCA 2 PCA 2 PCA Blank Blank 2 PCA 2 PCA 5 PCA 5 PCA Blank Blank 2 PCA 2 PCA 5 PCA 5 PCA 
Concentration of 
Nitrate in 
sample(mg N/L) 
0.4 0.4 0.4 0.3 0.4 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 
Average (mg N/L) 0.4 0.4 0.35 0.55 0.5 0.5 0.5 0.45 0.5 
Change Nitrate 
Concentration (mg 
N/L) 
- - - - - 0.15 0.1 0.15 -0.05 -0.05 0 
Oxygen Eq 
(4.57*N*V) (mg/L) - - - 0.21 0.14 0.21 -0.07 -0.07 0.00 
Concentration of 
Nitrite in sample 
(mg N/L) 
0.003 0.004 0.007 0.019 0.009 0.002 0.002 0.003 0.002 0.003 0.002 0.004 0.004 0.004 0.004 0.004 0.004 
Average, (mg N/L) 0.003 0.006 0.014 0.002 0.003 0.003 0.004 0.004 0.004 
Change Nitrite 
Concentration (mg 
N/L) 
- - - - - -0.001 -0.003 -0.012 0.002 0.002 0.002 
Oxygen Eq 
(3.43xNxV) (mg/L) - - - -0.001 -0.003 -0.012 0.002 0.002 0.002 
Total O2 eq (mg/L) - - - 0.205 0.134 0.194 -0.066 -0.067 0.002 
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APPENDIX D:  
SAMPLE CALCULATIONS 
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Sample Calculations Respiration Inhibition Test 
Sample Calculation using mPCA-2 data set: 
1. Activated Sludge MLSS:  3.38 g/L 
2. To prepare 1.6 g/L in 500 mL total volume use of the AS samples was 240 mL 
240 𝑚𝐿 ∗ 3.38𝑔
𝐿
𝑀𝐿𝑆𝑆 ∗
1500𝑚𝐿 = 1.622𝑔𝐿 𝑀𝐿𝑆𝑆  
3. After Exposing the microbes for 180-min the DO concentrations were collected for ten 
minutes at one minute intervals, the initial and final concentrations are presented below: 
a. Oxygen concentration at time zero= 8.42 mg/L 
b. Oxygen concentration after 10-min = 6.52 mg/L 
4. Graph all DO measurements in the 10-min  interval in a DO vs. Time graph 
 
y = -0.1904x + 8.4273 
R² = 0.9999 
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
0 2 4 6 8 10 12
DO
, m
g/
L 
Minutes 
DO Concentration vs Time  
Linear (Series1)
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From visual inspection of the graph and the R2 value, it can be seen that all measurements for the 
sample C1A are within the linear portion of the curve; therefore, all points will be used for the 
calculations 
5. Number of measurements: 10 (Δt) 
6. Determination of the specific oxygen uptake rate (SOUR) mg O2/g-h for the sample C1A:  
𝑆𝑂𝑈𝑅 mg∗O2
g−h
= ((8.42 − 6.52)mg/L)/(10min ∗ 1.622 g/L) ∗ (60min)/(1hr) = 7.03  
7. Following the same steps C1B, and C1C were calculated as 6.73 and 6.43 mg∗O2
g−h
 
8. The average SOUR from the initial control replicates is  
7.03 + 6.73 + 6.433 = 6.73 mg ∗ O2g − h  
9. The average value for the final control replicates is  
7.18 mg ∗ O2g − h  
10. Find the average from the initial and final sets of controls 
6.73 + 7.182 �mg ∗ O2g − h � = 6.95 mg ∗ O2g − h   
11. If the average SOUR for the three replicate of sample mP2 (mPCA at 750 mg/L) is 
known (7.62mg∗O2
g−h
) the total percentage inhibition can be estimated as follows using 
Equation (3-2: 
IT= [1-(7.62 mg∗O2g−h )/(6.95 mg∗O2g−h ) ] = -10% 
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12. If the same process is performed for the samples containing ATU, the heterotrophic 
respiration can be estimated as follows 
a. mPCA2AN sample (mPCA at 750 mg/L+ATU) SOUR  
4.25 mg∗O2
g−h
 
b. Average between initial and final controls containing ATU 
3.51 mg∗O2
g−h
 
c. Heterotrophic Respiration Inhibition using Equation (3-4: 
𝐼𝐻 = 1 − 4.253.51 �mg ∗ O2g − h � = −21% 
13. Knowing the heterotrophic respiration and the total respiration, the nitrification inhibition 
can be determined using Equation (3-3: 
a. 𝐼𝑁 = 1 − (7.62 − 4.25)/(6.95 − 3.51) mg∗O2g−h   = 2%  
There was only 2% respiration inhibition in the nitrification respiration at 750 
mg/L of mPCA. 
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Sample Calculations: Heterotrophic Plate Count – Viability Test 
Calculations for the control sample with 10-4 dilution 
1. Using 0.1 mL from the prepared 10-4 dilution for the reactor used as a blank control in the 
inhibition test. 
a. After incubation for 7 days at 27 °C, count the number of colonies in 13 squares 
(1 cm2 each) seven horizontal and 6 vertically (Table B-31) . 
Replicate A: 56 
Replicate B: 58 
b. Find the average between both replicates: 
Average = 𝑅𝑒𝑝𝑙𝑖𝑐𝑎𝑡𝑒 𝐴+𝑅𝑒𝑝𝑙𝑖𝑐𝑎𝑡𝑒 𝐵
2
= 56+58
2
= 57 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 
c. Surface area of disposable plastic petri dishes: 57 cm2 
d. Factor of the area of the 13 squares in which colonies were counted to the total 
area of the petri dish: 
Factor = 𝐴𝑟𝑒𝑎 𝑝𝑒𝑡𝑟𝑖 𝑑𝑖𝑠ℎ
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑 = 57 𝑐𝑚213 𝑐𝑚2 = 4.38 
e. Total count: 
Total Count= 𝐴𝑣𝑔 𝐶𝑜𝑙𝑜𝑛𝑖𝑒𝑠 ∗ 𝐹𝑎𝑐𝑡𝑜𝑟 = 57 Colonies * 4.38= 250 
f. Using Equation (3-6, the CFU/mL is determined as follows: 
𝐶𝐹𝑈
𝑚𝐿
= 2500.1 ∗ 110−4 = 2.5𝑋107 
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Sample Calculations: Determination of The Percentage Degradation of PCA and mPCA 
1.  Find the theoretical oxygen demand (ThOD) for PCA using Equation (3-7. The ThOD 
values are summarized in Table 4-9.  
𝑇ℎ𝑂𝐷𝑃𝐶𝐴 = 1.84 𝑚𝑔 𝑂2/𝑚𝑔 𝑃𝐶𝐴 
2. Using Equation (3-9 the biological oxygen demand on the PCA sample subtracting the 
oxygen demand in the controls after 28 days can be determined as follows: 
𝐵𝑂𝐷28,𝑚𝑔 𝑂2𝑚𝑔 𝑇𝑆 = (8.49 − 3.09)((𝑚𝑔 𝑂2)/𝐿 )  − (8.51 − 5.57)((𝑚𝑔 𝑂2)/𝐿 )2 𝑚𝑔 𝑃𝐶𝐴= 1.23 ((𝑚𝑔 𝑂2)/𝐿 )/(𝑚𝑔 𝑃𝐶𝐴) 
3. From Equation (3-10, the percent degradation is calculated: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 = 1.23 ((𝑚𝑔 𝑂2)/𝐿 )/(𝑚𝑔 𝑃𝐶𝐴)1.84 ( 𝑚𝑔 𝑂2)/𝐿/(𝑚𝑔 𝑃𝐶𝐴) 𝑥 100 = 66.8%   
From the oxygen depletion in the 2 mg/L PCA sample, 66.8 % degradation relative to its ThOD 
was observed.  
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